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The nicotinic acetylcholine receptor (nAChR) mediates fast signal transduction in peripheral and 
central nervous systems. It is a pentameric ion channel that belongs to the Cys-loop receptor 
superfamily. nAChR is one of the plausible targets for general anesthetics. The current concern 
about nAChR is ambivalent structures of the transmembrane (TM) domain, missing information 
for the intracellular (IC) domain and elusive mechanisms of the action of general anesthetics. 
Therefore, this thesis focuses on the following two important aspects: first, the structure and 
dynamics of the nAChR TM and IC domains; and second, general anesthetic effects on various 
proteins. 
 Part I. The secondary structure of human nAChR α7 TM domain and the monomeric 
tertiary structure of the water-soluble mutant of nAChR α1 TM domain from the Torpedo 
electrical ray were determined by NMR. The structures among WSA, nAChR α7, and a bacterial 
analogue of the pentameric channels (GLIC) are similar, but different from the cryo-EM structure 
of the nAChR. The backbone dynamics analyses of human nAChR α7 with and without the IC 
domain suggest that the presence of IC domains dramatically affected the intrinsic dynamics of 
the TM domains. 
Part II. The general anesthetic effects on the structure and dynamics of the proteins 
including two analogues and a real anesthetic target in non-channel and channel-like oligomers 
were studied. It revealed that general anesthetics prefer amphipathic environments. Compared 
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to the effect on the structures of proteins, general anesthetics show stronger effect on the 
dynamics. The effect on the dynamics of proteins can manifest directly or allosterically. 
Part III. The anesthetic effects on the Na+ flux through the reconstituted channels of 
nAChR TM domains were investigated by fluorescence microscopy. The anesthetic effects on 
them are the same as on the full-length nAChR. This indicates that the studies of anesthetic 
effects on the TM domains of nAChR are functional relevant. 
In summary, this dissertation clarifies the current structural ambiguities, provides 
additional invaluable dynamic information for the TM and IC domain and reveals the possible 
mechanism of action of general anesthetics. 
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CHAPTER 1 
 INTRODUCTION AND 
BACKGROUND 
1.1 FIELDS OF STUDIES 
1.1.1 Membrane proteins 
Membrane proteins are proteins located in the biological membranes and interact or 
associate with membrane lipids. It is estimated that more than 30% of the proteins in 
cells are membrane proteins, which play a vital role in the biological functions 1. 
Membrane proteins can be simply divided into two classes, integral membrane proteins 
(IMPs) and peripheral membrane proteins (PMPs). IMPs are usually deeply buried in the 
phospholipids of the membranes with their one or more membrane-spanning domains 
(TM domains). On the contrary, PMPs do not enter the hydrophobic cores formed by the 
phospholipids and they usually interact with the IMPs or the polar head groups of the 
membrane lipids. Until now, the membrane-spanning domains of the IMPs were found to 
be α helices or multiple β strands. These TM domains contain the hydrophobic residues, 
which interact with the hydrophobic core of the membrane lipids. Above 50% of the 
membrane proteins in the cells are predicted to be pharmaceutical targets 2. Knowing 
their structures and dynamics can help us to understand their important intrinsic 
functions. However, less than 1% of the deposited protein structures in the Protein Data 
CHAPTER 1  INTRODUCTION AND BACKGROUND 
 2	  
Bank (PDB) are membrane proteins. The low percentage of resolved structures reflects 
the difficulties of the structure determination for membrane proteins. Membrane proteins 
are usually very hard to be expressed and purified. After they are solubilized in the 
detergent micelles from the membrane lipid, membrane proteins are often misfolded and 
lose their native function. Therefore, how to perform structural studies on membrane 
proteins is a very challenging task.  
1.1.2 Nicotinic acetylcholine receptors 
Acetylcholine receptors are IMPs, which respond to the binding of the neurotransmitter 
acetylcholine. Based on their different responses to nicotine and muscarine in addition to 
the acetylcholine, acetylcholine receptors are classified into two receptor types, nicotinic 
acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors (mAChRs). 
nAChRs belong to ligand-gated ion channels and are members of a superfamily of Cys-
loop receptors that contain a characteristic loop formed by a disulfide bond between two 
cysteines. mAChRs are G protein-coupled acetylcholine receptors. In addition to 
acetylcholine receptors, the cys-loop receptor superfamily also includes glycine (Gly), γ-
aminobutyric acid (GABAA and GABAC) and serotonin (5-HT3) receptors. Based on their 
different expression sites at neuromuscular junction or nerve synapse, nAChRs can be 
generally divided into two subtypes: muscle type and neuronal type.  
Neurotransmitters, such as acetylcholine, are packaged in vesicles inside a 
presynaptic neuron. When the neuron is activated, these IC vesicles fuse with the 
neuron membrane and release the neurotransmitters into the synaptic cleft. Once the 
neurotransmitter is released in the synapse, it may diffuse across the synapse and bind 
to its receptor, such as nAChR on the postsynaptic membrane. However, the 
acetylcholine may also diffuse back to the presynaptic neuron and bind to a presynaptic 
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receptor to further modulate the release of neurotransmitters. Other events can also 
happen. For example, the neurotransmitters may be chemically altered by an enzyme in 
the synapse, or may be transported into a nearby cell. The binding of an acetylcholine to 
its receptor plays a very important role for the nAChR to mediate the fast synaptic 
transmission of electrical signals. It is also a key event in the action of many other 
neurotransmitters. The response of nAChR to acetylcholine is referred to as ‘fast-acting’ 
because the cellular effect occurs in the millisecond timescale after the acetylcholine 
binds to the nAChR. It has been proposed that the binding of acetylcholine to the nAChR 
could induce a conformational change of the receptor and thus allow sodium ions to flow 
inside the neuron through modulating the channel state. It also causes the depolarization 
of the cell, which could further result in the continuous nerve impulse.  
The atomic structure of nAChR has been a hot topic in structural biology for a 
long time and several key breakthroughs have emerged recently. X-ray structures of 
homologues of the extracellular domain (ECD) of nAChRs from acetylcholine binding 
proteins (AChBPs) and the ECD of α1-nAChR have been solved. These crystal 
structures give us atomic structural information for the ECD 3-6. The Torpedo marmorata 
nAChR, solved by electron microscopy at 4 Å resolution, provides additional structure 
information about the TM and partial IC domains 7,8. Until very recently, the prokaryotic 
pentameric ligand-gated ion channel (pLGIC) from the bacterium Erwinia chrysanthemi 
(ELIC) and the bacterial Gloeobacter violaceus pLGIC homologue (GLIC) have been 
solved by X-ray at atomic resolution 9-11. nAChRs are typically homo-pentameric or 
hetero-pentameric ion channels with a molecular mass of ~290 kDa 12. Each subunit 
includes a large N-terminal ECD, a TM domain and a large IC domain. The ECD is 
mainly composed of β sheets 5. They are divided into two groups, outer sheets and inner 
sheets, based on their relative position to the central pore. Two sheets are connected by 
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the characteristic loop formed by a disulfide bond between two cysteines in each sheet. 
The ECD is the main target of various ligands 13. On the contrary, α-helix is the main 
component of the TM domain 7. Each TM domain is formed by four TM α helices. Along 
these helices, TM2s from each subunit join together to form the central pore, while TM1, 
TM3 and TM4 form another two concentric circles. The conserved pore lining residues 
are located in the TM2 domain; these residues are responsible for the ion selectivity and 
conductivity 7. Until now, the understanding of the structure of the IC domain has been 
limited due to the lack of any atomic structure information of the IC domain. Previous 
studies on the IC domain suggest that this domain plays an important role in interaction 
with IC proteins, receptor targeting and ion channel properties 14-20.  
1.1.3 General anesthetics and mechanisms of general anesthesia 
Anesthetics are drugs that can cause anesthesia, temporary loss of consciousness or 
sensation, thereby allowing a patient to undergo surgery without suffering. Anesthetics 
can be categorized into two classes based on their effects: general anesthetics and local 
anesthetics. General anesthetics cause a reversible loss of consciousness (general 
anesthesia), while local anesthetics result in a reversible loss of sensation in a local 
region without loss of consciousness. General anesthetics are a diverse range of 
molecules, from structurally featureless gases to complex steroids. They are further 
classified roughly into two types, inhalational anesthetics and intravenous anesthetics, 
based on the anesthetics’ mode of administration. Inhalational anesthetics are volatile 
liquids or gases such as halothane and isoflurane and are usually delivered by an 
anesthesia machine. Intravenous anesthetics, such as etomidate, are administrated by 
injection.  
CHAPTER 1  INTRODUCTION AND BACKGROUND 
 5	  
General anesthetics render people into a state of unconsciousness known as 
general anesthesia and have been widely used in modern medicine; however, the 
molecular processes underlying general anesthesia remain largely unclear 21-27. Two 
distinct hypotheses, the lipid hypothesis and the membrane protein hypothesis, have 
been proposed. In the lipid hypothesis, nonspecific anesthetic-lipid interaction in the 
central nervous system may alter the property of membrane lipids. This change in the 
membrane could impact the response of neuronal membrane proteins. Although 
modulation of neuronal protein functions through nonspecific anesthetic perturbation to 
the lipids remains a distinct possibility, the current consensus is the protein hypothesis 
that anesthetic molecules interact specifically with proteins. It was first evidenced by 
observation of anesthetic effects on several water-soluble proteins that anesthetics can 
directly modulate their native function. For example, luciferase is in the class of oxidative 
enzymes, which are used by bioluminescent animals and bacteria to produce light. It 
was found that general anesthetics could inhibit these proteins through directly 
interacting with specific hydrophobic residues of luciferase 28. General anesthetics’ 
ability to inhibit proteins was directly correlated with their anesthetic potencies 29. From 
these studies on the water-soluble proteins, it was found that general anesthetics bind to 
preexisting pockets with amphiphilic environments that exist within protein monomers or 
the interface between subunits 29,30. The binding of anesthetics does not induce major 
changes in protein structure 31-34. Although general anesthetics can directly interact with 
water-soluble proteins, providing detailed information about the molecular interaction 
characters and protein motifs, these proteins are often not physiologically relevant. It has 
been demonstrated that neurotransmitter-gated ion channels, particularly Cys-loop 
receptors, are plausible targets for general anesthetics in the central nerve system 21,30. 
nAChRs are one of the potential targets, along with receptors for GABAA, glycine, and 
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5HT3. A wealth of electrophysiology experiments showed that the nAChR could be 
inhibited by general anesthetics 35-37. By anesthetic direct photoaffinity labeling of the 
nAChR, the TM domains (TM1, TM2, and TM3) were identified to be the targets of 
inhalational anesthetics 38. Due to a fundamental resolution limit on the photoaffinity 
labeling method, the anesthetic binding sites were not determined. Most important, how 
anesthetics specifically interact with proteins, and thus alter the protein’s native function 
remain unclear. The specific interaction sites between general anesthetics and nAChR 
are critical for anesthetic actions 39. NMR is a very powerful tool to study the mechanism 
of anesthetic effects on nAChR. It can offer not only the high-resolution picture with 
regard to the anesthetic binding sites, but also the unique dynamic information that 
corresponds to the protein critical function. In our group, advanced NMR techniques 
have been applied to the study of the anesthetic effects on various proteins including 
nAChRs 25,26,40-46. Based on our studies, we have hypothesized that the anesthetics alter 
the target protein’s biological function through specifically interacting with their targets 
and modulating the targets’ global dynamics.  
1.2 GOALS AND ACCOMPLISHMENTS 
1.2.1 Open questions and significance 
Several questions warrant further investigation. First, emerging structural studies 7-11 on 
the nAChR provide certain structural details. However, their limited resolutions in the 
case of the cryo-electron microscopy (cryo-EM) structure model from Torpedo electric 
ray or low sequence identities between the nAChR and recently published ELIC and 
GLIC structures from X-ray are inadequate to provide the structural basis for nAChR. 
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Second, by closely comparing the structures in the TM domains (TMs) along these 
proteins, the TM domain structures obtained from ELIC and GLIC are not consistent with 
the cryo-EM model structure form the torpedo nAChR. The differences exist particularly 
in the TM2 domain and its related loops. Third, both the cryo-EM model structure and X-
ray structures have failed to provide complete information about the IC domain. The 
present structural studies on the nAChRs not only clarify the current ambiguities and 
provide more structural details including the TM domains and the IC domain, but also 
offer additional invaluable dynamic information of the nAChR. The high-resolution 
structures, plus detailed backbone dynamic information, will finally allow us to 
understand the important channel function of nAChR. 
Much evidence suggests that the nAChR is one of the potential molecular targets 
for the general anesthetics 35-37. However, there is no comprehensive understanding of 
how general anesthetics modulate the structure and the dynamics of the nAChR at the 
molecular level, and ultimately modulate the protein function. In my current studies, 
general anesthetic effects on various proteins were intensively studied by multiple 
biophysical methods. These proteins ranged from a water-soluble protein to a 
membrane protein, from an analogue to a real anesthetic target, from a ‘non-channel’ 
monomer to a ‘channel-active’ oligomer. The results from these studies further enrich 
our understanding of the mechanism of general anesthetic effects. 
1.2.2 Strategies 
Two specific constructs, the nAChR α1 subunit from torpedo and the α7 subunit from 
human, were reconstituted for structural studies.  
The previous cryo-EM study 7,8 on the nAChR showed different results from the 
new published X-ray structures of GLIC and ELIC 9-11. Three possible reasons could be 
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responsible for this difference. First, the sequence similarity between nAChR and 
GLIC/ELIC is low, even though GLIC/ELIC are considered to be analogues of the ligand-
gated ion channels. The poor sequence identity may give rise to the structural 
difference. Second, the full-length nAChR structure of torpedo includes an IC domain, 
while GLIC and ELIC do not contain an IC domain. The presence of an IC domain in the 
torpedo nAChR could cause the structural difference between nAChR and GLIC/ELIC. 
However, the most distinct structural difference among them is at the TM23 loop, which 
is far away from the IC domain. Therefore, it is unlikely that the absence of the IC 
domain can cause the structural difference. Last, the structure of torpedo nAChR 
represents a closed state, which is different from GLIC. GLIC is in the open state. The 
different states may cause the structural difference between GLIC and torpedo nAChR. 
ELIC is also considered in a closed state. However, the artifacts from crystallization may 
contribute to the difference between ELIC and nAChR. In consideration of the size 
limitation of protein NMR, we only focused on the TM domain of nAChR from torpedo in 
the present study. The EC domain and IC domain were truncated and a five-glycine link 
was used to replace the entire IC domain. Since the resulting protein has the same 
sequence and no IC domain, the structure determination of this resulting protein can 
address the structural difference between nAChR and GLIC/ELIC. In practice, however, 
structure determination of mammalian membrane proteins is challenging due to a low 
expression level, unpredictable folding, and poor protein stability. In order to overcome 
these critical issues, a novel water solubilization approach was applied. In such a way, 
the membrane protein was transformed into a completely or partially water-soluble 
protein, while retaining its original structure and important function. The new redesigned 
nAChR is suitable for structure determination by solution-state NMR. 
The structure study of the IC loop domain was performed on the human nAChR 
α7. Two protein constructs, the TM domain only and the TM domain plus the full-length 
CHAPTER 1  INTRODUCTION AND BACKGROUND 
 9	  
IC domain, were prepared. The water solubilization approach was only applied to the TM 
domain and the IC loop domain remained unchanged. Through studying the human 
nAChR α7 in the presence and absence of the IC domain, we not only can obtain 
structural information about the IC domain, but also confirm the structures of the TM 
domains for nAChR α1 subunit, GLIC and ELIC. Further, the IC domain effects on the 
TM domain can also be addressed. 
For the study of the mechanism of general anesthesia, we focused on three 
distinct proteins. 
 nAChR is a potential anesthetic target, however, as a membrane protein, 
nAChR is usually difficult to study directly. The water-soluble dimeric protein (A α2-
L1M/L38M)2  was engineered to simplify this study by de novo design, which mimics the 
nAChR with a long hydrophobic core within a ubiquitous four-α-helix bundle scaffold. 
More importantly, this four-α-helix bundle also has an anesthetic binding affinity in the 
range of clinical volatile anesthetic concentration. Therefore, (Aα2-L1M/L38M)2 is 
regarded as a suitable model for the study of general anesthetic effect.  
It has been shown that general anesthetics are presumed to binding to the TM 
domain of nAChR 38. A membrane model protein (membrane integrating sequence for 
translation of integral membrane protein constructs, or Mistic) shares a four-α-helix 
bundle structural motif with the TM domain of nAChR. Mistic was chosen as a model of 
the target of general anesthetics not only because it naturally folds into a four-α-helix 
bundle motif in micelles, but also the structure of Mistic has been previously determined 
by NMR spectroscopy in lauryl dimethylamine oxide (LDAO) micelles, which will simplify 
our research 47. 
Neuronal α4β2 nAChR is one of the receptor subtypes that are hypersensitive to 
general anesthetics. It is also one of the most abundant nAChR subtypes in the brain. 
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Despite ample evidence showing that general anesthetics could alter α4β2 nAChR 
functions, it remains largely unclear at a molecular level how anesthetics perturb the 
protein structures and dynamics that ultimately affect the protein functions. It has been 
reported that the TM2 domains of nAChR themselves can form an authentic channel 48. 
Due to the size limitation of protein NMR, we focused on the most relevant TM2 domains 
of neuronal α4β2 nAChR, instead of the full-length protein.  
TM domains are the presumed anesthetic binding sites 38. In electro-
physiological experiments, the functional studies indicate that the full-length neuronal α7 
nAChR is insensitive to general anesthetics, while the neuronal α4β2 is sensitive to 
general anesthetics 35. Therefore, we hypothesize that the general anesthetics may 
directly interact with the TM domains and be capable of modulating the channel function 
of the TM domains even without the EC and IC domains. The TM domains of neuronal 
α4β2 and α7 were separately reconstituted into lipid vesicles. The channel activity was 
monitored using fluorescence microscopy. 
1.2.3 Summary of achievements 
Structure Determination 
Monomeric structures of water-solubilized nAChR TM domains, WSA, were 
solved to a backbone RMSD of ~1.1 Å. The overall structure of WSA is similar to the 
GLIC rather than the cryo-EM model of torpedo nAChR. The very short TM2-TM3 loop 
(VPLI) in the cryo-EM structure was replaced by a significantly longer loop (LIPSTSSA) 
and shifted by five residues towards the TM2 domain in both WSA and GLIC. More 
interestingly, the structure and dynamics obtained from the solution sample provide 
additional details. For example, STSSA in loop23 exists in two conformations: a rigid 
distorted helix and a flexible coil, and these two conformations are in slow exchange on 
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the NMR timescale. Given that the interaction between the TM23 loop and the EC 
domain likely mediates channel gating, the two conformations in this important loop 
might represent the critical transitions required for the channel to open. 
Human nAChR α7 TM domains with (nAChRα7TM-IC) and without the IC domain 
(nAChRα7TM-5G) were successfully heterologously over-expressed in E. coli. The 
expression yield for these proteins were 5 mg/l and 10 mg/l, respectively, in M9 media. 
The secondary structures of our recombinant proteins have been investigated by circular 
dichroism (CD). Both nAChRα7TM-IC and nAChRα7TM-5G folded into stable structures 
in ~1% empigen with helical content of 41% and 50%, respectively. Highly resolved 
NMR HSQC spectra for the two proteins have been obtained. Both CD and NMR spectra 
suggest that the expressed proteins are well folded. Furthermore, backbone dynamics 
R1, R2, and heteronuclear NOE were performed and qualitatively analyzed using the 
histogram method. The comparison of the backbone dynamics of these two proteins 
indicates that the IC domain dramatically affects the intrinsic dynamics of the TM domain 
and makes the TM domain much more flexible.  
In summary, the NMR studies on both monomeric WSA and nAChRTM-5G/IC 
are consistent with the X-ray results of GLIC 9,11. All of them differ from the cryo-EM 
model structure of nAChR from torpedo with regard to the length of the helix and the 
loop positions 7,8. The new findings from our studies not only clarify the discrepancies 
among several structures and offer more structural details, but also provide invaluable 
dynamic information for both the TM domain and the IC loop domain, which is missing 
from both the cryo-EM and X-ray structures. 
Anesthetic-protein interaction 
The high-resolution structure of (Aα2-L1M/L38M)2 in the presence of halothane, a 
clinically used volatile anesthetic, was determined by NMR. The 1.8 Å resolution 
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structure (2JST) confirmed that the primary halothane binding site is located between 
two side-chains of W15 from each monomer. While halothane produces minor changes 
in the monomer structure, the quaternary arrangement of the dimer is shifted by about 
half a helical turn and twists relative to each other, leading to the closure of the lateral 
access pathway to the binding site. Dynamics studies confirm that the anesthetics make 
the helix regions more ordered and at the same time suppress the conformational 
exchange term (Rex) at several residues. Our results revealed a novel mechanism of an 
induced fit between the anesthetic molecule and its protein target, with the direct 
consequence being the change in protein dynamics on a global rather than a local scale. 
This mechanism may be universal for anesthetic action on neuronal proteins. 
NMR studies of anesthetic halothane interaction with the membrane protein 
Mistic in DPC micelles provide an experimental basis for understanding molecular 
mechanisms of general anesthesia. Although the presence of halothane had little effect 
on Mistic structure, 
15
N NMR relaxation dispersion measurements revealed that 
halothane affected Mistic’s motion on the microsecond−millisecond time scale. The 
motion on the microsecond−millisecond time scale in several residues disappeared in 
response to the addition of halothane. Most of the residues experiencing halothane-
induced dynamics changes also exhibited profound halothane-induced changes in 
chemical shift, suggesting that dynamics modification of these residues might result from 
their direct interaction with halothane molecules. Allosteric modulation by halothane was 
also found to contribute to the dynamics changes, as reflected in residues I52 and Y82 
where halothane introduction brought about dynamics changes but not chemical shift 
changes. The study suggests that inhaled general anesthetics could act on proteins via 
altering protein motion on the microsecond−millisecond time scale, especially motion in 
the flexible loops that link different alpha helices. The validation of anesthetic effect on 
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protein dynamics that are potentially correlated with protein functions is a critical step in 
unraveling the mechanisms of anesthetic action on proteins. 
The structure, topology, and dynamics of the α4 TM2 and (α4)2(β2)3 TM2 in 
magnetically aligned phospholipid bicelles were investigated using solid-state NMR 
spectroscopy in the absence and presence of halothane and isoflurane, two clinically 
used volatile anesthetics. 2H NMR demonstrated that anesthetics increased lipid 
conformational heterogeneity. Such anesthetic effects on lipids became more profound 
in the presence of TM proteins. PISEMA experiments on the selectively 15N-labeled α4 
TM2 showed that the TM2 formed TM helices with tilt angles of 12° and 16° relative to 
the bicelle normal for the α4 and (α4)2(β2)3 samples, respectively. Anesthetics changed 
the tilt angle of the α4 TM2 from 12° to 14°, but had only a subtle effect on the tilt angle 
of the (α4)2(β2)3 TM2. A small degree of wobbling motion of the helix axis occurred in the 
(α4)2(β2)3 TM2. In addition, a subset of the (α4)2(β2)3 TM2 exhibited counterclockwise 
rotational motion around the helix axis on a time scale slower than 10–4 s in the presence 
of anesthetics. Both helical tilting and rotational motions have been identified 
computationally as critical elements for ion channel functions 49. This study suggested 
that anesthetics could alter these motions in order to modulate channel functions. 
The anesthetic effects on the Na+ flux through the reconstituted channels of 
nAChRs were investigated by fluorescence microscopy. Two sub-types of human 
nAChRs, α4β2 and α7, were studied. For the TM domains of nAChR α4β2, the apparent 
flux rates were distributed between 0.5 s-1 and 3.5 s-1 in the absence of isoflurane. The 
flux rates were obviously decreased by the addition of the isoflurane. This suggests that 
the general anesthetics did inhibit the channel function. However, for the TM domains of 
nAChR α7, there was no difference with or without the addition of the isoflurane. The TM 
domains of α7 were therefore determined to be insensitive to isoflurane. The anesthetic 
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effects on the truncated nAChR with TM domains only are the same as on the full-length 
nAChRs. This indirectly proves that the TM domains are probably the main targets of 
general anesthetics. 
In conclusion, anesthetic effects on various proteins were examined through 
multiple biophysical methods. The structural and dynamical analysis of these proteins 
indicate that anesthetics not only directly interact with the proteins and alter the 
dynamics of the specific residues within the binding sites, but also allosterically regulate 
the dynamics of the residues in other regions. Anesthetics have more obvious effects on 
the dynamics rather than the structures of the target proteins. The allosteric effects and 
dynamic changes caused by general anesthetics may be critical to the anesthetic effect.  
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CHAPTER 2 
 GENERAL OVERVIEW OF METHODS 
2.1 PROTEIN EXPRESSION AND PURIFICATION 
2.1.1 Introduction 
Protein expression is a process that specifically produces a protein of interest in a cell 
line. It is a part of gene expression. In gene expression, a gene of interest is translated 
into functional gene products such as proteins (protein expression) or RNAs.  Protein 
expression exists everywhere in all known life, eukaryotes, prokaryotes and viruses. The 
basis of protein expression involves transcription and translation. Two expression 
systems are used: cell-based systems and cell-free systems. The cell-based expression 
system is the most widely used expression system. The cell-based expression system 
requires a cloned foreign DNA segment that will be translated into the protein of interest, 
an expression vector that will be ligated with a DNA segment, and a host cell that will be 
transformed with the plasmid. The common expression host cells, which the expression 
systems are usually referred to, are bacteria, yeast, insect, and mammalian cells.  
Each expression system has its own advantages and disadvantages. Therefore, 
a specific expression system is usually selected to express the particular protein. For 
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instance, if one protein requires posttranslational modification (PTM) such as acylation to 
be functional, the yeast expression system will be preferred over the bacterial one. 
Nevertheless, the bacteria expression system is the most simple, rapid, and highly 
efficient expression system, which can yield enough proteins for the structural studies. In 
some cases, the function of the expressed protein is either toxic to the bacterial host 
cells or the protein is heterologous and does not originate from bacteria; therefore, these 
proteins are very difficult to overexpress in the bacteria. In order to overcome these 
problems, many series of E. coli bacteria host strains have been developed including 
BL21, Rosetta, C41, C43, etc. BL21 is one of the most widely used E. coli host strains. 
In the BL21, there is a sub-strain known as BL21 (DE3) CodonPlus-RP, which is 
specifically modified to express heterologous protein in E. coli. The resulting BL21 (DE3) 
CodonPlus-RP host strain allows the expression of genes encoding tRNAs for rare 
amino acids codons for the heterologous protein such as arginine codons AGA and AGG 
and proline codon CCC.  
Besides the host cells, expression vectors are also important to protein 
expression. An expression vector is a plasmid that will introduce a foreign DNA into a 
host cell. When the expression vector is inside the host cell, the foreign DNA will be 
transcribed and translated by the host cell. Different types of host cells require different 
expression vectors. More importantly, to facilitate the subsequent purification of the 
overexpressed protein, a tag is usually engineered into the expression vector with the 
cloned gene. 
In order to isolate the specific protein to further study its function or structure, 
protein purification is conducted. Although various proteins are usually purified in 
different ways, in general, the procedure is similar. The overexpressed protein of interest 
coexists with all the endogenous bacterial proteins after the culture is harvested and the 
cells are lysated. Therefore, the aim of the first step is to achieve a large quantity of pure 
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protein for subsequent study. In the purification process, we first remove non-protein 
components from the proteins, such as DNA, and then separate the protein of interest 
from other proteins based on its own properties, such as binding affinity and protein size. 
Based on the protein’s solubility, the protein of interest can be expressed in the 
membrane part, inclusion body, or the water-soluble part. Because they are expressed 
in different places in the host cell, we usually selectively collect the part where the 
protein is located. In this way, the protein undergoes the first primary purification 
process. In the second step, more accurate procedures are performed. For example, a 
protein engineered with a His tag can be purified by nickel affinity column. We can also 
purify them using ion exchange chromatograph based on their charge. Different proteins 
are of different size thereby allowing us to separate them based on their size. 
2.1.2 Expression vector design and plasmid construction  
Usually the expression system and expression method will determine what kind of 
expression vector should be chosen. For example, if the study focuses on the structure 
determination using NMR spectroscopy or X-ray tomography, the protein yield will be 
one of the important factors. In this case, bacteria expression systems such as E.coli 
may be a reasonable candidate.  
Although E.coli is a convenient host for the heterologous protein expression, 
sometimes, the protein yield of interest is low or the gene expression may lead to 
insoluble or nonfunctional products. This is often due to the toxicity of the target proteins. 
For example, the overexpressed channel proteins may form pores on the cell membrane 
thereby causing cell death. Or the absence of co-factors, such as chaperons, leads to 
protein misfolding. A recombinant fusion protein, in many cases, may solve these 
problems. Here the recombinant fusion protein is the combination of two proteins, a 
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fusion protein and the protein of interest. The fusion protein is usually an independent 
domain from a homologous bacteria protein or a functional peptide such as a 
hexahistidine. The recombinant fusion protein is created through a genetic engineering 
approach. The gene for the fusion protein is ligated with the target gene by polymerase 
chain reaction (PCR) or ligation methods. The fusion protein does not only facilitate the 
protein yield but also helps with the protein purification. Hexahistidine can bind to the 
nickel affinity column, while glutathione S-transferase (GST) or maltose-binding protein 
(MBP) can bind to their respective affinity columns. After the protein is expressed and 
purified, the fusion proteins are usually cleaved off to prevent potential distortion caused 
by the extra fusion protein. A specific protease cleavage site is created between the 
fusion protein and the target protein, which is recognized and cleaved by its 
corresponding enzyme. 
2.1.3 Purification methods and strategies  
Protein purification is essential for the structural and functional studies of the target 
proteins. The development of a general successful and efficient protein purification 
protocol is challenging due to the diversity of biological samples. In general, three 
phases of purification strategies are considered, which are capture, intermediate 
purification and polishing (Protein Purification Handbook. Amersham Biosciences. 18-
1132-29, Edition AC). In the capture phase, the protein is solubilized, isolated, 
concentrated and stabilized. The majority of impurities of non-protein parts and other 
proteins are removed in the intermediate purification phase. In the polishing phase, the 
purity of the protein is further improved by removing traces of impurity. Before we 
choose the appropriate purification methods for each phase, the objective of the 
purification should be defined first. What the recombinant protein is applied for will 
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determine the purity of the protein. High purity will require more purification steps. For 
example, if the protein of interest is for therapeutic use, the purity should be extremely 
high >99%. However, the protein purified for the NMR experiments usually has a purity 
less than 90% because impurities are usually below the NMR detection limit for most of 
the practical purposes. In such a case, three phase purification steps are not necessary. 
Intermediate purification will be enough to achieve the appropriate purity for an NMR 
study. For the studies covered in this thesis, all of the proteins I worked with are purified 
using His affinity column. Whenever necessary, additional steps with size exclusion 
chromatography were used. 
2.2 SPECTROSCOPIC TECHNIQUES 
2.2.1 Nuclear magnetic resonance 
Nuclear magnetic resonance (NMR) is a phenomenon in which a physical property of an 
atom’s nucleus called “nuclear spins” absorbs the energy in a magnetic field from an 
electromagnetic pulse, which causes a transition of the spins from the ground state to 
one of the excited state. A mathematical description is presented as  	 

µ = γ?

? , where 
the magnetic moment of a nuclear spin  is proportional to its spin angular momentum
; γ is the gyromagnetic ratio and  is the reduced plank constant. The energy of a 
nuclear magnetic moment   
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Larmor frequency is given by 
  
€ 
ω =
ΔE

= γB0 , which is the emission frequency of a 
transition from the excited sate to the ground state in NMR spectroscopy.  
Because the absorption frequency of a nuclear spin depends on the magnetic 
field that is actually sensed by the nucleus, the absorption frequency 
€ 
ω i for a specific 
nuclear spin i in a protein should be 
€ 
ω i = γ iBi = γ i(1−σ i)B0 , where Bi is the local 
magnetic field of the nuclear spin i and it relates to B0 by a shielding factor, 
€ 
σ i. This 
shielding effect is caused by the electronic environment of the nuclear spin i. Therefore, 
the absorption frequency can give us the local structural information from NMR 
spectroscopy. 
2.2.2 Circular dichroism 
Circular dichroism (CD) is the difference in absorption of left and right circularly polarized 
light when the chiral molecules are interacted with circularly polarized light. By this 
definition, 
€ 
ΔA = AL − AR . using Beer’s law: 
€ 
ΔA = (εL −εR )⋅ c⋅ l, then, 
€ 
Δε = εL −εR =
ΔA
c⋅ l
, where 
€ 
εL  and 
€ 
εR  are the molar extinction coefficients for the corresponding left and 
right circularly polarized light; c is the molar concentration for the chiral molecules; 
€ 
l is 
the light path length. 
€ 
Δε  is the molar circular dichroism, which is the intrinsic property of 
the chiral molecule and measured by circular dichroism. Because each type of the 
secondary structure, alpha helix, beta strand, and random coil, has its own distinct CD 
spectrum, the secondary structure can be predicted (or decomposed) based on its CD 
spectrum. 
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2.2.3 Fluorescence spectroscopy 
Fluorescence is an emission of light by a substance after it absorbed a light of a different 
wavelength. The substance has multiple energy states and most of the times it is in the 
ground state, which is the most stable state. When the substance absorbs light, it is 
excited from the ground state to one of relative unstable excited states, followed by 
relaxation to a metastable excited state. As the substance transitions from the 
metastable state to the ground state, fluorescence light of a different wavelength is 
emitted. Usually, the wavelength of absorption is shorter than the wavelength of 
emission. Fluorescence spectroscopy measures and analyzes the fluorescence from a 
sample.  
2.3 DATA PROCESS AND ANALYSIS 
2.3.1 Spectral assignments 
NMR is one of the most powerful tools that are aimed at investigating the protein 
structures and dynamics. Many NMR experiments are specifically designed to 
accomplish these aims. In these experiments, all the structural and dynamical 
information can be extracted from the chemical shift or intensity of each peak. In order to 
obtain the atomic resolution, each peak has to be assigned to a corresponding residue. 
This step is known as spectral assignments. Spectral assignments include, at least, two 
steps, backbone sequence assignment and side-chain assignment. Recently developed 
triple resonance heteronuclear experiments, requiring additional 15N and 13C labeled 
samples, provide much more robust methods to quickly achieve the reliable backbone 
assignments. For a typical membrane protein, HNCA, HN(CO)CA, and CBCA(CO)NH 
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are three key triple resonance experiments, which are the minimum requirements for the 
backbone assignments. HNCA and HN(CO)CA are a pair of experiments. HNCA spectra 
for residue 
€ 
i  gives two alpha carbon resonances, 
€ 
Cαi  from residue 
€ 
i  itself and 
€ 
Cαi−1 from 
the preceding residue. HN(CO)CA spectra for residue 
€ 
i  only provide the alpha carbon 
resonance of 
€ 
Cαi−1, helping identify the peak of the preceding residue in the two peaks in 
HNCA spectra. In the same way, for residue 
€ 
i −1 in HNCA and HN(CO)CA, 
€ 
Cαi−1 and 
€ 
Cαi−2  can be identified. Therefore, the connectivity between residue 
€ 
i  and 
€ 
i −1  is 
defined. Similar to HN(CO)CA, CBCA(CO)NH for residue 
€ 
i  provides additional 
resonance for the beta carbon, 
€ 
Cβi−1 , besides 
€ 
Cαi−1 . Based on the protein known 
sequence, the connectivity and the chemical shift of alpha and beta carbon, the 
resonances for residue 
€ 
i  and 
€ 
i −1 can be assigned. After the backbone assignment is 
completed, side-chain assignment is relatively straightforward. The strategy for the side-
chain assignment is similar to the backbone assignment. TOCSY type experiments 
provide the connectivity along the side-chain carbons and protons. Given that these 
resides are already known from the backbone assignment, therefore, side-chain 
assignment can be completed.  
2.3.2 Secondary structure predictions 
The secondary structure of protein can be accurately predicted by 13C and 1H chemical 
shifts without NOE information. Backbone carbon 13Cα and 13Cβ and backbone proton 
1Hα are sensitive to the local conformation of the protein. In general, the chemical shifts 
for alpha helix, beta strand and random coil can be separated into three different 
classes. For example, 13Cα chemical shift in alpha helix conformation is higher than in 
random coils, while 13Cα chemical shift in beta strand conformation is lower than in 
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random coils. This relationship is reversed for the 13Cβ and 1Hα chemical shifts. By 
comparing the chemical shifts of backbone carbon 13Cα and 13Cβ and backbone proton 
1Hα with the data base of corresponding chemical shifts in random coils, we can tell the 
different between the alpha helix and beta strand. A semi-empirical procedure has been 
incorporated in the software package TOLAS for secondary structure prediction 50. 
2.3.3 Structure calculation 
NMR is one of the major tools to determine high-resolution structures. Two major 
restraints, distance restraints and torsion angle restraints, are used in NMR structure 
determination. NOESY type experiments can provide the NOE restraints, which are the 
major distance restraints to be used for structure determination. In the NOESY type 
experiments, the cross-peak intensity is proportional to 
€ 
1 r6 , where 
€ 
r  is the distance 
between two 1H protons. They are represented as the upper bound distances, while the 
low bound distances are basically the sum of two van der Waals radii. 
Hydrogen bonds are usually involved in defining the secondary structure. Both 
alpha helix and beta strand show different pattern of hydrogen bonds. By D2O exchange 
experiment or temperature effect on chemical shifts, the hydrogen bonds of water-
exchangeable amide proton can be determined. Applying additional hydrogen bonding 
constraints as distance restraints to structure calculation can further improve the quality 
of the resulting structures. 
In NMR, it is usually challenging to detect the long-range NOESY cross peaks, 
which can be converted into the long distance restraints. Paramagnetic relaxation 
enhancement (PRE) experiment is an alternative method. For example, MTSL (S-
(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate) is a 
chemical compound with an unpaired free electron, which can reduce the intensity of the 
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NMR signal due to nucleus-electron dipole interaction. The distance restraints generated 
by MTSL probes can be extended to 20~25 Å of paramagnetic centers.  
Magnetic dipole-dipole interaction is the interaction between two magnetic 
dipoles. Each magnetic nuclear such as 1H can generate a local magnetic field, which 
can interfere the magnetic field of other nuclear nearby. Therefore, the original Larmor 
frequency, which is determined by the external magnetic field, is modified by this 
additional local magnetic field. Such interaction is also called dipole coupling. The 
magnitude of the dipole coupling not only depends on the distance between two 
interacting nuclei, but also depends on the angle between the internuclear vector along 
two nuclei and the external magnetic field. Because the protein particles are tumbling 
isotropically in the solution, the dipole-dipole interaction is averaged to zero due to its 
angular dependence. However, in the specific alignment medium, partially restricted 
tumbling can be achieved. In this case, the dipole coupling is non-zero and is also called 
residual dipole coupling (RDC). Structural information can be obtained from RDC. In the 
principal axis frame of the alignment tensor, A, the RDC between two spins I and S is 
given by: 
€ 
DIS (θ,φ) = Da[(3cos2θ −1) + 32Dr(sin2θ cos2 φ)]                                           (2.3.1) 
where the polar coordinates, θ and φ, describe the orientation of the internuclear vector 
in the principal axis frame of the alignment tensor, A. Da=1/3[DZZ-(DXX+DYY)] and 
Dr=1/3(DXX-DYY)/AZZ are the axial and rhombic components of the traceless diagonal 
tensor D, with DZZ>DYY≥DXX. Da and Dr can be experimentally determined by measuring 
the magnitude of the alignment. Therefore, DIS can be used to refine the calculated 
structures. 
Dihedral angle, also called torsion angle, is defined as the angle between two 
planes that have a common interface. In protein geometry, two backbone torsion angles 
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are often used, Φ and φ. Φ is the angle along C’-N-Cα-C’, while φ is the angle along N-
Cα-C’-N. Therefore, dihedral angle restraints are also used to calculate the structure. 
Backbone chemical shifts are sensitive enough to the local conformation. It has been 
shown that the triplets with similar backbone chemical shifts and sequences will share 
the similar dihedral angles. Through searching the database, the dihedral angles can be 
determined. 
2.3.4 Protein dynamics analysis 
NMR is also uniquely suited to characterize molecular motions on the time scale from 
picoseconds to milliseconds. Two basic relaxation processes, spin-lattice relaxation rate 
(R1) and spin-spin relaxation rate (R2), have been applied to investigate protein 
dynamics. Spin-lattice relaxation rate (R1) is the decay constant that the magnetization 
recovers from its excited state to its thermal equilibrium, while spin-spin relaxation rate 
(R2) is the decay constant that the transverse magnetizations lose their coherence. 
Additionally, dynamics information can also be obtained from the nuclear Overhauser 
effect (NOE) experiment, which measures the perturbation of one spin through 
saturating its coupled spin.  
Stimulated emission is considered as the major source of relaxation. It requires 
the presence of an oscillating electromagnetic field, which matches to the absorption 
frequencies of the NMR transition. The oscillating electromagnetic field is mainly 
generated by random tumbling of the protein or by internal molecular motion such as the 
reorientation of the amide bond. The spectral density function, J(ω), describes how the 
intensity of the oscillating electromagnetic field is distributed with the frequency. A rate 
W is defined as the transition rate caused by the electromagnetic fields. In principle, 
molecular motion can be derived in following scheme, from R1, R2 and NOE to W; from 
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W to J(ω); from J(ω) to molecular motions. However, due to limit independent 
information, an iterative fitting computer program, such as Modelfree 51, becomes useful.  
Most biological processes occur on a slow timescale from microseconds to 
milliseconds or seconds. These biological processes also accompany with the 
conformational exchanges of proteins. Different from R1, R2 and NOE, which 
characterize the dynamics on the fast timescale (ps~ns), the conformational exchanges 
in the slow timescale (us~ms) can be examined by the CPMG 
(Carr−Purcell−Meiboom−Gill) R2 dispersion experiment. By measuring R2 as a function 
of a systematically variable CPMG field strength, vCPMG, relaxation dispersion curves can 
be obtained, which can be further analyzed by a two-site exchange model. By fitting the 
curves, the detailed dynamic information of the conformational exchanges such as the 
exchange rate constant, the populations of each sites, and the chemical shift difference 
between them can be determined.  
2.3.5 PISEMA and PISA Wheels 
Polarization inversion spin exchange at the magic angle (PISEMA) is an experiment that 
correlates the chemical shift of a spin such as 15N with its heteronuclear dipolar coupling 
to another spin 1H. The theory of the PISEMA experiment has been work out previously 
52. Both the chemical shift tensors σ and the dipolar tensor ν are fixed in the peptide 
plane. The principal axis frame for the 15N chemical shift tensor is (σ11, σ22, σ33) with σ11 
and σ33 in the peptide plane. The dipolar tensor is axially symmetric with unique axis 
along the covalent amide bond. Let (x, y, z) be the coordinates of B0 in the principal axis 
frame of the 15N chemical shift tensor, then the PISEMA equations in the principal axis 
frame of the chemical shift tensor are 
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where β is the angle from σ33 to the NH bond. ν|| is the value of ν when B0 is the direction 
of dipolar interaction vector. 
In Eq. 2.3.2 and 2.3.3, σ and ν are measured in the PISEMA experiments. The 
principal values of the 15N chemical shift tensors for non-glycine residues are σ11=64 
ppm, σ22=77 ppm, and σ33=217 ppm 53. Therefore, the coordinates (x, y, z) of B0 in the 
principal axis frame of the 15N chemical shift tensor can be determined. If the 
coordinates (x, y, z) of B0 in the principal axis frame of the 15N chemical shift tensor are 
known, then the orientation of the principal axis frame of the 15N chemical shift tensor 
with respect to the magnetic field is mathematically known. In theory, all the parameters 
for the structure of the protein backbones can be finally resolved if the standard peptide 
bond geometry is assumed. In practice, to simplify it, each helical segment in the 
standard α-helix is defined by two parameters, which are a tilt angle τ and a rotation 
angle ρ . The angle τ describes the relative orientation of the helix with respect to the 
magnetic field. Polar Index Slant Angle (PISA) wheel defined by the two parameters (τ, 
ρ) is a typical fourth order curve that is used to fit the PISEMA spectrum 52. Thus, the 
structure of the peptides descript by (τ, ρ) is determined. 
 
 
€ 
σ =σ11x 2 +σ22y 2 +σ33z2
v = v||2 (3(sinβx + cosβz)
2 −1)
(2.3.2) 
(2.3.3) 
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CHAPTER 3  
STRUCTURAL STUDY OF NICOTINIC 
ACETYLCHOLINE RECEPTORS 
3.1 NMR STUDY OF THE TM DOMAIN OF THE nAChR α1 
SUBUNIT 
3.1.1 Significance 
nAChRs are members of a superfamily of neurotransmitter-gated ion channel receptors, 
which also include other channel proteins such as the glycine and γ-amino-butyric acid 
type (GABA) receptors. These receptors are typically pentameric ion channels formed by 
either one or a combination of subunits. The composition of the subunits determines the 
receptor’s subtype. Muscle AChRs have four different subunits (typically two α1, β1, γ, 
and δ, with the δ subunit sometimes replaced by an ε subunit). While these are the 
characteristic subunits for muscle AChRs, there are as many as ten kinds of α-subunits 
and multiple β-subunits 54. Recent understanding is that the α-subunit is the key subunit 
for ligand binding and that the binding sites are located at the interface of an α-subunit 
and its neighboring subunit, with only one binding site per α-subunit 55. Each subunit is 
comprised of a large EC domain, a four-helix TM bundle, and an IC loop domain. 
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Because of its nature as the key to receptor gating, the structure of the α-subunit 
of the AChR has drawn a significant amount of attention. However, its nature as a 
membrane protein makes structural studies inherently difficult. The subunit protein is too 
large to study by the conventional means of NMR and is not easy to crystallize. At this 
point, a 4-Å resolution structure of α1 nAChR from Torpedo electric ray has been solved 
using cryo-electron microscopy (cryo-EM). The cryo-EM structure presents the receptor 
in its closed form 8. The limitation of cryo-EM’s resolution and its incapability of studying 
the dynamics effects leave much to be desired. More recently, two bacteria analogues of 
pentameric ion channels, ELIC and GLIC, were solved by X-ray crystallography. The 
structures of ELIC and GLIC are believed to represent the closed and open form, 
respectively 10,11. These structures are different from the cryo-EM structure, as a result of 
low sequence identity among them. High atomic resolution is still needed and will 
provide useful new information regarding the function of the receptors. 
3.1.2 Novel water solubilization approach  
This part of the designing work was done in collaboration with Professor Jeff Saven’s 
group at the University of Pennsylvania. For completeness, the designing idea is 
presented in this section. My contribution is in the experimental phase of the study, 
covered by the rest of the chapter. 
Structure determination of mammalian membrane proteins is challenging due to 
a low expression level, unpredictable folding, and poor protein stability. We addressed 
these critical issues by using a systematic approach to mutate the hydrophobic residues, 
which were identified in the lipid-protein interaction sites, to hydrophilic residues. In such 
a way, the membrane protein was transformed into a complete or partially water-soluble 
protein, while retaining its original structure and important function. Using a 
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computational approach, a designed water-soluble variant of the bacterial potassium ion 
channel KcsA has been developed and its solution structure has been elucidated using 
computer simulation and experimentally by NMR 56-58.  The resolved structure is 
consistent with the tertiary and quaternary structure of the wild type structure 57. These 
previous findings strongly support the idea that developing water-soluble variants of 
membrane proteins is suitable for structural studies.  
The computational redesign sequence of the nAChR α1 subunit was selected 
based on the cryo-EM model structure of the TM portion of the nAChR α1 subunit that 
was reported by Unwin et al 7,8. This design was performed by our collaborators at the 
University of Pennsylvania. First, the residues with more than 40% solvent exposure, 
calculated by GETAREA1.1, were identified as the exposed residues 59. Second, among 
the exposed residues, hydrophobic residues such as AFILMVW were considered. Third, 
the selected residues from above two steps were targeted for mutation, if they were 
expected to reside in the TM region. Residues at the interfaces between helices within 
the subunit were not touched and retain as in the wild type protein (I219, M243, V261, 
F414, I420 and V425). Eventually, 23 positions were identified, which were targeted for 
computational redesign (I220, L223, L224, F227, L245, I247, L251, V255, F256, L258, 
V259, M282, I283, I286, I290, V293, V294, L411, M415, L416, I419, V423 and F426). 
The site-specific probabilities of the amino acid residues in the 23 mutation sites 
were calculated as described previously 58,60-64. For each of the 23 mutation sites, 20 
types of amino acids were applied while the remaining mutation sites were constrained 
as wild type. Side chain conformations were restricted to those from a library that 
includes only frequently observed conformations 65. At most 10 rotamer states were 
applied to each amino acid. Two energy functions were used to characterize the 
ensemble of variants. The first one is to address inter-atomic interactions by using the 
AMBER force field 66. The second one is to quantify hydrophobic and solvation effects. 
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An environmental energy was constrained to the average value of soluble proteins that 
have the same size as the nAChR alpha subunit 58.  
In Fig. 3.1.1, a sequence representing the most probable amino acids at each of 
23 mutation sites was generated by the above computational approaches (Seq. 1). An 
additional constraint was applied in an effort to increase the diversity of different amino 
acids in the protein sequence. The new sequence was generated (Seq. 2). In order to 
only express the TM domain of the nAChR α1 subunit as a single chain, a polyglycine 
loop was selected and built. To minimize the artificial linker effects on the structure and 
orientation of TM helices and remain the native form of TM3 and TM4 as much as 
possible, the flexible loop was introduced between TM4 and TM1, while truncating IC 
domain and leaving TM3 and TM4 open. The connectivity of the resulting protein is 
different compared to the wild type nAChR α1 subunit, where TM4 connects to TM3 by a 
large IC domain. The particular flexible loop was systematically designed through using 
MODELLER 67. Different lengths of polyglycine linker (4~8 Glys) were investigated and 
50 independent calculations for each length of loop were performed. The 5-glycine linker 
shows the lowest value of the modeling energy function. Using NAMD 68 and the 
CHARMM force field 69, the results were further confirmed. 
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Fig. 3.1.1. Protein sequences of a wild type nAChR and its various mutants. The 
sequence for the wild type nAChR TM domain α1 subunit from torpedo is shown (WT). 
Seq. 1 represents the most probable amino acids at each of 23 mutation sites. The 23 
mutation sites are bold and underlined. In Seq. 2, the 4 positions are depicted in blue 
due to the diversity constraint implemented. Considering protein expression and 
purification, Seq. 2 was further modified to the final WSA. In WSA, the IC loop domain 
was truncated and the TM4 was moved to precede TM1. A five-glycine linker (in Orange) 
was used to connect the TM4 and TM1 and a his6-tag (in Green) was attached to the N-
terminus. 
 
                 220       230       240       250       260       270    
WT      PLYFVVNVIIPCLLFSFLTGLVFYLPTDSGEKMTLSISVLLSLTVFLLVIVELIPSTSSAVPLI  
Seq.1   PLYFVVNVIEPCKKFSELTGLVFYLPTDSGEKMTESKSVLKSLTEKLKKIVELIPSTSSAVPLI  
Seq.2   PLYFVVNVIEPCKKFSELTGLVFYLPTDSGEKMTESKSVLKSLTEKLKKIVELIPSTSSAVPLI  
 
             280       290       300         410       420       430       
WT      GKYMLFTMIFVISSIIITVVVINTHHRS  AMVIDHILLCVFMLICIIGTVSVFAGRLIELSQEG  
Seq.1   GKYMLFTKKFVESSIKITKEVINTHHRS  AMVIDHILKCVFEKICKIGTESVKAGRLIELSQEG  
Seq.2   GKYMLFTKEFVESSIKITEEVINTHHRS  AMVIDHILKCVFDKICKIGTESVEAGRLIELSQEG  
 
                 10        20        30        40        50        60       
WSA     MAHHHHHHAMVIDHILKCVFDKICKIGTESVEAGRLIELSQEGGGGGGPLYFVVNVIEPCKKFSE   
            70        80        90        100       110       120       130 
        LTGLVFYLPTDSGEKMTESKSVLKSLTEKLKKIVELIPSTSSAVPLIGKYMLFTKEFVESSIKIT   
                 140  
        EEVINTHHRS   	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3.1.3 Protein expression and purification 
A his6-tagged computationally designed nAChR α1 subunit (WSA) was expressed using 
a BL21 (DE3) cell line (EMD biosciences), which was obtained from our collaborators at 
the University of Pennsylvania. Cells were first grown at 37°C in LB media with 100 
µg/ml ampicillin to an OD600 of approximately 0.6. Cells were then harvested and re-
suspended into a quarter of the starting volume of 13C and 15N-rich M9 media containing 
100 µg/ml ampicillin. After one hour recovery period at 30°C, cells were induced with 1 
mM IPTG and continued to grow overnight.  
Cells after overnight growth were collected by centrifugation at 4°C and then re-
suspended into the proper volume of lysis buffer (50 mM Tris-HCl pH 7.5, 15% glycerol 
and 1 mM NaN3). The suspended cells were incubated with 100ug/ml lysozyme and 
25U/ml DNase for one hour at room temperature, followed by sonication. The lysate was 
centrifuged at 38724×g for 20 minutes. The supernatant was discarded and the inclusion 
bodies were solubilized in an 8 M urea, pH 8.0, 20 mM Tris-HCl buffer. After a second 
centrifugation at 38724×g for 20 minutes, the supernatant was incubated with 2 mL Ni-
NTA resin (Sigma) for one hour at room temperature. The resin was then washed with 
40 ml of wash buffer (8 M urea, 20 mM Tris-HCl, pH 8.0) and eluted with 6 ml 250 mM 
imidazole, 8 M urea, 20 mM Tris-HCl, at pH 8.0. A size exclusion column was optionally 
used to improve the sample purity. The final protein yield was approximately 7 mg/liter in 
M9. 
WSA was then refolded into 1 mM phosphate buffer pH 8.0 by removing the 8 M 
urea through dialysis. The protein was only soluble in high pH and can be concentrated 
into at least 2 mg/ml. In order to prevent soluble aggregation and adjust pH to 5.8, which 
allows to generate a decent NMR spectrum, a detergent, 1-Palmitoyl-2-Hydroxy-sn-
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Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt) (LPPG) (Avanti Lipids), was added 
to NMR samples to further solubilize WSA. The addition of LPPG to our WSA sample 
allowed WSA to fold into the expected four-α-helix bundle. The final concentration of 
LPPG is 2%.  
3.1.4 NMR experiments and data processing 
Uniformly 15N- and 13C-labeled WSA was prepared in 2% LPPG, 10% D2O, and 20 mM 
sodium phosphate buffer at pH 5.8. NMR data were collected on Bruker Avance 600, 
700, 800, and 900 MHz spectrometers with Topspin 1.3 software at 40°C. In order to 
complete backbone and side assignments, the following pulse sequences from the 
Topspin sequence library were used HNCOCA, HNCA, HNCACB, CBCACONH, HCCH-
TOCSY, and 3D 15N- and 13C-filtered NOESY. The mixing times for the 3D NOESY 
spectra were 120 ms and 150 ms for 15N-edited NOESY and 150 ms for 13C-edited 
NOESY. Most of 3D experiments were acquired with complex time domain size of 1024 
(direct observation dimension) × 48-80 (edit dimension) ×128-256 (indirect observation 
dimension). 
Relaxation rate constants, R1 and R2 and the steady-state 15N-{1H} NOE were 
measured at 14.1T using 4, 2.5, and 4s recycle delays, respectively. The longitudinal 
rate constant, R1, was recorded with 9 delay values: 10, 50, 150, 300, 600, 1000, 1600, 
2200, 3000 ms. The transverse relaxation constant, R2, was recorded using 7 delay 
values: 16, 32, 48, 64, 96, 128, and 176 ms. The steady-state 15N-{1H} NOE was 
measured with and without 1H saturation in an interleaved fashion. The R2 dispersion 
measurements were carried out at 14.1 T and 40 °C by using the relaxation-
compensated, constant-time, Carr–Purcell–Meiboom–Gill (CPMG) sequence with the 
following 8 CPMG field strengths: 25, 50, 75, 100, 150, 250, 400.00, and 650.00 Hz 70,71. 
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The reference spectrum was acquired without the CPMG period. A relaxation delay of 
2.5 s was used. 
NMRPipe 72 and Topspin 2.1 (Bruker NMR software) were used to process the 
NMR data. Sparky 73 was used to make resonance assignments. Structure calculation 
was performed using CYNA 2.1 74 based on the distance restrains generated from 15N- 
and 13C- edited NOESY data and dihedral angle restrains predicted by Talos 75 based on 
the chemical shifts as well as the hydrogen bonding restraints derived from temperature 
effect on the proton chemical shifts 76. A total of 100 structures were calculated and 20 
structures with the lowest target function are presented. Structures were further 
analyzed using VMD 77 and Molmol 78. 
The 15N relaxation parameters and 15N-{1H} NOE were analyzed quantitatively in 
DYNAMICS by using the extended model-free approach 79,80. A 15N-1H internuclear bond 
distance of 1.02 Å and a 15N chemical shift anisotropy -170 ppm were used. The global 
tumbling correlation time (τm) was determined by extensive search for the τm value that 
gives the minimum reduced χ2 value and the least number of non-fitted residues in the 
Modelfree data fitting. 
3.1.5 Secondary structure of WSA as determined by CD and NMR 
Circular Dichroism (CD) measurements were performed using a Jasco Model J-810 
spectrophotometer and analyzed using the K2D algorithm on the DICHROWEB server. 
The results are shown in Fig. 3.1.2. The secondary structure prediction is 50% based on 
the K2D output, which indicated a high helical content, as would be expected for our 
protein. The CD result is consistent with a native acetylcholine receptor TM domain α1 
subunit, given the prediction error by circular dichroism. The chemical shift index (CSI), 
which is a commonly accepted NMR method used for the identification of secondary 
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protein structures, can provide more accurate information about the secondary structure 
of WSA. A typical 1H-15N heteronuclear single quantum coherence (HSQC) spectrum is 
shown in Fig. 3.1.3, revealing a dramatically improved NMR spectrum for a membrane 
protein. With this well resolved spectrum and other high quality 3D spectra, a nearly 
complete backbone assignment was achieved, allowing us to predict the secondary 
structure using the CSI method. Fig. 3.1.4 represents the CSI for the Cα atoms. Four 
distinct α -helix domains with a fold similar to that of GLIC or Torpedo nAChR can be 
identified, indicating that the secondary structure of native acetylcholine receptor TM 
domains is retained in its water-solubilized counterpart. Overall, the α -helical content 
~74% predicted by CSI fits well with GLIC and the Torpedo nAChR. More interestingly, 
there are two sets of backbone assignments with two different CSI values identified for 
S104-S107 in the TM23 loop region as shown in Fig. 3.1.5, suggesting that they are in 
two different dynamic conformations. 
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Fig. 3.1.2. Far-UV circular dichroism (CD) spectrum of WSA in LPPG micelles. It 
was analyzed by online server DICHROWEB K2D program, which predicted ~50% 
helical content. This result is in agreement with sequence-based prediction for the 
secondary structure of WSA.  
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Fig. 3.1.3. Representative 800-MHz backbone amide proton 1H-15N HSQC spectrum 
of WSA in 2% LPPG micelles at 40˚C (pH 5.5). The homogeneous spectrum with a 
relatively large dispersion suggests WSA is monodispersed and folds correctly. 
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Fig. 3.1.4. 13Cα chemical shift index (CSI) of WSA. CSI was determined by subtracting 
the average 13Cα chemical shifts of the residues in the random coil from the 
corresponding residues in WSA. Higher 13Cα CSI indicates a higher tendency to be in the 
helical conformation. Obvious four helical domains were identified. The predicted 
secondary structure of WSA based on the 13Cα CSI is in agreement with two X-ray 
structures for GLIC and ELIC, but not with the cryo-EM model structure of nAChR. The 
helical contents are comparable for all three proteins. 
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Fig. 3.1.5. 13Cα chemical shift index of the TM23 loop. TM23 loop residues STSS can 
exist in two conformations, rigid (Red) and flexible (Green) conformations, as indicated 
by the CSI. The intrinsic multiple conformations of TM23 loop may be caused by the 
absence of the EC domain in WSA. The interaction between TM23 loop and the EC 
domain is critical to channel gating.  
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3.1.6 High-resolution structure of WSA determined by NMR 
The highly resolved peaks in our NMR spectrum assure the accuracy of these 
assignments and subsequent structure determination. For the majority of the WSA 
sequence, only one set of peaks was present, with only four residues in the TM2-3 loop 
region showing two sets of peaks, suggesting that the protein is structurally 
homogeneous. The solution NMR structure of WSA was determined using conventional 
methods. The 20 lowest-energy structures calculated from NMR constraints are shown 
in Fig. 3.1.6. The structure with minimal RMSD from the other structures in the bundle is 
highlighted in ribbon representation. In Fig. 3.1.7, the NOE connectivity of most of the 
residues is again suggestive of a helical structure with clear i, i+3 connectivity. A total of 
1169 pairs of NOEs are assigned and summarized in Table 3.1.8. Forty-two long-range 
inter-helical NOEs are identified and used to define the tertiary structure of WSA. The 
overall backbone RMSD for the four helical regions is 1.11 ± 0.20 Å. 
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Fig. 3.1.6. Solution-NMR structure of WSA in LPPG micelles. A bundle of twenty 
lowest-energy structures of WSA with the ribbon diagram of the structure closest to the 
mean was shown. The structure was derived from NMR constraints with the backbone 
RMSD for the helical region being 1.11 ± 0.20 Å. 
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Fig. 3.1.7. Summary of the short-range NMR restraints determined for WSA. They 
were shown with the line thickness proportional to the intensity of the NOESY cross 
peaks. 
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Table 3.1.8. NMR structure statistics and restraints summary of WSA in LPPG 
micelles 
 
Intra-residue 415 
Short range (|i–j| = 1) 399 
Medium range (1<| i–j| ≤ 4) 269 
NOE 
distances 
Long range (|i–j| > 4) 43 
Dihedral angles 209 
Restraints  
Hydrogen bonds 0 
Residual upper limit constraint violations 
  > 0.5 Å 0 
Residual dihedral angle constraint violations 
  > 5° 0 
Backbone RMSD 
Residues in helical regions only  
(10-40,50-70,80-100,111-136) 
1.11 ± 0.20 Å 
Heavy atom 
RMSD 
Residues in helical regions only  
(10-40,50-70,80-100,111-136) 
1.51 ± 0.21 Å 
Residues in most favored regions 87.5% 
Residues in allowed regions 12.1% 
Ramachandran 
Plot  
Residues in disallowed regions 0.4% 
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These structures show two long and two short TM helices, with TM3 and TM4 
being of greater length, while TM1 and TM2 are shorter. In Fig. 3.1.9A and Fig. 3.1.9B, 
WSA was superimposed on to the GLIC X-ray structure. Given that there is less than 
10% sequence identity (8.6%) between WSA and GLIC for the TM domains, the 
structural agreement between them is remarkable. Such an agreement cannot be 
reached between WSA and the cryo-EM structure of Torpedo nAChR, although there is 
more than 80% sequence identity. These unexpected findings indicate that WSA could 
represent an open state just as GLIC does, while the Torpedo nAChR cryo-EM structure 
is in the closed state.  
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Fig. 3.1.9. Structure comparison of WSA and GLIC. (A) WSA structure (Purple) is 
aligned with GLIC TM domain (Yellow), showing that WSA has more similar structure 
profile to GLIC than to Torpedo nAChR α1 subunit (alignment with cryo-EM structure not 
shown). (B) WSA (Purple) superimposed onto GLIC (Yellow), with the EC domain of 
GLIC shown.  In the absence of the EC domain, the TM23 loop region of WSA is in a 
different conformation from that of GLIC. In the comparison between WSA and the 
Torpedo nAChR, TM23 loop in WSA, LIPSTSS (Red), replaces original VPLI (Green) in 
the nAChR. It indicates that the TM23 loop in WSA shifts to the TM2 and the TM2 is 
shorter in comparison to the cryo-EM model. 
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A close comparison of the two structures, the WSA and the Torpedo nAChR 
cryo-EM structure, reveals more obvious structural differences. First, the cryo-EM 
structure of Torpedo nAChR shows four α helices with equal length, as shown in Fig. 
3.1.10B. TM1, TM2, and TM3 span ~8 helical turns, while TM4 is tilted and spans ~10 
helical turns. In contrast, both WSA and GLIC have an uneven length of helices. In Fig. 
3.1.6 and 3.1.10C, TM1 and TM2 span ~6 helical turns, while TM3 and TM4 are ~8 
helical turns long. In previous studies 81-85, TM1 and TM2 were truncated and isolated 
from nAChR or glycine receptors (GlyRs) and studied by NMR. In these studies, the 
helical lengths from single TM1 and TM2 are also consistent with the TM lengths in 
WSA. These two domains are shorter in WSA, isolated TM1 and TM2, and GLIC than in 
the cryo-EM structure of the Torpedo nAChR. Secondly, the loop positions are different 
between WSA and the Torpedo nAChR. Fig. 3.1.10A shows the sequence alignments of 
WSA, GLIC and the Torpedo nAChR. WSA and GLIC have very similar loop positions 
that are different from the cryo-EM structure of the Torpedo nAChR. Both of them shift to 
the N terminus resulting in longer helices in TM3 and TM4. Loop 12 in WSA is 
composed of residues LPTD, which are in the helical conformation in the cryo-EM 
structure. It is the same case for the loop 23 LIPST. The loops 12 (SGE) and 23 (VPLI) 
in the cryo-EM structure of the Torpedo nAChR become helices. More interestingly, 
residues STSS in loop 23 exist in two different conformations based on the CSI analysis. 
The structure we present here is the major rigid conformation. The clear differences 
between the NMR structure WSA and the cryo-EM structure for Torpedo nAChR suggest 
that WSA may represent a different state, compared to the cryo-EM structure. 
Interestingly, GLIC, which has been proposed to represent an open state of nAChR, has 
a similar loop position. Loop 12 (STS) and loop 23 (LPKTPYMT) correspond respectively 
to LPTD and LIPST in WSA. This suggests that WSA may represent the open channel of 
nAChR. The solved monomeric form of WSA was computationally assembled into a 
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model of the expected pentameric acetylcholine channel, using GLIC as a template. The 
created homopentameric WSA is shown in Fig. 3.1.11A. With the TM2 helices lining the 
center of the channel, the homopentameric WSA shows a clear clockwise tendency, 
compared to GLIC. The pore profile was calculated by using the HOLE program 86, 
shown in Fig. 3.1.12. E79, E83, S90, E93 and K97 were identified as the pore-lining 
residues. These results are consistent with the previous findings in the cryo-EM model 
structure of the nAChR, except for E83 7. Instead of E83, in WSA, T82 was supposed to 
be the pore-lining residue based on the cryo-EM model. However, even in the cryo-EM 
model, both T244 and L245, which are corresponding to T82 and E83 in WSA, are very 
close to pore. In WSA, L245 was mutated to E83 due to the water solubilization 
approach. The difference on the side chains between Glu and Leu may affect the 
orientation of E83, making E83 reside within the pore. The cryo-EM model structure is 
considered as the closed model for the Torpedo nAChR. L251, S252 and V255 are 
predicted to be the restriction site, which are corresponding to K89, S90 and E93. 
However, in the pore profile of WSA, K89, S90 and E93 are not in the narrowest region 
any more. In fact, they reside in a widely open region. Therefore, the pentamer 
arrangement of WSA is also agree with an open channel configuration. Thirdly, the WSA 
is more tightly packed than the Torpedo nAChR. Fig. 3.1.11A and B show the top view of 
WSA and the torpedo nAChR. The TM2 domain of the torpedo nAChR shows the largest 
displacement. More tightly coupled side chain interactions are present in the WSA 
structure than in the Torpedo nAChR. Last, TM1 is not straight. There is an obvious kink 
present in the WSA around residue P59. The same kink was also observed in previous 
studies for the isolated TM1 of nAChR. In GLIC, this kink also exists, although it is not 
obvious as in WSA. 
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Fig. 3.1.10. Structure comparison of the cryo-EM model of Torpedo nAChR 
structure and the X-ray GLIC structure. (A) Sequence alignments of WSA, nAChR 
from torpedo, and GLIC. It shows 82.6% amino acid identity between WSA and nAChR 
and 18% between nAChR and GLIC. Two ligand-free structures have been reported: the 
torpedo nAChR solved by electron microscopy (B) and the 2.9 Å GLIC X-ray structure 
(C). Although the two structures are similar, the difference of channel state (closed 
channel for nAChR and open channel for GLIC), helix length, loop position and a kink in 
helix is clear.  
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Fig. 3.1.11. Comparison of the pentameric model WSA and the GLIC TM domains. 
(A) Pentameric WSA was built by superimposing the monomeric WSA upon the 
pentameric ligand-gated ion channel homologue (GLIC). (B) The TM domain of the cryo-
EM model structure of the Torpedo nAChR. WSA is more tightly packed than the 
torpedo nAChR. 
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Fig. 3.1.12. Pore profile of WSA. The pore profile was calculated using the HOLE 
program. E79, E83, S90, E93 and K97 were identified as the pore-lining residues. The 
V-shape profile suggests that WSA may form an open channel. 
 
 
3.1.7 Backbone dynamics of WSA 
The 15N relaxation parameters, R1 and R2, as well as the steady-state heteronuclear 
NOEs (hetNOE) were measured for WSA at 14.1 T, which correspond to the 600 MHz 
1H resonance. R2/R1 values were calculated for all residues, and all of these parameters 
are shown in Fig. 3.1.13. A majority of the R1 values are between 0.8 and 1.2 s-1, and 
the R2 values range from 7 to 18 s-1. The NOE is higher than 0.6 for most residues in the 
helical regions. The hetNOE values of the residues in the polyglycine linker between 
TM4 and TM1 are significant lower than those in the helices, suggesting that the 
polyglycine linker, similar to the C-terminus, is the most flexible region in WSA. 
Compared to the polyglycine linker, the native loop 12 and loop 23 are relatively rigid. 
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Given that the ratio of the average R2 to R1 value is approximately half the weight of the 
protein molecular weight, the average of R2/R1 for WSA is ~15, suggesting that the NMR 
data describes the monomeric form of the WSA in the LPPG micelles. 
 
 
 
 
Fig. 3.1.13. Dynamics analysis of the backbone amide 15N of WSA in LPPG 
micelles. The relaxation data were acquired at 600 MHz. Longitudinal and transverse 
relaxation rate constants R1 R2 and 15N-{1H} steady-state NOE are shown. Error bars are 
the standard errors of the least-squares fitting to the exponential decay function for R1 
and R2 and the calculated uncertainties for NOE. 
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The quantitative analysis with the extended model-free approach was performed 
using DYNAMICS 79,80. The total correlation time we used was 12 ns, which was 
determined by minimizing the reduced χ2 value. Results are shown in Fig. 3.1.14. This 
analysis provides us with values of the generalized order parameter (S2), the local 
correlation time τe, the exchange term (Rex), the generalized order parameter for the fast 
effective local motion (Sf2) and the models used to fit the data for each residue. S2 is 
above 0.7 and Sf2 is 1 in the helical regions, which is typical for globular proteins.  For 
the loop region, most residues have τe ~1-3 ns and Sf2 is smaller than 1. More 
interestingly, some residues have non-zero Rex contributions to R2, indicating that those 
residues may undergo chemical and conformation exchange. Particularly, the TM2 
region shows more non-zero Rex terms than other TMs. This suggests that the TM2 
domain is more flexible than other TMs domains. We confirmed the presence of 
exchange contribution to relaxation by the CPMG R2 dispersion measurements 87,88. 
Results are shown in Fig. 3.1.15.  
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Fig. 3.1.14. Quantitative extended model free analysis of WSA by the program 
DYNAMICS. Total correlation time was determined as 12 ns based on minimum reduced 
x2 value. The generalized order parameter (S2), the local correlation time τe, the 
exchange term (Rex), the generalized order parameter for the fast effective local motion 
(Sf2) and the models used to fit the data for each residue are shown.  
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Fig. 3.1.15. Structure mapping of residues experiencing conformational exchange. 
CPMG R2 dispersion measurement was performed to confirm the presence of exchange 
contribution to relaxation. The residues, which show the R2 dispersion curve, are 
highlighted in yellow. They are TM1 51 64 70, TM2 78 82 85 89 97 100, TM3 109 114 
122 123 and TM4 9 14 15 32.  
 
 
Residues 79, 82, 86, 89, 93, 96, 97, and 100 in WSA are considered as the key 
residues lining the pore. Note that residues 89, 93, 96 and 97 have been mutated to 
hydrophilic residues such as E or K in order to increase the solubility of WSA. R2 
dispersion experiments show that 82, 89, 97 and 100 undergo conformation exchange 
on an us-ms timescale. E79 is located on the cytoplastic termini of TM2 and forms the 
CHAPTER 3 STRUCTURAL STUDY OF NICOTINIC ACETYLCHOLINE RECEPTORS 
 56	  
narrowest restriction site. In the Torpedo nAChR cryo-EM structure, E79 is located in 
loop 12, suggesting its large flexibility. On the contrary, the same residue is in the helical 
conformation in WSA, based on the CSI and structure. Interestingly, mode-free analysis 
of the backbone dynamics indicates that E79 does not meet the basic Lipari-Szabo 
assumption and can only be fitted in mode 5. It means E79 undergoes additional fast 
effective local motion. In fact, all the residues SGE that were originally located in the 
loop 12 of the torpedo nAChR and become structured in WSA now have the term Sf2. 
This indicates that these residues are somewhat flexible, although they do have a helical 
structure in WSA. Additionally, G78, which is near the E79 also shows a R2 dispersion 
curve, which supports SGE are flexible. It was also found that the loop 23 VPLI of the 
torpedo nAChR is in the helical conformation in WSA, however, V109 undergoes 
conformational exchange based on the R2 dispersion experiments and L111 has non-
zero Rex term suggested by mode-free analysis. It also indicates that residues VPLI are 
in highly dynamic helical conformation. As discussed before, STSS exists in two different 
conformations based on CSI methods. It is supported by the findings that both T105 and 
S106 have non-zero Rex, suggesting they undergo conformational exchange. 
3.1.8 Conserved Pro in TM1 and its dynamics 
Pro-59 is the only conserved proline in TM1 among all the members of AChR and other 
Cys-loop receptor family 89. It has been proposed that the TM1 helix has an irregular 
structure, which may be caused by this conserved proline 90. From our previous NMR 
study on the TM1 of the nAChR β 2 subunit, we found that the Pro-219 may lead to 
helical distortions 84. In WSA, a more obvious kink near Pro-59, present in the center of 
TM1 helix, has been identified. This kink separates TM1 into two parts, the half nearer 
the EC domain and the C-terminal half of the TM1 helix. This separation could allow for 
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motion of the C-terminal half of the TM1 helix, and more importantly of the dynamic TM2 
helix. In Fig. 3.1.14, τe indicates the local motions of the amide backbones. A close 
examination of τe data reveals two different dynamics characterizations in TM1 helix. 
Most residues in the C-terminal half of the TM1 helix show τe, while the N-terminal half 
shows fewer τe. It infers that the C-terminal half of the TM1 helix is much more flexible 
than the N-terminal half. As TM2 forms the channel, it is the most important domain for 
the channel gating, and many residues in TM2 involve conformational exchanges. TM1 
is connected to TM2 and may cooperate with TM2 to gate the channel, as suggested by 
the higher flexibility of the C-terminal half of TM1. Pro-59 plays a role like a ‘hinge’, 
which fixes the TM2 and the mobile part of TM1 to the stable N-terminal half of TM1. It 
seems that the non-straight helical structure with a kink in the center might 
accommodate the requirement of channel gating mechanisms.  A detergent-protein 
interacting site was identified near Pro-59, which may contribute to the stabilizing of the 
N-terminal half of TM1. A similar lipid-protein interaction site can also be found in GLIC 
11. 
3.1.9 Unique dynamics of TM2 
From the cryo-EM model structure of nAChR, it has been suggested that there are two 
basic structural components to line the pore, inner helices and outer helices. The group 
of TM1, TM3 and TM4 comprises the outer helices, while TM2 of each subunit forms 
inner helices. The outer helices are believed to stabilize the pentameric receptor in the 
membrane, suggesting that TM1, TM3 and TM4 are less flexible. The inner helices, 
however, directly face the channel. In contrast to the dynamics of the outer helices of 
TM1, TM3 and TM4, TM2 dynamics feature is closely related to its important function, 
namely, channel gating. Therefore, the TM2 domain is considered to be the most flexible 
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helix, which is connected to TM1 and TM3 through two important loops, 12 and 23. 
Although WSA was designed and solved in a monomeric form, the intrinsic dynamics 
and relative helix positions of TM2 can still indicate the possible motions, which are 
related to the channel function. In fact, both R2 dispersion and backbone dynamics 
analysis show that TM2 is more flexible compared to other TMs. For example, residues 
88, 90, 95, 97, 98 and 99 in TM2 show Rex terms by backbone dynamics analysis. 
Residues 78, 82, 85, 89, 97 and 100 involve chemical and conformational exchanges 
confirmed by R2 dispersion experiments. On the contrary, only a few residues from TM1, 
TM3, and TM4 show the flexibility. 
3.1.10 Importance of TM23 loop 
The TM23 loop has been proposed as the key loop that communicates with the EC 
domain 7,8. By comparing the structures of the TM23 loop between the nAChR cryo-EM 
model and WSA, we found that there is a notably major difference in the TM23 loop, a 
region believed to be important for the receptor’s gating activity. Residues VPLI, which 
comprise the TM23 loop in the nAChR cryo-EM model structure, have undergone a 
notable shift toward the TM3 helix, while the residues SSTS shift the same way and 
become a new TM23 loop in WSA. WSA is designed as a high sequence identity to the 
torpedo nAChR α1 subunit; however, its structure is solved more similar to GLIC, which 
is in the open state. Given that the TM23 loop can directly couple with the EC domain to 
gate the channel, without the EC domain, WSA may represent the state of nAChR 
differently from the cryo-EM model for the closed state. It is possible that the presence of 
interactions between the TM2-3 loop and the EC region of the protein makes the TM23 
loop shift toward TM2, allowing it to further interact with the Cys-loop of the EC region 
and serve to switch the receptor channel from open to closed. Without the restriction of 
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the EC domain, the TM23 loop in WSA can undergoes multiple conformations. In Fig. 
3.1.5, the two conformations of the TM23 loop, identified by NMR chemical shift index 
method are shown. Interestingly, our previous study on the secondary TM domain of the 
human neuronal GlyR α1 subunit also shows two conformations for the TM23 loop 
residues 81. Both WSA and the GlyR TM2 NMR studies suggest that the flexibility of two 
conformations is different, as indicated by CSI for WSA and backbone dynamics for 
glycine receptor TM2. These intrinsic pre-existing multiple conformations for the TM23 
loop may relate to the channel gating mechanism. As discussed above, the TM2 helix is 
more flexible due to its gating function. Now, the TM23 loop exists in two conformations, 
further enabling the motion of the TM2 helix. Interestingly, there is only one conformation 
for the TM12 loop. It suggests that TM2 helix motions will not be even. The C-terminal 
part of the TM2 helix has more capability to move than its N-terminal counterpart. It 
further proves that the TM2 helix involves the channel gating by twisting or tilting around 
its N-terminus.  
Fig. 3.1.9B show the overlap of WSA with GLIC. It appears that the highly 
dynamic nature of the region is responsible for the difference in loop size and 
arrangement of specific residues within the structure, while the specific orientation of the 
loop (bent toward the center of the bundle) could be a result of the lack of interactions 
with the EC domain. The x-ray crystal structure of the EC domain alone had similar 
observations: the Cys-loop region structure was significantly different from that of the 
cryo-EM model structure 5. These structural differences are also believed to be a result 
of the lack of important interactions between the TM domain and the EC domain. 
Therefore, the fact that these two regions, known to strongly interact in the intact protein, 
both adopt different structural arrangements without the other present should be 
expected, and is a reasonable observation. 
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3.1.11 Protein-detergent interaction sites 
Previous experimental and computational studies have shown that the nAChR requires 
the proper compositions of lipids in order to maintain proper protein function. The WSA 
structure has been solved in 2% lyso-lipid LPPG, which is well mimetic for the natural 
lipid. WSA was originally designed as a detergent-free analogue of the TM domain of the 
nicotine acetylcholine receptor. The location of lyso-lipid molecules in the WSA can 
provide us with information regarding why WSA is partially water-solubilized. Further, we 
can deduce what kind of protein lipid interaction may be necessary in order to for nAChR 
function properly. 15N edited NOESY spectrum was used to identify the protein detergent 
interaction sites. Due to the application of the water-soluble approach on WSA, we did 
not observe the detergent interaction sites on the outside of WSA. However, several 
protein detergent interaction sites inside the WSA have been identified, as shown in Fig. 
3.1.16. The most interesting one is located between TM1 and TM4. In Fig. 3.1.16, we 
see that there is a relatively larger space separating TM4 from all other TMs. The same 
space can also be found in the cryo-EM structure model of the torpedo marmorata 
nAChR and the X-ray structures of the two bacteria homologues, ELIC and GLIC. In 
WSA, the lyso-lipid LPPG was identified to be located in this large space. A very similar 
lipid protein interaction site is also found for the GLIC. Two lipid molecules can be found 
between TM4 and TM1 in its x-ray structure. These unexpected detergents for WSA and 
lipids for GLIC suggest that the TM4 domain may function separately or differently from 
other TMs. Several studies proposed that cholesterol might be located in this 
hydrophobic core. However, for both WSA and GLIC, there is no extra space allowed for 
other molecules such as cholesterol. 
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Fig. 3.1.16. Structure mapping of the detergent binding sites. Detergent-WSA 
interaction sites were identified based on the 15N edited NOESY experiments. The 
residues, which show the cross peaks with the detergents, were highlighted in yellow. 
They are TM1 48, 50, 64, 67, TM2 88, 89, and TM4 24, 33, 34, 35, 39, 40, 41, 43. 
 
 
3.1.12 Conclusion 
Through mutating specific lipid-facing residues to hydrophilic ones, which greatly 
improved the TM protein solubility in water, the engineered water-solubilized TM domain 
of nicotine acetylcholine α1 subunit (WSA) was studied by NMR. The monomeric WSA 
structure was resolved to the backbone RMSD of 1.19 ± 0.16 Å. The overall structure is 
similar to the open structure of GLIC, while it disagrees with the cryo-EM model 
structure. In particular, the position of the TM23 loop was found to shift close to TM2. 
TM1 and TM2 are shorter, while TM3 and TM4 are longer in comparison to cryo-EM 
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model structure. In addition, STSS in TM23 region has two distinct conformations, the 
rigid conformation and the flexible conformation. The shifting motion of the TM23 loop 
with two different conformations could involve the channel gating through communicating 
with the EC domain. Backbone dynamics analysis of amide 15N of WSA further 
investigated its intrinsic dynamic properties. 
3.2 NMR STUDY OF TM AND IC DOMAINS OF THE HUMAN 
nAChR α7 SUBUNIT 
3.2.1 Significance 
For the first time, the novel water solubilization approach was applied to the human 
nAChR α 7, which mediates fast signal transduction in the central nervous system. 
Human nAChR α7 is a homo-pentameric ion channel and each subunit includes a large 
N-terminal EC domain, four TM domains and a large IC domain, which connects TM3 
and TM4. Currently, most structural studies are based on the low-resolution cryo-EM 
model structure 7,8 from Torpedo and two X-ray structures 9-11 from the bacterial 
homologues of pentameric ligand-gated ion channels. However, the sequence identity 
between human nAChR α7 and their homologues is low. Moreover, for both cryo-EM 
and X-ray structures, there is very limited or no information for the IC domain. We 
successfully heterologously over-expressed human nAChR α7 TM domain with 
(nAChRα7TM-IC) and without the IC domain (nAChRα7TM-5G) in E. coli. Protein 
expression yield for these proteins are 5 mg/l and 10 mg/l, respectively, in M9 media. 
The secondary structures of our recombinant proteins have been investigated by circular 
dichroism (CD). Both nAChRα7TM-IC and nAChRα7TM-5G folded into stable structures 
in ~1% empigen with helical content of 41% and 50%, respectively, which are consistent 
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with previous studies 91. Highly resolved NMR HSQC spectra for these proteins have 
been obtained. Both CD and NMR spectra suggest that expressed proteins are well 
folded. Furthermore, backbone dynamics R1, R2, and heteronuclear NOE were 
performed and qualitatively analyzed using the histogram method. The comparison of 
the backbone dynamics of these two proteins indicate that the IC domain dramatically 
affects the intrinsic dynamics of the TM domain and makes the TM domain much more 
flexible. Further study of the human nAChR α7 using NMR will allow us to continue to 
investigate its function and role in ion channel gating and signaling. 
3.2.2 Protein design 
Human nAChR α7 DNA was first subcloned into the pTBSG1 expression vector shown 
in Fig. 3.2.1. Sixteen mutation sites in the TMs were experimentally implemented by 
PCR mutagenesis. nAChRα7TM-5G was engineered using five Glys to replace the IC 
domain of nAChRα7TM-IC. Both nAChRα7TM-5G and nAChRα7TM-IC were expressed 
with Rosetta (DE3) pLysS cell line (EMD biosciences). The specific mutation sites were 
identified empirically based on our novel water solubilization approach. In order to keep 
human nAChR α7 in a native state as much as possible, we minimized the number of 
mutation sites. The IC domain in the nAChRα7TM-IC was not touched, due to its high 
percentage of hydrophilic amino acids. The TM2 domain in both nAChRα7TM-5G and 
nAChRα7TM-IC were also not mutated as they face the channel pore. Particularly, it has 
been found that the segments of the TM2 domains of the human GlyR α1 subunit, in the 
same superfamily as nAChR, can form a functional homopentameric channel by 
themselves with reasonable conductance comparable to the authentic receptors 81,92-94. 
With the native TM2s, both nAChRα7TM-5G and nAChRα7TM-IC may form 
homopentameric channels. Regarding the solubility of the protein, hydrophilic amino 
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acids were selected to replace the hydrophobic amino acids and broke down the 
hydrophobic patches along the lipid-facing surfaces of the TM domains (TM1, TM2 and 
TM3). Along these hydrophilic amino acids, the positive charged amino acids were not 
preferred in order to lower the isoelectric point (PI) of the recombinant protein. We found 
the low PI facilitates protein expression and NMR sample preparation. Finally, 16 key 
hydrophobic amino acids were identified and mutated. 
 
 
 
 
Fig. 3.2.1. Novel designed human nAChRα7TM-IC. With 300 residues, it 
encompasses an entire TM domain (Blue) and a long IC domain (Uderline). Sixteen 
mutation sites (Green) were identified and experimentally implemented on the TM1, TM3 
and TM4, while TM2 and IC domains are in the native sequence. Replacing the long IC 
loop with a short 5-Gly linker, a TM only domain of human nAChR α7 subunit 
(nAChRα7TM-5G) was also reconstituted. PNU-120596 binding site is highlighted in red.  
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3.2.3 Protein expression and purification 
Both nAChRα7TM-5G and nAChRα7TM-IC were expressed with the Rosetta (DE3) 
pLysS cell line (EMD biosciences). Cells were first grown at 37°C in 100 ml LB media 
with 100 µg/ml ampicillin and 70 mg/ml chloramphenicol overnight. Then cells were 
harvested and re-suspended into 1 l 13C and 15N rich M9 media containing 100 µg/ml 
ampicillin and continued to grow at 37°C until it reached OD600 of approximately 0.5.  
After one hour recovery period at 30°C, cells were induced with 0.2 mM IPTG and 
continued growing ~1 day.  
After 1 day, cells were collected by centrifugation at 4°C and then re-suspended 
into the proper volume (20ml lysis buffer/1L cell culture) of lysis buffer (50 mM Tris-HCl, 
pH 7.5, 15% glycerol and 1 mM NaN3). The suspended cells were incubated with 
100ug/mol lysozyme and 25U/ml DNase for ~1 hour at room temperature, followed by 
sonication (20s on/20s off for 5mins). The lysate was centrifuged at 38724×g for 20 
minutes. The supernatant was discarded and the inclusion bodies were solubilized in 0.8 
ml 35% empigen (Sigma) overnight. After centrifugation at 38724×g for 20 minutes, the 
supernatant was diluted into 10 ml 20 mM Tris-HCl, pH 8.0 buffer and incubated with 1 
ml Ni-NTA resin (Sigma) for one hour at room temperature. The resin was then washed 
with 40 ml of wash buffer (10 mM imidizole, 100 mM Nacl, 0.3% empigen, 20 mM Tris-
HCl, pH 8.0) and eluted with 3 mL 250 mM imidazole, 0.3% empigen, 20 mM Tris-HCl, 
at pH 8.0. The resultant mutant (nAChRα7TM-IC) was expressed with a typical yield of 5 
mg/l in M9 medium for NMR investigation. Replacing IC loop with a 5-Gly linker 
(nAChRα7TM-5G) increased the yield to 10 mg/l in M9. 
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3.2.4 NMR experiments and data processing 
NMR sample preparation, and all NMR methods for the spectrum assignments were 
identical to those in Chapter 3, section 3.1.4. Briefly, the conventional suite of two-
dimensional (2D) and three-dimensional (3D) heteronuclear, filtered experiments for 
spectral assignment.15N- and 13C-filtered NOESY was measured with a mixing time of 
120 ms. NMRPipe 72 and Topspin 2.1 (Bruker NMR software) were used to process the 
NMR data. Sparky 73 was used to make resonance assignments. 
Relaxation rate constants, R1 and R2 and the steady-state 15N-{1H} NOE were 
measured at 16.4 T using 4, 3, and 4 s delays respectively. The longitudinal rate 
constant, R1, was recorded with 8 delay values: 10, 50, 150, 300, 500, 700, 1000, 2500 
ms. The transverse relaxation constant, R2, was recorded using 7 delay values: 16, 32, 
64, 96, 128, 160, 240, and 400 ms. The steady-state 15N-{1H} NOE was measured with 
and without 1H saturation in an interleaved fashion. The R2 dispersion measurements 
were carried out at 16.4 T and 45 °C by using the relaxation-compensated, constant-
time, Carr–Purcell–Meiboom–Gill (CPMG) sequence with the following 8 CPMG field 
strengths: 33.33, 66.67, 100, 166.67, 266.67, 366.67, 500.00, and 666.67 Hz 71,95. The 
reference spectrum was acquired without the CPMG period. A relaxation delay of 2.5 s 
was used. 
3.2.5 Secondary structure as determined by CD and NMR 
CD measurements were performed using a Jasco Model J-810 spectrophotometer and 
analyzed using the K2D algorithm on the DICHROWEB server. The results are shown in 
Fig. 3.2.2 for both nAChRα7TM-5G and nAChRα7TM-IC. The secondary structure 
prediction for nAChRα7TM-5G is 50% based on the K2D output. CD result is consistent 
with a native acetylcholine receptor TM domain α1 subunit, given the prediction error by 
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circular dichroism. In the same way, the helical content of nAChRα7TM-IC was predicted 
to be 41%. Thus, the helical content of IC can be calculated to be at least 29%, which is 
in agreement with sequence-based predictions. The chemical shift index (CSI), which is 
commonly accepted NMR method for the identification of protein secondary structure, 
can provide higher resolution information of the secondary structure of the protein. A 
typical 1H-15N heteronuclear single quantum coherence spectrum (HSQC) of 
nAChRα7TM-5G is shown in Fig. 3.2.3A. Comparison of nAChRα7TM-5G with its wild 
type counterpart, the human nAChR α7 (Fig. 3.2.3B), reveals a dramatically improved 
NMR spectrum for membrane protein. Note that for the wild type human nAChRα7, we 
used 8 times more scans and the sample stability was poor. With the well resolved 
spectrum and other high quality of 3D spectra for nAChRα7TM-5G, a nearly complete 
backbone assignment of nAChRα7TM-5G was achieved, allowing us to predict the 
secondary structure by CSI method. Fig. 3.2.4 represents the chemical shift index for the 
Cα atoms. Four distinct α -helix domains with a similar position to GLIC and Torpedo 
nAChR can be identified, indicating that the secondary structure of native acetylcholine 
receptor TM domains is still retained in its water-solubilized counterpart. Overall, the α-
helical content predicted by CSI is ~74%, fitting well with GLIC and the Torpedo nAChR.  
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Fig. 3.2.2. Far-UV circular dichroism spectra of nAChRα7. Far-UV circular dichroism 
(CD) spectra were analyzed by online server DICHROWEB CDSSTR program, showing 
~41% helical content for nAChRα7TM-IC (Green) and ~50% for nAChRα7TM-5G (Red). 
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Fig. 3.2.3. HSQC spectra of nAChRα7TM-5G and its wild-type counterpart. 
Representative backbone amide proton 1H-15N HSQC spectrum of nAChRα7TM-5G in 
~1% empigen pH 7.5 at 45˚C with 16 numbers of scans (A) and wild type nAChRα7TM-
5G (B) in the comparable buffer conditions with 128 numbers of scans. The water 
solubilization approach dramatically improves the NMR signals and sample stability. 
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Fig. 3.2.4. 13Cα chemical shift index of nAChRα7TM-5G. The 13Cα chemical shift index 
(CSI), which was determined on the basis of Cα chemical shifts, also indicates a high 
helical content. Two disorder regions are observed in the middle of TM1 and TM4 
domains. The residues of loop 12 and loop 23 are TLPAD and MPAT respectively, which 
are consistent with GLIC and WSA. 
 
  
3.2.6 Backbone dynamics of TM and IC domains of human nAChR α7 
R1 and R2 15N relaxation parameters, as well as the steady-state heteronuclear NOEs 
were measured for nAChRα7TM-5G at 16.4 T, corresponding to 700 MHz 1H resonance. 
R2/R1 values were calculated for all residues, and all of these parameters are shown in 
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Fig. 3.2.5. A majority of the R1 values are between 0.8 and 1.3 s-1, and the R2 values 
range from 3 to 19 s-1. The NOE is higher than 0.5 for most residues in the helical 
regions. The hetNOE values of the residues in the polyglycine linker between TM3 and 
TM4 are significantly lower than those in the helices, suggesting the most flexible region 
of nAChRα7TM-5G is in the polyglycine linker, the same as C termini. Compared to the 
polyglycine linker, the native TM12 loop and TM23 loop are relative rigid. Interestingly, 
the R2/R1 for the TM2 is higher than other TMs, which suggests that the TM2 helices in 
this water-soluble form still form a channel. The oligomeric state cannot be simply 
predicted based on the R2/R1 ratio, if the protein involves more complicated motion 57. 
R1, R2 and NOE experiments were also measured for nAChRα7TM-IC. Backbone 
dynamics analyses of nAChRα7TM-IC using our newly developed histogram method, 
which does not require full spectral assignment, were performed. Interestingly, for 
nAChRα7TM-IC, the average R2/R1 ratio is ~5 and most hetNOE values are negative. 
This indicates that most residues are very flexible. One of the possibilities is that in the 
low pH sample condition, the peaks from the IC loop of nAChRα7TM-IC dominate the 
NMR spectra. 
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Fig. 3.2.5. Dynamics analysis of the backbone amide 15N of nAChRα7TM-5G. The 
relaxation data were acquired at 700 MHz. Longitudinal and transverse relaxation rate 
constants R1 and R2 and 15N-{1H} steady-state NOE are shown. Error bars are the 
standard errors of the least-squares fitting to the exponential decay function for R1 and 
R2 and the calculated uncertainties for NOE. TM2 domain shows intrinsically different 
dynamic properties from other TM domains. R2 dispersion experiment determined that 
the higher R2/R1 values for TM2 are contributed from anisotropic rotational diffusion.  
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3.2.7 IC domain effects on the TM domain 
The sample nAChRα7TM-IC was prepared in two distinct pHs: pH 7.2, comparable to 
the sample condition for nAChRα7TM-5G and pH 4.6, the NMR preferred condition. Two 
1H-15N heteronuclear single quantum coherence (HSQC) spectra for both sample 
conditions are shown in Fig. 3.2.6. In the high pH condition, the HSQC spectrum of 
nAChRα7TM-IC can be partially overlapped with its TM counterpart. This indicates that 
the TM domain itself can fold independently and the reductionist approach is valid. Some 
peaks in the HSQC spectrum for the TM domain of nAChRα7TM-IC disappeared. It 
might be due to the large protein size, aggregation or the dynamic changes, induced by 
the IC domain. The dynamics of the TM domain show different profiles in the absence 
and presence of the IC domain. The hetNOE experiments were performed for 
nAChRα7TM-IC in the high pH condition and the low pH condition. The two 
heteronuclear NOE spectra with and without saturation, measured in high pH conditions, 
were overlapped in Fig. 3.2.7. Compared to the same experimental results for 
nAChRα7TM-5G, the hetNOE values are smaller, indicating that the TM domain 
becomes more flexible in the presence of the IC domain. 
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Fig. 3.2.6. pH effects on the HSQC spectra of nAChRα7TM-IC. (A) 1H-15N HSQC 
spectrum of nAChRα7TM-IC at pH 7.3 (Green) was overlapped with nAChRα7TM-5G 
(Red). (B) At pH 4.6, the peaks from the IC domain of nAChRα7TM-IC dominated the 
1H-15N HSQC spectrum due to the intrinsic dynamics of the IC domain. 
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Fig. 3.2.7. Dynamics of nAChRα7TM-IC. 1H-15N heteronuclear NOE spectroscopy of 
nAChRα7TM-IC shows extremely dynamic domains. The spectra with (positive signals, 
Red; negative signals, Green) and without saturation (Blue) were overlapped. Most 
peaks disappeared in the saturated spectrum. This indicated that in the presence of the 
IC domain, the TM domain might become very flexible.  
 
 
Note that for the same protein sample, the HSQC spectrum at low pH cannot be 
overlapped with the HSQC at high pH. Two possibilities exist. At low pH, the sample 
does not fold correctly. However, CD spectra in both pH conditions show no difference, 
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suggesting that the protein was still folded correctly at low pH. The other possibility is 
that at high pH, the IC domain undergoes a water exchange process, which decreases 
the peak intensities of the residues from the IC domain. In contrast, at low pH, the peak 
intensities of the residues from the IC domain start to show up and increase dramatically 
due to the slow water exchange process. The peak intensities for the IC domain are very 
strong and dominate the spectra. In this case, the most peaks in the HSQC spectrum 
represent the IC domain. Therefore, the histogram analysis of the backbone dynamics of 
nAChRα7TM-IC at low pH condition mainly reflects the IC domain dynamics.  
3.2.8 Secondary structure analysis of nAChRα7TM-5G  
The fully assigned backbone chemical shift of nAChRα7TM-5G allows us to predict the 
secondary structure accurately. The number of residues for the TM1, TM2, TM3, and 
TM4 of nAChRα7TM-5G is 23, 25, 27 and 35 respectively, which are similar to the 
numbers of each helix for the TMs in WSA (24, 22, 34 and 31) and GLIC (22, 25, 29 and 
30) 9,11, but different from the cryo-EM model (27, 29, 26 and 34) 7,8. For nAChRα7TM-
5G, WSA and GLIC, TM1 and TM2 are shorter than TM3 and TM4. Therefore, the 
surface of the cytoplasmic side of the TM domain is not flat. With relatively longer 
helices, the cytoplasmic sides of TM3 and TM4 form a large empty space, which may be 
water accessible. On the contrary, in the cryo-EM model, with the C-terminal side titled, 
TM4 shares a length similar to TM1, TM2 and TM3, although TM4 is slightly longer. 
Therefore, the space is not observable in the cryo-EM model.  
The loops connecting TMs 1 and2 (TM12 loop) and TMs 2 and 3 (TM23 loop) are 
also different. In the nAChRα7TM-5G, TM12 loop and TM23 loop are residue TLPAD 
and residue MPATS, respectively, which are also located on the homologous loop 
positions for WSA and GLIC. All of them contradict cryo-EM model of nAChR from 
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Torpedo. Compared to the cryo-EM model, both TM12 loop and TM23 loop shift to the 
N-terminus. One of the explanations is that nAChRα7TM-5G, WSA and GLIC represent 
the open state of nAChR, while the cryo-EM model represents a closed state. 
It has been proposed that the TM1 helix in the nAChR has an irregular structure, 
which may be caused by the conserved prolines 90. Pro-37 in nAChRα7TM and Pro-59 in 
WSA are the only conserved proline in TM1 among all the AChR and Cys-loop receptor 
members 89. In the previous study of WSA, it was found that a clear kink near Pro-59 
presents in the middle of the TM1 helix, separating TM1 into two parts, the N-terminal 
half and the C-terminal half of the TM1 helix. Dynamic analysis suggests that the Pro-59 
may facilitate the motion of the C-terminal half of the TM1 helix and may be more 
important to the dynamics of the TM2 helix. Based on the CSI analysis on nAChRα7TM-
5G, a clear kink can be also predicted in the TM1 helix. The residues GLNLEIPCS show 
different CSI values from the typical helical CSI values. Therefore, they are not in the 
helical conformations. Compared to the kink in the TM1 helix of WSA, the counterpart of 
nAChRα7TM-5G involves many more residues and is much more obvious.  
Although the TM4 domain is always long among all the known structures of 
nAChR, the shape of TM4 is not the same. The TM4 helices in the cryo-EM model 7,8 
and WSA are relative straight and less disturbed, compared to GLIC 9,11. This is 
because there is a proline residue in the TM4 helix of GLIC and it bends the helix, while 
no proline presents in the TM4 helix of the cryo-EM model and its water-soluble 
analogue WSA. In the TM4 helix of nAChRα7TM-5G, the presence of Pro-153 disturbs 
the chemical shifts of surrounding residues. It can be predicted that there is a kink, which 
bends the TM4 helix of nAChRα7TM-5G. Therefore, the TM4 helix in nAChRα7TM-5G 
may have a similar shape as in GLIC. 
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3.2.9 Possible ion channel formation 
It has been found that the segments of the TM2 domains of the human GlyR α1 subunit, 
in the same superfamily as nAChR, can form a functional homopentameric channel by 
themselves with reasonable conductance comparable to the authentic receptors 81,92-94. 
Recently, fluorescence studies on the TM2 domain of nAChR also suggest that TM2 
domains from different subunits such as α4 and β2 can form a heteropentameric 
channel 96. In the nAChRα7TM-5G construct, the TM2 domain remains in the native 
sequence. It is highly possible that the nAChRα7TM-5G with the native TM2 domain can 
form a homopentameric channel. 
The amide protons from NMR samples always undergo the chemical shift 
exchange process with water peaks (~4.6 ppm). This information could be used to probe 
the environment of the protein, which conversely give us the structure information. The 
NMR sample and experimental conditions for nAChRα7TM-5G are at pH 7.4 with a 
temperature of 45°C. Under the high pH and high temperature conditions, the water 
exchange process is more serious and can affect the amide proton chemical shifts in the 
HSQC spectrum and shift them to the upfield. The residues on the TM2 helix experience 
two distinct environments, the water-accessible environment and the non-water 
accessible environment. Most of the pore-lining residues are accessible to the water 
molecules, while other residues are not. Therefore, under the same experimental 
condition, the pore lining residues are affected much more by the water exchange 
process than others in the TM2 helix due to the ability of exchange between the pore 
lining residues and the water molecules. Additionally, the geometry of the pore can be 
predicted by the water accessibility. The residues in a large aqueous pore will undergo 
greater water exchange process than in a small one. In Fig. 3.2.8, the peaks in the 
HSQC spectrum of nAChRα7TM-5G are color-coded based on the domains they 
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belonged to. The peaks in the TM2 helix show larger chemical shift dispersion for the 
amide protons than others. The amide proton chemical shifts of the TM2 domain were 
plotted as a function of the residue numbers in Fig. 3.2.9. As mentioned before, most of 
the pore lining residues except L9’ (L67) show relatively more upfield proton chemical 
shifts than their adjacent residues due to their particular environments. More 
interestingly, the residues close to the EC side in the TM2 helix show more upfield 
proton chemical shifts than the IC side, suggesting that C-terminal residues of the TM2 
helix undergo more water exchange process than its N-terminal residues. This finding 
further suggests that N-terminus of the TM2 helix may form a narrower pore than its C-
terminal counterpart does. It is consistent with the previous study on the Torpedo nAChR 
that the TM2 helices from the different subunits form a funnel-shaped channel with an 
ion selective filter on its IC side 97. The gate of the pore for the α1 subunit from the 
nAChR in the Torpedo based on the cryo-EM model structure was identified on α-Leu 
251 and α-Val 255 7. Residue L67 (L9’) in the nAChRα7TM-5G, a homologue residue to 
α-Leu 251 in the cryo-EM model, shows the highest amide proton chemical shift, 
suggesting that L67 is well protected from the water molecules. Therefore, it can be 
predicted that there is also a hydrophobic gate located near L67 (L9’) in the TM2 helix of 
the human nAChR α7. 
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Fig. 3.2.8. Distribution map of each TM domain of nAChRα7TM-5G in a HSQC 
spectrum. The TM2 domain of nAChRα7TM-5G in 1H-15N HSQC spectrum shows a 
relatively large chemical shift dispersion.  
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Fig. 3.2.9. 1HN chemical shifts profile of the TM2 domain of nAChRα7TM-5G. The 
amide proton chemical shifts (1HN) of the TM2 domain of nAChRα7TM-5G were plotted 
as a function of the residue numbers. Most of the pore lining residues (Cyan) except L9’ 
show relatively lower 1HN than their adjacent residues. The proton chemical shifts of the 
EC side are lower than the IC side. Amide proton chemical shift analysis on the TM2 
domain indicates TM2 domains may form a channel with the constriction site at L9’. The 
entire channel is in a funnel shape widely open on the EC side.  
 
 
3.2.10 Unique backbone dynamics 
The TM2 helix shows unusual dynamics, compared to others in Fig.3.2.5. In the hetNOE 
experiment, for each helix, the NOE value is similar except for the C-terminal half of the 
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TM4 helix, suggesting that the flexibility for each domain is comparable. However, in 
terms of the R2/R1 ratio, the value for the TM2 helix, ~25, is higher than others. Two 
possible reasons correspond to the high R2/R1 ratio, the conformational exchange or the 
chemical shift anisotropy. The TM2 helix has higher R2 and lower R1, and thereby, the 
chemical shift anisotropy is more possible contributing factor to the dynamics of the TM2 
helix. In order to confirm this finding, CPMG R2 dispersion measurements were 
performed 87,88. There are no R2 dispersion curves identified for any residue in the TM2 
helix. Therefore, the possibility of conformational exchange was rule out. As we 
mentioned above, the oligomerization of the native TM2 domains could lead the 
nAChRα7TM-5G to form a funnel-shape channel. The additional interaction along the 
TM2 helices may result in the chemical shift anisotropy for the nAChRα7TM-5G. If 
indeed, the nAChRα7TM-5G can form the homopentamer, then the R2/R1 ratio is too low 
for a typical globular protein with the molecular weight 85 kDa. In our previous study on 
the water-solubilized channel protein KcsA (WSK3), it also exhibits an unusual dynamic 
profile 57. The nAChRα7TM-5G may experience the same situation as WSK3. A further 
analysis on the dynamics of the nAChRα7TM-5G will be continued. 
Two prolines in the TM1 and TM2 domains not only break the helices to form a 
clear kink in terms of the structures, but also affect the dynamics of the TMs and cause 
the residues before and after the proline to behave differently in terms of the dynamics. 
The CSI values for them are still positive, except the residues near the kink, suggesting 
that they are in the helical conformation. In the TM1 helix, the R2/R1 ratio for the residues 
in the helical conformation before Pro-37 is ~8, which is lower than the ratio of the 
residues after the proline, ~15. A similar trend for NOE values was also observed. Both 
the low R2/R1 ratio and low NOE values indicate that the N-terminal side of the TM1 helix 
is more flexible than the C-terminal side. Although the TM1 helix in nAChRα7TM-5G 
does not connect with its native EC domain instead of a small fusion peptide for protein 
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purification purposes, the intrinsic flexibility of the N-terminal half of the TM1 helix may 
play a role in the signal transduction from the EC domain to the IC domain. Two distinct 
dynamic profiles can also be identified in the TM4 helix. The Rex contributions to the 
relaxation of the C-terminal half of the TM4 helix were confirmed by the CPMG R2 
dispersion measurements.  
Interestingly, the TM3 helix also has two distinct dynamics. In Fig. 3.2.5, the 
R2/R1 ratio for two regions in the TM3 helix are ~15 and ~8 respectively. In nAChRα7TM-
5G, a glycine linker was used to replace the long IC loop. It is possible that this artificial 
linker makes the C-terminal side of the TM3 helix flexible. However, the Gly linkers have 
been successfully used in other proteins from our group and we have not yet observed 
this effect. Therefore, it could be also the intrinsic dynamics of the TM3 helix. As signal 
transduction is bidirectional, the signal from the IC domain is conducted through the TM3 
helix to the TM2 helix and the EC domain. The intrinsic dynamics of TM3 may play an 
important role here. 
3.2.11 Conclusion 
Using the novel water solubilization approach, two new reconstituted proteins, human 
nAChRα7TM-5G and human nAChRα7TM-IC, were successfully expressed in E. coli. 
The expression levels for both of them are suitable for structure determination. Full 
spectrum assignment and dynamics analysis were completed for the nAChRα7TM-5G. 
The results indicate that the secondary structure of the nAChRα7TM-5G is consistent 
with GLIC and WSA, but different from the cryo-EM model for Torpedo nAChR, 
suggesting that the new reconstituted nAChRα7TM-5G and WSA may represent the 
same open state of nAChR as with GLIC. Two prolines residing in the middle of TM1 
and TM4 disturbed the helix and made obvious kinks. Both the structure and the 
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dynamics were affected by two prolines. The partially flexible TMs near the EC side may 
facilitate signal transduction from the outside to the inside. The TM3 helix was also found 
to be partially flexible near the IC side, which may facilitate signal transduction from the 
inside to the outside. Without the spectrum assignment, the dynamics of nAChRα7TM-IC 
was analyzed by histogram method. By comparing the HSQC spectra and the backbone 
dynamics between nAChRα7TM-5G and nAChRα7TM-IC, the presence of the IC 
domain affect the dynamics of the TM domain.  
CHAPTER 4 NMR STUDY OF INHALATIONAL ANESTHETIC MECHANISM 
 85	  
CHAPTER 4  
NMR STUDY OF INHALATIONAL 
ANESTHETIC MECHANISM 
4.1 ANESTHETIC EFFECTS ON THE WATER SOLUBLE 
PROTEIN, FOUR-α-HELIX BUNDLE 
This section has been published in Biophys J 94, 4464-4472, (2008) as a full article. I 
am the first author. The language was directly taken from the paper.  
4.1.1 Significance 
A variety of small molecules, which have no common structural features and exist in 
different forms, can render people into a state of total unconsciousness, commonly 
known as general anesthesia. These small molecules are called general anesthetics. 
The anesthetics have been used since the 18th century; however, the molecular 
processes underlying this phenomenon remain unclear 21-27. The current consensus 
about the anesthetic mechanism is the “protein theory”, which postulates that the 
anesthetics interact specifically with their target proteins. The competing “lipid theory”, 
which focuses on the anesthetic-induced changes in neuronal functions through 
nonspecific perturbation to membrane lipids in the central nervous system, remains 
viable 22. Previous studies 31,32 have centered on the hypothesis that anesthetics occupy 
the hydrophobic pockets or cavities in the proteins to change the protein function. How 
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exactly it happens, however, is still a mystery. 
The potential target proteins for anesthetics, ligand-gated ion channels, are 
membrane proteins, which are hard to study due to their intrinsic nature. The lack of 
structural information of ligand-protein complexes has impeded the progress of 
understanding as to how the anesthetics alter the biological function of protein. The 
water-soluble dimeric protein, (Aα2-L1M/L38M)2, was engineered to simplify this study by 
de novo design. The designed protein mimics ligand-gated ion channel proteins with a 
long hydrophobic core within a common four-α-helix bundle scaffold 98,99. More 
importantly, this four-α-helix bundle has an anesthetic binding affinity in the range of 
clinical volatile anesthetic concentration. Therefore, it is regarded as a suitable model for 
the protein targets of general anesthetics 99,100. We first completed the NMR structural 
and dynamical analysis of (Aα2-L1M/L38M)2 in the absence of anesthetic 34. The 
apoprotein backbone structure was resolved to a root -mean-square deviation (RMSD) 
of 1.77 Å. As originally designed, two monomers of the helix-turn-helix motif form an 
anti-parallel dimer. The dimeric structure shows that two N-terminus domains from each 
monomer are held together and the same for two C-terminus domains by the ring 
stacking of F12 and W15 along the hydrophobic core and by a leucine zipper from 
complementary pairs of L4, L11, L18, and L25 from each monomer. By examining the 
high-resolution structure, we also identified a lateral access pathway near K47 between 
the two C-terminus domains in the dimer (helix 2 and helix 2′). This specific lateral 
access pathway facilitates the amphipathic anesthetic molecules to enter the 
hydrophobic core directly from the aqueous phase. Different from the initial design, in 
which two symmetrical anesthetic binding sites were intended between W15 and M38 99, 
only one primary anesthetic binding pocket was identified within the hydrophobic core 
suggested by our NMR structure34. By determining the high-resolution structure of (Aα2-
L1M/L38M)2 in the presence of halothane and comparing the structures and dynamics of 
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(Aα2-L1M/L38M)2 in the presence and absence of a bound halothane molecule, we not 
only confirmed the binding sites of anesthetics in (Aα2-L1M/L38M)2, but also revealed 
that an interesting change in protein quaternary structure and in the overall dynamics of 
the protein in the presence of anesthetics. These results shed new light on how volatile 
anesthetics might potentially produce functional changes in proteins in general. 
4.1.2 Materials and methods 
(Aα2-L1M/L38M)2 expression and purification, NMR sample preparation, and all NMR 
methods for structure determination have been described in detail in our previous paper 
34. Briefly, the conventional suite of 2D and 3D heteronuclear filtered experiments for 
spectral assignment and for TALOS dihedral angle constraints and NOESY distance 
restraints were carried out using the standard pulse sequences from the Bruker 
sequence library. 15N- and 13C-filtered NOESY was measured with a mixing time of 120 
ms. The NOESY assignment was done initially using the Cyana program and then 
improved manually 74. Because of the high helical content in (Aα2-L1M/L38M)2 and the 
characteristic short- and mid-range NOE connectivity to define the helix regions in the 
structure, the long-range inter-subunit NOEs from residues on the opposite ends of the 
helices can be distinctively and positively identified by the chemical shift matching with 
an exclusion strategy, without resorting to mixing labeled and unlabeled samples and 
using specific filtering or purging pulse sequences. In the halothane titration 
experiments, the (Aα2-L1M/L38M)2 concentration was 500 µM in 10%D2O/90%H2O with 
0.4% 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS) and 0.02% NaN3. Neat halothane 
was added in 0.3 µl increments using a Hamilton microsyringe. Because evaporation 
during the repeated titration procedure could not be controlled, the halothane 
concentrations in the NMR sample were measured by the halothane 1H intensities after 
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each titration step and then calibrated against the final titration point, at which both 1H 
and 19F intensities were measured, with the 19F intensity calibrated against known 
concentrations of trifluoroacetate solutions 44,45. Based on this calibration, the halothane 
concentrations in the titration experiment ranged from 0 to 2.2 mM, at which point the 
chemical shift change started to plateau. At very low halothane concentrations, the 
halothane peak was too weak to be accurately measured. This technical difficulty 
prevents the site-specific Kd values from being accurately quantified. Therefore, the 
chemical shift change as a function of halothane titration is used in this study only as a 
qualitative indication of the halothane binding site(s). To estimate the magnitude of Kd at 
the binding site, non-linear regression with the following equation was used to fit the 
chemical shift changes as a function of halothane concentration, including the point with 
zero halothane 101,102: 
 
€ 
Δ obs =
Δmax
2[P]0
(KD + [A]0 + [P]0) − (KD + [A]0 + [P]0)2 − 4[A]0[P]0{ }  (4.1.1) 
where [A]0 and [P]0 are the anesthetic and protein concentration, respectively, and ∆max 
is the limiting chemical shift difference. 
Except for temperature dependent amide proton exchange measurements, for 
which HSQC experiments were performed at 25, 30, 35, and 40°C to determine the 
temperature coefficient for hydrogen bonding constraints, all other NMR experiments 
were conducted at 35°C. Most of the NMR experiments were carried out using a Bruker 
Avance 600 spectrometer. For selected experiments, Bruker Avance 700 and 800 
spectrometers were used. 
Two different types of experiments were conducted to determine the halothane 
binding to (Aα2-L1M/L38M)2 by measuring the inter-molecular NOE. The conventional 
two-dimensional 1H-1H NOESY was used to measure the coherent NOE build-up, 
whereas selective saturation transfer was used to measure the non-coherent cross 
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relaxation between the two interacting molecules. The 1H saturation transfer NOE 
experiments used tr-HSQC-based pulse sequence. Selective saturation of halothane 
proton resonance was achieved using an IBURP2 pulse train (80-ms shaped pulses with 
an inter-pulse delay of 4 µ s and a total duration of 1.6 s) preceding the tr-HSQC 
sequence. Interleaving on-resonance and off-resonance (–5000 Hz) spectra were 
acquired to determine the saturation-transfer effects between halothane and individual 
residues. 
The halothane effects on backbone dynamics were measured in the presence of 
2.2 mM halothane and compared with the results obtained without halothane as 
described in our previous paper 34. The 15N R1 and R2 relaxation and 15N-{1H} 
heteronuclear NOE (hetNOE) data were analyzed using the Lipari-Szabo model-free 
approach with the ModelFree program 51,103,104. 
The R2 relaxation dispersion spectra were acquired at 35°C on Bruker 800 MHz 
NMR spectrometers with 15N operating frequencies of 81.09 MHz. The spectra were 
recorded with 1024 t2 and 128 t1 data points, with spectral widths of 10 ppm for 1H and 
24 ppm for 15N dimensions. The relaxation-compensated constant-time Carr-Purcell-
Meiboom-Gill (CPMG) sequence was used 70,71. The total CPMG constant-time delay 
was set to TCPMG = 60 ms (two 30 ms CPMG periods). The spectra were collected with 
10 different CPMG field strengths, measured by vCPMG of 33.33, 66.67, 100.00, 133.33, 
200.00, 266.67, 333.33, 400.00, 500.00, and 666.67 Hz, where vCPMG = 1/(4tCPMG), and 
the separation between the centers of successive refocusing 180° pulses equals 2tCPMG. 
An additional reference spectrum was collected by removing the CPMG periods in the 
pulse sequence. A relaxation delay of 2.5 s was used. The 1H chemical shifts were 
referenced to DSS resonance at 0 ppm, and the 15N chemical shifts were indirectly 
referenced 105. 
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To analyze transverse relaxation dispersion, the intensities of cross-peaks in 2D 
R2 relaxation dispersion spectra with a given CPMG field strength were measured and 
then converted into the 15N transverse relaxation rate constant R2 and associated 
uncertainties according to the well-established relations 106:  
€ 
R2 νCPMG( ) = −
1
TCPMG
ln I νCPMG( )I0
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟      (4.1.2) 
and 
€ 
dR2(vCPMG ) =
1
TCPMG
dI(vCPMG )2
I(vCPMG )2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ +
dI02
I02
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
⎡ 
⎣ 
⎢ 
⎤ 
⎦ 
⎥ 
1/ 2
      (4.1.3) 
where I(vCPMG) and I0 are the intensities for a given cross-peak, and dI(vCPMG) and dI0 the 
noise levels, in the dispersion spectra with and without the CPMG pulse trains, 
respectively. Three exchange parameters, R20, Φex/kex and kex were calculated using the 
fast exchange limit approximation (∆ω = ωa - ωb < kex) with two exchanging sites to fit the 
R2 dispersion profile R2(vCPMG) by 107: 
 
€ 
R2(vCPMG ) = R20 +
Φex
kex
(1− 4vCPMGkex
tanh( kex4vCPMG
))    (4.1.4) 
in which R20 is the R2 without exchange (in the limit of vCPMG = ∞), Φex = (ωa - ωb)2papb, pi 
and ωi are the populations and Larmor frequencies for the nuclear spin in site I; and 
kex is the exchange rate. It should be noted that kex describes exchange rate on the µs-
ms timescale and is not the same as the phenomenological Rex term used in the Model-
Free approach 108,109. 
4.1.3 Specific anesthetic binding 
Two independent NMR methods were used to determine possible site-specific 
interactions between anesthetics and (Aα2-L1M/L38M)2. The first was an anesthetic 
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titration experiment, in which the dependence of chemical shifts of individual residues in 
(Aα2-L1M/L38M)2 was measured as a function of halothane concentration. Fig. 4.1.1 A 
depicts the representative overlaps of HSQC contour plots for four residues where the 
backbone amide 1H or 15N chemical shifts are profoundly affected by varying 
concentration of halothane. Non-linear fitting with Eq. 4.1.1, including the point without 
halothane, yield an estimate of Kd at W15 to be 2.6 ± 1.7 mM (R2 = 0.996). To visualize 
the overall halothane effects on HSQC chemical shifts, the normalized changes in the 
weighted average of the 1H and 15N chemical shifts with and without 2.2 mM halothane 
are color-coded onto the protein structure (see below for structural determination), as 
shown in Fig. 4.1.1 B. Clearly, the most sensitive region is near W15. To further confirm 
that the concentration-dependent chemical shift changes are indeed due to halothane 
binding instead of other non-specific effects, a second, independent NMR method was 
used to measure the saturation transfer between halothane and various residues 110. 
The percentage change in tr-HSQC peak intensity from the saturation transfer difference 
spectroscopy is mapped on the structure (Fig. 4.1.1 C), showing again the specific 
interaction between halothane and the protein near W15, A22, and A44.  Neither 
chemical shift titration nor the saturation transfer difference spectroscopy showed 
significant halothane effects on M38, confirming the prediction from a computer 
simulation 111 and our own structural study 34 that M38 is not directly involved in the 
halothane binding. Thus, the 3.5-fold enhancement in the halothane binding affinity due 
to L38M mutation must result from allosteric effects. 
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Fig. 4.1.1. Halothane binding to the four-α-helix bundle (Aα2-L1M/L38M)2. (A) 
Overlap of HSQC contour plots for residues F12, E14, W15, and A44 in response to 
halothane titration, which was done by adding neat halothane to the NMR sample in 0.3-
µl increments. The same contour scale is used for all peaks in each plot to show relative 
intensities. The peak colors in the order of red, orange, green, blue, and purple indicate 
increasing concentrations of halothane from 0 to 2.2 mM. In the contours for W15 and 
A44, the shifted A44 peaks (Blue and Purple) overlap with the unshifted W15 peak 
(Red). Notice that W15 shows a large chemical shift jump at the first titration point and 
greatly increased intensities at higher halothane concentrations. (B) Individual residues 
in the NMR-determined structure are color-coded according to their normalized chemical 
shift sensitivities to halothane titration, with blue to red representing the least to most 
sensitive, respectively. (C) Normalized saturation transfer NOE is mapped onto the NMR 
structure of (Aα2-L1M/L38M)2 using the blue-white-red color code. This figure was 
reproduced from Biophys J 94, 4464-4472, (2008) 
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4.1.4 High-resolution structure with a bound halothane 
Parallel to the studies without anesthetics as described in the previous study 34, the 
same batch of the expressed proteins was used in the present study to determine the 
(Aα2-L1M/L38M)2 structure in the presence of halothane. The same suite of 
heteronuclear, multidimensional NMR experiments was performed for assignment and 
structure determination. The NOE connectivity and chemical shift index (CSI) pattern 
resemble those shown in Figure 3 of the previous study 34. Again, two helical segments, 
from R5 to E27 and from E36 to R58, are readily identifiable in the NOE connectivity and 
CSI. The two termini and the glycine linker between the two helices appear to be 
unstructured based on the CSI and dynamics results (see below). The statistics of the 20 
structures with the lowest target function is given in Table 4.1.2. The overall backbone 
RMSD is 1.72 ± 0.39 Å; the backbone RMSD of the helical regions is 1.05 ± 0.28 Å. The 
insignificant difference in RMSD between the apo and halothane-bound protein 
structures is likely due to the difference in the spectral quality and the different numbers 
of total constraints available for the structural calculation.  In the presence of halothane, 
at least two inter-molecular NOE peaks were positively identified in 2D NOESY between 
halothane and L18 and A44 (Fig. 4.1.3). Structural calculations with the inclusion of a 
halothane molecule clearly define the halothane binding pocket, which is shown to be 
bordered by the aromatic side chains of W15 and the hydrophobic side chains of L18 
and A44 in the dimeric form (see Fig. 4.1.4 E). Fig. 4.1.4 A and Fig. 4.1.4 B show the 
superposition of the structures with and without halothane in the monomer and dimer 
form, respectively, exhibiting nearly the same secondary and tertiary monomer 
structures and pronounced quaternary structural changes after the addition of halothane. 
The side-chain arrangements surrounding the primary halothane binding site without and 
with a bound halothane are depicted in Fig. 4.1.4 C and D, respectively, and the packing 
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details of halothane interaction with the protein at the binding site are shown in Fig. 4.1.4 
E. While the halothane orientation in the pocket is not fixed, there is a clear orientation 
preference in binding interaction in the bundle of structures (Fig. 4.1.5) due to cation-pi 
type of interaction between the partial positive charge on the hydrogen atom of 
halothane 112 and the aromatic ring of W15. Among the 20 lowest-energy structures, 12 
have a halothane orientation as shown in Fig. 4.1.4E, with halothane’s Br and Cl each 
interacting with one of the two hydrophobic side chains of L18, and the hydrogen and the 
CF3 moiety orienting towards the W15 aromatic ring and the A44 side chain, 
respectively. In the remaining 8 structures, the halothane flips about 180° to point the 
proton to the aromatic ring of the other W15. 
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Table 4.1.2. Structural statistics of 20 (Aα2-L1M/L38M)2 structures with halothane 
NMR structure Statistic 
Restraints per monomer 
 NOE distances  
  Intraresidue 144 
  Short range (i-j = 1) 128 
  Medium range (1 < i-j ≤ 4) 96 
  Long range (i-j > 4) 15 
  Dimer (intermonomer) 6 
 Dihedral angles 72 
 Hydrogen bonds 20 
 
Residual upper limit constraints violations number > 0.5 Å 0 
 
Residual dihedral angle constraints violations number > 5° 0 
Backbone RMSD 
 Residues 5-27, 36-58, 205-227, 236-258 1.05 ± 0.28 Å 
 All residues (1-62, 201-262) 1.72 ± 0.39 Å 
 
Heavy atom RMSD 
 Residues 5-27, 36-58, 206-226, 236-258 1.56 ± 0.32 Å 
 All residues (1-62, 201-262) 2.07 ± 0.36 Å 
 
Ramachandran plot 
 Residues in most favored regions 91.0% 
 Residues in allowed regions 8.9% 
 Residues in disallowed regions 0.2% 
 
This table was reproduced from Biophys J 94, 4464-4472, (2008) 
 
CHAPTER 4 NMR STUDY OF INHALATIONAL ANESTHETIC MECHANISM 
 96	  
 
 
 
 
 
 
Fig. 4.1.3. A contour plot of a 1H-1H 2D NOESY spectrum. It shows unambiguous 
crosspeaks between halothane resonance at 6.4 ppm and the side chains of L18 and 
A44. This figure was reproduced from Biophys J 94, 4464-4472, (2008) 
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Fig. 4.1.4. Comparison of high-resolution NMR structures of (Aα2-L1M/L38M)2 
determined with and without halothane. (A) The monomer structure determined in the 
presence of halothane (Purple) is superimposed onto the structure of the apoprotein 
(Yellow). (B) Superposition of the dimer structures. Notice the quaternary structural 
changes and supercoiling of the helices in the presence of halothane. (C) Side view of 
hydrophobic core of the four-α-helix bundle in the absence of halothane. (D) Side view of 
hydrophobic core of the four-α-helix bundle with a halothane bound in the primary 
binding site. (E) Detailed interactions between halothane and the residues surrounding 
the anesthetic binding pocket. In C, D, and E, important side chains are shown in licorice 
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representation: W15 (Orange); K47 (Cyan); E43 (Pink); F12 (Green); and A22 and A44 
(Lime). The halothane molecule is shown in VDW spheres: C (Cyan); H (White); Cl 
(Blue); Br (Red); and F (Pink). This figure was reproduced from Biophys J 94, 4464-
4472, (2008) 
 
 
 
 
Fig. 4.1.5. Orientations of halothane molecules in the binding pocket. A bundle of 
20 halothane molecules (C-C bond (Cyan); C-H bond (White)) is depicted in relation to 
the bundle of W15 side chains (Orange) in the 20 lowest energy structures. Although the 
halothane orientation is not fixed, the hydrogen, with partial positive charge, has the 
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tendency to point to the aromatic ring of W15 due to cation-pi type of interaction. This 
figure was reproduced from Biophys J 94, 4464-4472, (2008) 
4.1.5 Anesthetic effects on the backbone dynamics 
The backbone dynamics was determined by analyzing the R1, R2, and hetNOE of the 
backbone amide 15N with and without halothane using the Model-Free approach 103,104. 
In addition, the conformation exchange on the µs-ms timescale was examined using the 
CPMG R2 dispersion measurements. The effects of halothane binding on the local and 
global dynamics are depicted in Fig. 4.1.6 and Fig. 4.1.7. Fig. 4.1.6 shows the 
conventional Model-Free analysis, depicting the generalized order parameter, the 
correlation time of the fast local motion (τe), the exchange contribution to the relaxation 
(Rex) 113, and the model number used to fit the data. As in the case without anesthetics, 
the two termini and the loop regions are significantly more flexible with order parameters 
lower than 0.5. The loop region does not meet the basic Lipari-Szabo assumption and 
can only be fitted with Model 5. In the presence of halothane, the residues in the 
immediate vicinity of the binding site showed slightly elevated order parameters, 
becoming more ordered than without halothane. The most profound changes are seen in 
the global distribution of the Rex term in the helical regions. Overall, Rex is reduced upon 
halothane binding, suggesting a lesser degree of conformational exchange. The 
involvement of non-zero Rex terms in many residues is confirmed by the R2 dispersion 
measurements, which are independent of the model selection or the spectral density 
mapping. As shown in Fig. 4.1.7, many residues exhibit the R2 dependence on the 
CPMG frequencies. The ΔR2 values, which are estimated from the R2 values at the two 
extreme CPMG frequencies achievable with our NMR hardware, display the same 
distribution pattern as Rex along the protein sequence (Fig. 4.1.7B). It should be noted 
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that the ΔR2 measured by the relaxation dispersion underlies the phenomenological non-
zero Rex term in the Model-Free analysis, albeit the two are not expected to be identical 
108 because the two experimental methods are sensitive to motions on different 
timescales. Nevertheless, the overall trend is clear, and the binding of halothane 
reduces the conformational exchange on the global scale. The significance of this 
reduction in Rex (or ΔR2) will be discussed below. As in the case without halothane, two 
residues, M38 and C41, still show a larger Rex than other residues, albeit halothane 
reduced the Rex values by a factor of 2. There seems to be also a slight tendency that 
halothane binding makes the loop region more ordered as shown in the S2 values. This 
is supported by the slightly elevated R2 values for some of the loop residues in the R2 
dispersion measurements (e.g., G30 in Fig. 4.1.7A). However, since the R2 dispersion 
method is prone to artifacts when R2 is not significantly larger than R1 114, which is indeed 
the case for the loop residues, the small difference in the R2 dispersion with and without 
halothane should be taken with caution for the loop and terminal residues. Using the 
same method as in the previous paper 34 to search for the best-fitted τ m value, the 
ModelFree calculations yielded the global tumbling time of 5.00 ± 0.08 ns, in agreement 
with the global tumbling time of the apo protein. 
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Fig. 4.1.6. Comparison of (Aα2-L1M/L38M)2 dynamics in the presence and absence 
of halothane binding. (A) The squared order parameter (S2), (B) the local correlation 
time (τe), (C) the exchange contribution (Rex), and (D) model number used in the model-
free analysis are plotted as a function of the residue numbers of the four-α-helix bundle, 
depicting the dynamics in the absence (○) and presence (●) of 2.2 mM of halothane. 
Notice that halothane stabilizes overall protein motion as evidenced by the increased S2 
in the immediate vicinity of W15 and the globally reduced Rex terms at many residues. 
This figure was reproduced from Biophys J 94, 4464-4472, (2008) 
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Fig. 4.1.7. Backbone
15
N relaxation dispersion profile of (Aα2-L1M/L38M)2. (A) 
Representative plots of the 15N transverse relaxation rate, R2, as a function of the CPMG 
field strength, νCPMG, for L4 (◊), G30 (Δ), M38 (□), C41 (○), and E50 (∇) in (Aα2-
L1M/L38M)2 without (Open symbols) and with (Solid symbols) 2.2 mM halothane at 18.8 
T (800 MHz). Uncertainties in R2 were determined from the signal/noise ratio using Eq. 
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4.1.3. The R2(νCPMG) dispersion profiles for L4, M38, C41, and E50 demonstrate the 
contribution of conformation exchange to the 15N transverse relaxation rate. The solid 
and dash lines are the best fit to the data for the protein in the absence and presence of 
the anesthetic, respectively, using Eq. 4.1.4. G30 shows no conformation exchange and 
is presented here as a reference. (B) Values of Δ R2 = R2(νCPMG=33.3 Hz) −  
R2(νCPMG=666.7 Hz) are plotted as a function of residue numbers in (Aα2-L1M/L38M)2 
without (○) and with (●) halothane at 18.8 T. Most residues show a decreased ΔR2 in the 
presence of halothane, indicating that halothane suppresses the global conformational 
exchange in the protein. This figure was reproduced from Biophys J 94, 4464-4472, 
(2008) 
 
 
4.1.6 Primary anesthetic binding site in the four-α-helix bundle 
Four-α-helix bundle is a common scaffold found in many important functional proteins. 
For example, the TM domains of anesthetic-sensitive superfamily of Cys-loop receptors 
are composed of pseudosymmetric pentamers of four-α-helix bundles. Serving as a 
model for anesthetic protein targets, (Aα2-L1M/L38M)2 was designed with a few 
iterations of design changes aimed at improving the binding affinity for volatile 
anesthetics 98,99. Our structural studies of (Aα2-L1M/L38M)2 in the absence of a bound 
anesthetic, as detailed in previous study 34 ,  suggested a primary binding site between 
the two W15 side chains in a dimer and an amphipathic lateral access pathway from the 
aqueous phase through the flexible C-terminal helix interface into this binding site. 
These findings are somewhat unexpected because the intended binding sites by design 
are closer to the two ends of the hydrophobic core of the four-helix bundle, and thus 
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there should be two sites that are mirror images of each other. In the present structural 
study with halothane, we confirmed that the main halothane binding site is indeed 
sandwiched between the two W15 residues. The chemical shift changes in response to 
titration with varying concentrations of halothane, the saturation transfer experiment, and 
2D NOESY experiment all indicate that the preferred halothane interaction site are in the 
middle section of the four-helix bundle, instead of between W15 and M38 as the latest 
iteration of design had intended. The apparent dissociation constant for halothane 
binding to (Aα2-L1M/L38M)2 is estimated to be in the submillimolar range based on the 
fluorescence quenching on (Aα2-L38M)2 99. Our chemical shift titration experiments, 
which measure the halothane influence on the protein backbone amide nitrogen and 
proton chemical shifts, probe the relative involvement of individual residues in the 
anesthetic binding. Since the side chains at the binding site are more directly involved in 
the interaction than the backbone, the site-specific Kd determined from the backbone 
chemical shifts does not necessarily reflect the true binding affinity at the interaction site. 
Nevertheless, the approximate Kd value obtained from the chemical shift titration 
measurements is consistent with the apparent Kd from the fluorescence quenching 
experiments 99. 
It is interesting to note that when the experimental structures were used in a 
docking search for potential halothane binding sites, we found that the site between two 
W15 side chains is highly preferred (~98%) but not exclusive in the apoprotein. In 
contrast, with the lowest energy structure determined in the presence of halothane, 
Autodock 115 found the halothane-binding site to be exclusively between W15 side 
chains. The estimated free energy of binding from Autodock is –3.35 kcal/mol (4.89 
mM), which is in agreement with the experimental titration data. 
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4.1.7 An induced fit for anesthetic binding 
Detailed structural analysis revealed that the monomeric helix-turn-helix fold is very 
similar in the two structural bundles with and without a bound anesthetic, as shown in 
Fig. 4.1.4 A. When fitting the helical regions of the monomers, the RMSD between the 
two structural bundles is ~1.5 Å, which is only slightly larger than the RMSD of the 
monomers among the 20 lowest-energy structures of each bundle. Thus, halothane 
binding did not greatly affect the monomer (secondary and tertiary) structure. As shown 
in Fig. 4.1.4 B, the most significant structural change upon halothane binding is the 
quaternary association of the four helices in the dimer. There is a vertical shift of the 
monomers relative to each other by approximately half a helix turn and a super-coil 
twisting of the helices when a halothane molecule is bound at the site between the two 
W15s. These quaternary structural changes removed the asymmetry found in the 
apoprotein due to wider separation between helix 2 and helix 2′. The halothane-induced 
quaternary changes led to a better fitting between halothane and the amphipathic cavity 
of the binding site. Measured by the Q-SiteFinder program 116, the binding cavity 
bordered primarily by the side chains of W15, L18, and A44 (Fig. 4.1.4, D and E) 
reduces its size from ~381 Å3 in the structures without halothane to ~162 Å3 in the 
structures determined with halothane (after removing halothane from the structure). The 
latter value better matches the molecular volume of halothane (~130 Å3 117,118). Thus, our 
structural data suggest an induced fit between halothane and its binding site. The high 
structural flexibility of the apoprotein, the lateral opening between helix 2 and helix 2′ for 
direct access to the binding site from the aqueous phase, and the quaternary structural 
re-arrangement for an induced fit can all contribute to an increase in the binding on-rate. 
As evidenced in the packing between the halothane molecule and the residues 
surrounding the binding pocket (Fig. 4.1.4 E), the interaction at the binding site is both 
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hydrophobic and electrostatic in nature. Optimization of the fitting in the binding site and 
the closure of the lateral pathway as a result of the twisting of helices 2 and 2′ relative to 
helices 1 and 1′ will likely decrease the binding off-rate, thereby achieving the high-
affinity specific binding of halothane in this designed protein. 
4.1.8 Implications of anesthetic effects on local and global dynamics 
In addition to the structural changes, halothane binding to the four-α-helix bundle also 
resulted in profound changes in the protein dynamics, not only locally but also globally at 
residues remote from the binding site. This finding is important because protein function 
always involves protein motion. Thus, the four-α-helix bundle offers more than just a 
structural model. The characteristics of halothane effects on the dynamics of (Aα2-
L1M/L38M)2 may have universal implications on how anesthetic binding to protein 
ultimately leads to changes in protein functions 23,24,26,27,119-121. 
In the absence of halothane, (Aα2-L1M/L38M)2 appears extremely dynamic on 
the NMR timescale 34. Model-free analysis showed that many residues in the helical 
regions contain the Rex contribution to the backbone amide 15N relaxation, suggesting 
the presence of a conformational exchange process at these residues 104,112,122. This 
finding is confirmed in this study by the R2 dispersion measurements. By comparing the 
model-free analyses of the relaxation data with and without halothane as shown in Fig. 
4.1.6 and of the R2 dispersion data as shown in Fig. 4.1.7, it is clear that halothane 
binding not only stabilizes the residues in direct contact with halothane, but also reduces 
the Rex (or ΔR2) on a global scale. The most noticeable Rex changes in (Aα2-
L1M/L38M)2 are at W15 and near M38 and C41. In the apoprotein, W15 signal is 
relatively weak (hence precluding the R2 dispersion measurement), presumably due to 
an intermediate exchange. Indeed, when the site is not occupied, there is a large degree 
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of orientation freedom for the W15 side chains within the hydrophobic core. The NMR 
structure of the apoprotein suggests that W15 side chains tend to swing toward F12 to 
form an aromatic ring stack within the long stretch of hydrophobic core, leaving a large 
space between the W15 side chains to accept halothane. When the site is occupied, the 
two W15 side chains are locked into a parallel configuration (Fig. 4.1.4, D and E) with 
reduced local flexibility, as indicated by the increased order parameter at W15 and 
nearby residues. This not only changes the chemical shift but also increases the 
intensity of W15 in HSQC (Fig. 4.1.1 A). One of the direct consequences of the reduced 
W15 side chain flexibility—in addition to the induced fitting for high-affinity halothane 
binding as discussed above—is the largest decrease of the Rex term associated with 
W15 (Fig. 4.1.4 E). 
As discussed previously 34, another dynamic hotspot in (Aα2-L1M/L38M)2 is 
located near M38 and C41. Both of these residues showed a large Rex term compared 
to the rest of the protein when no halothane is bound. It is known that a point mutation at 
residue 38 from Leu to Met can result in a 3.5-fold increase in halothane binding 99. 
Such an increase could be due to changes in either structure or dynamics, or both. 
Structurally, Leu-Met mutation has been shown to be well tolerated by numerous studies 
99,100. Because M38 (or L38) is not even part of the halothane binding site according to 
the NMR structure, local steric effects in a structural sense are unlikely to be the cause 
of the increased binding affinity after the mutation. In searching for other possible 
explanations, we believe that global dynamics is an obvious candidate, given the 
unusual dynamics property near the mutation site. The allosteric coupling between W15 
and M38 is clearly evident in the large reduction of the Rex term at M38 and C41 on 
halothane binding at W15. This suggests that residue 38 is situated at a pivotal point to 
control the global dynamics of the protein. Although Leu and Met are close on the 
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hydrophobicity scale 123, methionine's side chain is longer and narrower than leucine's 
side chain. Residue 38 is at the first heptad g position in the first turn of helix 2 after the 
flexible glycine linker. From the apoprotein structure, it can be seen clearly that the M38 
side chain is sandwiched between the adjacent L37 and the more distant E27 and A23, 
all of which congregate at the two ends of the flexible glycine loop. The long and linear 
M38 side chain can either point toward the glycine loop or toward the lateral aqueous 
phase, depending on the glycine loop orientation. If L38 resumes the same local 
structure as M38, its side chain has predictably less orientation freedom relative to the 
glycine loop due to its bulkier branching methyl groups. Therefore, it is conceivable that 
the mobility at residue 38 in relation to the flexible linker is critical to the opening and 
closing of the lateral pathway between helix 2 and helix 2′. The higher halothane binding 
affinity found in the L38M mutation can be explained by the increased on-rate, whereas 
the off-rate should be dictated by the W15 ring stacking and induced fit after halothane 
has occupied the binding site, which would be similar irrespective of L38 or M38. 
In support of this viewpoint is the dynamics change at E43 and K47, where 
sizeable Rex terms can be seen when halothane is absent. After halothane binding, the 
high-resolution NMR structures reveal that the quaternary structural changes shift E43 of 
one monomer to almost the same level as K47 of the other monomer. The super-coil 
twisting brings E43 at heptad b position closer to K47 at heptad e position of the 
opposing helix. The electrostatic interaction stabilizes E43 and closes the interface (and 
thus the lateral access pathway) between helices 2 and 2′. As a consequence, both E43 
and K47 show a significantly reduced Rex term after halothane binding. 
Our results suggest an interesting interplay between structural fitting and 
dynamical contribution to anesthetic binding at protein targets. From a pure structural 
viewpoint without considering protein mobility, the space between two W15 side chains 
in the apoprotein would not seem ideal for halothane binding. As discussed above, there 
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is a large discrepancy between the cavity size (381 Å3) and the volume of the anesthetic 
molecule (130 Å3) for a snug structural fit. However, the opening between helices 2 and 
2′ and their conformational flexibility create an easy access directly from the aqueous 
phase to this site. The intrinsic global mobility of this dimeric protein and the interaction-
induced structural fitting between halothane and the key residues at the binding site 
make this site more favorable than other potential sites. For example, the minor sites 
found by the Autodock program in the apoprotein between F12 and F52 would be 
theoretically suitable for halothane binding. These minor sites, however, are not 
occupied with high affinity due to divergence of the structural and dynamical factors at 
these sites. As discussed in the previous study 34, the side chain of F52 seems to be “out 
of place” in the aqueous phase. Although the local rotational freedom of F12 and F52 
side chains would allow halothane to bind, the absence of a consequent structural 
change to secure the binding would render any halothane occupancy between F12 and 
F52 short-lived. Similarly, Q-SiteFinder revealed two amphipathic pockets bordered 
mainly by A8, F12, L51, L54, and R58 of one monomer and L26, E27, L37, M38, and 
C41 of the other monomer, along with three residues from the glycine loop. These 
pockets have a volume of 303 Å3 but show no interaction with halothane experimentally 
and yield no population by flexible docking. The controlling factor in this later case is 
likely to be the protein dynamics. Thus, when searching for important anesthetic 
interaction site or sites in neuronal proteins to understand the molecular mechanisms of 
general anesthesia, one must analyze and differentiate the structural and dynamical 
contributions to the functional consequences of anesthetic-protein interactions. 
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4.1.9 Conclusion 
In conclusion, we identified a novel anesthetic binding site in the designed four-α-helix 
bundle (Aα2-L1M/L38M)2 by solving its high-resolution structure in the presence of 
halothane. Different from the designed locations, this site becomes preferred over other 
potential sites, including the two designed sites, for anesthetic binding after the 
interaction between the anesthetic and protein has occurred. The intrinsic global 
dynamics characteristics of this protein make the induced fitting possible, and the 
induced structural fitting upon anesthetic binding, in turn, modifies the local and global 
dynamics of the protein. For neuronal proteins, the latter aspect is likely to account for 
functional change of the proteins, ultimately leading to the anesthetizing effects. It is 
consistent with what we have proposed more than a decade ago, based on the analysis 
of xenon 25, that some molecules would not normally be classified as general anesthetics 
due to their lack of basic properties found in common anesthetizing agents, but they 
nevertheless can produce anesthesia by gaining these properties after interactions with 
their targets takes place (e.g., induced dipole in xenon). We now show an example of a 
related phenomenon, namely, that the protein targets can be turned into relevant to 
anesthetic action only after the interaction between anesthetic and protein has taken 
place. The value of the designed four-α-helix bundle as a model for anesthetic targets 
lies not only in its structural resemblance to the ubiquitous scaffold found in many 
functional proteins, but also in its dynamics characteristics that are perhaps more 
relevant to the functional response to anesthetics 23,24. 
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4.2 ANESTHETIC EFFECTS ON THE MEMBRANE PROTEIN, 
MISTIC 
This section has been published in J Phys Chem B 112, 14312-14318, (2008) as a full 
article. I am the co-author. I rewrote it based on the paper. 
4.2.1 Significance 
The current consensus about the mechanism of general anesthesia is that inhaled 
anesthetics act on the membrane proteins in the central nervous system (CNS) and 
affect neural networks. A wealth of molecular biology and electrophysiology studies have 
demonstrated that neurotransmitter-gated ion channels, particularly Cys-loop receptors 
21,30, are plausible targets for general anesthetics. These ion channels are sensitive to 
volatile anesthetics at clinically relevant concentrations. However, it is still unclear where 
anesthetic binding sites reside and whether the induce fit between anesthetics and their 
target proteins, such as what we have found in the four-α-helix bundle 34, is still 
applicable for anesthetics interacting with proteins. Furthermore, we have recently 
proposed that anesthetics exert their action on proteins through disrupting the modes of 
global motion essential to protein functions 24. 
To experimentally validate our hypothesis, directly obtaining structural and 
dynamic information of neuronal proteins with atomic resolution is often challenged by 
technical obstacles, such as limitations of protein size and low expression yields, for 
nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography. Instead, a 
membrane model protein (membrane integrating sequence for translation of integral 
membrane protein constructs, Mistic) that mimics certain properties of Cys-loop channel 
receptors was investigated in the absence and presence of general anesthetics by NMR 
spectroscopy. Mistic shares four-α-helix bundle structural motif with other TM domains of 
Cys-loop receptors. It has been shown that general anesthetics are presumed to binding 
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to the TM domain of Cys-loop receptors 124. And a de novo designed prototype protein 
with specific anesthetic binding pocket 32,34,98 and a natural soluble protein (ferritin) 125, 
both of them with such a special four-α-helix bundle motif, served previously as models 
for investigating the structural basis of inhaled anesthetic binding in proteins. Mistic was 
chosen not only because it naturally folds into a four-α-helix bundle motif in micelles, but 
also the structure of Mistic has been previously determined by NMR spectroscopy in 
lauryl dimethylamine oxide (LDAO) micelles 47. High-quality NMR spectra of Mistic 
facilitate us to explore molecular details of anesthetic and Mistic interaction at atomic 
resolution. The information obtained from these studies could be applicable for 
understanding molecular insight on anesthetics in much more complex membrane 
proteins, neurotransmitter-gated ion channels and further validate our working 
hypothesis that inhaled general anesthetics act on proteins via altering protein motions, 
especially motions in the flexible loops, which connects different TM helices.  
Halothane binding sites were identified mostly in the interfacial loop regions. 
Although halothane had little effect on Mistic structure, R2 relaxation dispersion 
experiments revealed that halothane affected Mistic’s motion on the microsecond-
millisecond time scale. Compared to the absence of anesthetics, halothane can affect 
the equilibrium of chemical exchange in some residues. It is also shown that the motion 
of the microsecond-millisecond time scale was suppressed and disappeared for several 
residues. Most residues show the obvious chemical shift changes in the presence of 
halothane, while their dynamics were modulated by halothane at the same time. It 
indicates that halothane modulates the dynamics of the protein through directly 
interacting with these residues. In addition to the direct interaction, allosteric modulation 
by halothane was also found to contribute to dynamics changes. For example, I52 and 
Y82 do not experience chemical shift changes but show the dynamics changes. In 
conclusion, general anesthetics could act on the target protein by modulating its motion 
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on microsecond-millisecond time scale. The most profound region is located in the 
flexible loops, which connect with different TM helices. Interestingly, the corresponding 
loop region is critical for signal transduction in Cys-loop receptors. And many 
biochemical events occur on microsecond-millisecond time scale. Therefore, we propose 
that anesthetics modulate the microsecond-millisecond time scale motion that is 
correlated with protein function and it may be a critical step in the mechanisms of 
anesthesia. 
4.2.2 Materials and methods 
The gene-encoding Mistic was cloned from B. subtilis into the expression vector 
pTBSG1 (a gift from Prof. Timothy A. Cross’ laboratory at Florida State University). 
Mistic was expressed in strain BL21(DE3) CodonPlus cells (EMD biosciences) using the 
Marley protocol 126. Typically, expression was induced with 0.2 mM isopropyl β -d-1-
thiogalactopyranoside and kept in M9 minimal medium at 12 °C for about 80 h. The 
protein was purified using published procedures 47. A yield of 120 mg of purified Mistic 
was obtained from each liter of M9 minimal media. In order to extend the stability of 
Mistic samples, Mistic was exchanged into DPC during purification. The samples for 
NMR experiments typically contained 0.5 mM of either 15N-labeled or 13C/15N-labeled 
Mistic, 30 mM DPC, 0.2 mM dithiotreitol, 50 mM KCl, and 10 mM potassium phosphate 
buffer at pH 6.0. 
All 1H, 15N, and 13C NMR experiments were performed at 30 °C on Bruker 
Avance 600 or 700 or 800 MHz NMR spectrometers equipped with cryoprobes (Bruker 
Instruments, Billerica, MA). The 1H chemical shifts were referenced to the 2,2-dimethyl-
2-silapentene-5-sulfonate resonance at 0 ppm, and the 15N/13C chemical shifts were 
indirectly referenced. 19F NMR experiments were performed on a Bruker Avance 600 
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spectrometer with a Bruker TXO probe to determine halothane concentrations in 
reference to a solution with 10 mM trifluoroacetic acid (TFA). Although the chemical 
shifts assignments of Mistic in LDAO were done previously 47 and the 1H−15N TROSY-
HSQC spectra of Mistic in DPC showed high similarity to that in LDAO, we repeated the 
same two-dimensional (2D) and three-dimensional (3D) NMR experiments 47 for the 13C 
and 15N chemical shift assignments of Mistic in DPC. A series of 1H−15N TROSY-HSQC 
spectra were collected on samples with five different halothane concentrations, ranging 
from 0 to 13 mM, to determine site-specific dissociation constants. The CBCA(CO)NH 
and HBHA(CO)NH spectra were acquired in the absence and presence of halothane so 
that the chemical shifts of Cα, Cβ, Hα, and Hβ at these two different conditions were 
obtained for comparison. 1H−15N residual dipolar couplings (RDCs) of Mistic were 
measured using a TROSY-IPAP-HSQC pulse sequence with 1024 (1H) × 256 (15N) 
complex points. A weak alignment of 15N-labeled Mistic in DPC micelles was achieved 
in both compressed and stretched charged polyacrylamide gel. The degree of alignment 
for each sample was checked using one-dimensional (1D) 2H NMR experiments. 
To confirm anesthetic direct interaction with Mistic, 1H saturation transfer 
difference (STD) NMR 127 was performed on a 0.5 mM 15N-labeled Mistic sample in 30 
mM DPC in the presence of 10 mM halothane. As a control, the same experiment was 
also performed on a similar sample but without Mistic. The spectra were obtained in an 
interleaved manner using irradiation of 50 ms Gaussian pulses applied on-resonance at 
0.58 ppm, corresponding to Mistic methyl protons, and off-resonance at 40 ppm. The 
pulse sequence utilized the WATERGATE water suppression and spoil sequence to 
destroy unwanted magnetization 128. A series of STD spectra were acquired within a 
range of saturation times: 0.5, 1, 3, 5, 10, 20, and 40 s. Each spectrum had 64 scans 
with a relaxation delay of 40 s. The STD (ΔI = Ioff − Ion) was calculated by subtraction of 
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the intensities of the on-resonance peak (Ion) from those of the off-resonance peak (Ioff) 
40,129. 
To characterize the dynamic property of Mistic, spin−lattice (R1) and spin−spin 
(R2) 15N relaxation rate constants were measured with 512 (1H) × 128 (15N) complex 
points using standard pulse sequences with echo−antiecho gradient selection 130. Nine 
(ranging from 10−1800 ms) or 10 (16−160 ms) variable delays were used for the R1 or 
R2 measurements, respectively. The effective transverse relaxation rate was also 
measured using relaxation-compensated Carr−Purcell−Meiboom−Gill (CPMG) 
experiments as a function of CPMG field strength (νCPMG) 71,109. The 15N R2 relaxation 
dispersion data are suited to determine Mistic’s conformation exchange on the 
microsecond−millisecond time scale in the presence and absence of halothane. The R2 
relaxation dispersion profiles were recorded at two different magnetic field strengths 
corresponding to 1H frequencies of 600 and 800 MHz. The experiments were performed 
in a constant time manner (TCP = 60 ms) on uniformly 15N-labeled Mistic samples. The 
CPMG field strength, νCPMG, was varied to 33.33, 66.67, 100.00, 133.33, 200.00, 266.67, 
333.33, 400.00, 500.00, and 666.67 Hz. 
All NMR data were processed using NMRPipe 72 and analyzed with Sparky 73. 
The chemical shift assignments were accomplished with the aid of AutoAssign 131 and 
manual comparison to the assignments of Mistic in LDAO 47. The structure of Mistic in 
DPC micelles was obtained through refinement of the lowest-energy structures (PDB: 
1YGM) of Mistic in LDAO micelles 47 using dihedral angle restraints obtained from Cα  
and Cβ chemical shift index (CSI) processed using Talos 75 and RDC data of helical 
regions obtained from two different alignment mediums. The refinement used the slow 
cooling simulated annealing protocol in Xplor-NIH 132. The axial (Da) and rhombic (R) 
components of the alignment tensor in RDC experiments were determined using the 
histogram method 133, producing Da = −10.8 and R = 0.23 for samples in compressed 
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gel and Da = −10.0, R = 0.27 for samples in stretched charged gel, respectively. A total 
of 100 structures were produced in the refinement, and half of them with lower energies 
were used for an averaged structure. The best-fit comparison between experimental 
RDCs and the refined structures were performed using the program MODULE 1.0 134. 
15N relaxation dispersion data were analyzed using Eq. 4.2.1, which encompasses all 
chemical exchange timescales: 135 
€ 
R2 = [R20 + (kex /2) − vCPMG cosh−1(D+ cosh(η+) −D− cos(η−))]                        (4.2.1) 
where D± = 1/2(±1 + (ψ + 2Δω2)/(ψ2 + ξ2)1/2), η± = (νCPMG/2(2)1/2)(±ψ + (ψ2 + ξ2)1/2)1/2, ψ = 
kex2 −  Δω2, ξ = −2Δω(pakex −  pbkex), R20 is the intrinsic transverse relaxation rate, kex is 
the exchange rate, Δω is the difference of chemical shifts between exchange sites a and 
b, the population of site a is denoted by pa = (1 − pb), νCPMG = 1/(2τ), and τ is the time 
between centers of successive 180° pulses in the CPMG pulse sequence. 
4.2.3 Halothane interaction site in Mistic 
Halothane and Mistic direct interaction was confirmed by the STD experiments shown in 
Fig. 4.2.1. A halothane peak obviously appeared in STD spectra in the presence of 
Mistic (fig. 4.2.1A), while in the absence of protein the halothane peak cannot be 
observed in the same experimental conditions (fig. 4.2.1B). The on-resonance saturation 
frequency was set at 0.58 ppm, which is a frequency far away from halothane proton but 
near the methyl group of the protein side chain. The halothane binding sites in Mistic 
were studied by halothane titration experiments, shown Fig. 4.2.2. 
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Fig. 4.2.1. Halothane Mistic interaction.
1
H STD NMR spectra of 10 mM halothane 
(resonance at 6.48 ppm) in (A) 30 mM DPC with 0.5 mM Mistic and (B) 50 mM DPC 
without Mistic. The arrow indicates the frequency for on-resonance saturation at 0.58 
ppm that is near the Hδ resonance of Leu and Ile residues in Mistic. Note that the 
halothane signal was not observed in panel B under the same NMR conditions as in A, 
but without Mistic, indicating a direct interaction between halothane and Mistic. A stick 
chemical structure of halothane is inserted for reference. This figure was reproduced 
from J Phys Chem B 112, 14312-14318, (2008) 
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Fig. 4.2.2. NMR mapping of halothane effects on Mistic. Overlay of 
1
H−
15
N TROSY-
HSQC spectra of 0.5 mM Mistic in 30 mM DPC micelles in the absence (Black) and 
presence (Red) of 10 mM halothane. The spectra were acquired at 30 °C. Despite many 
residues being undisturbed by the addition of halothane, some residues experienced 
significant chemical shift changes and/or intensity changes of their resonance signals. A 
few examples are highlighted in small boxes. This figure was reproduced from J Phys 
Chem B 112, 14312-14318, (2008) 
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 A number of residues showed profound chemical shift changes in the presence 
of halothane. For some residues, such as A40 and Q66, both chemical shifts and peak 
intensity changed after the addition of halothane. The S58 signal became much 
stronger, while the I52 peak intensity became much weaker. The peak intensity changes 
suggest that there may be the dynamic modulation in the region where the residue 
resided. Fig. 4.2.3 highlights Mistic residues that experienced obvious changes in 
chemical shift (HN > 0.05 ppm, Cα and Cβ > ± 1 ppm, Hα and Hβ > ± 0.1 ppm) upon 
halothane titration. The chemical shifts of most residues in helices were insensitive to 
anesthetics, except for some residues in the middle of α2 helix or adjacent to the loop 
regions. And both N- and C-terminal residues of Mistic do not respond to the addition of 
anesthetics, suggesting they may be buried in the similar hydrophobic environment as 
most helical residues do. It was confirmed by detergent exchange experiments. Most 
helical residues and both N- and C-terminal residues were insensitive to the different 
types of detergents. In contrast to less sensitive helical residues, all loop residues were 
more or less perturbed by halothane. Thee loop residues were identified to be located in 
the aqueous phase in the micelle, because they are sensitive to the head group of the 
detergents. A40 and M44, near to the kink in α 2 helix, were affected by halothane, 
suggesting they may form a specific pocket for anesthetics. 
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Fig. 4.2.3. Halothane interaction sites in Mistic. The residues whose chemical shifts 
were significantly perturbed by halothane are highlighted in orange color. The four TM 
helices are marked as α1−α4.  This figure was reproduced from J Phys Chem B 112, 
14312-14318, (2008) 
 
 
Halothane dissociation constants in the loop regions were determined. Halothane 
interaction with Mistic loop residues at aqueous interface of the micelle indicates that 
general anesthetics prefer to the amphipathic environment, water−lipid interfaces 25,40,42. 
As we know, protein loops play a certain role in the protein function. The role will be 
more critical, when the loop is located in the aqueous phase. For example, a point 
mutation introduced in the TM2-3 loop in the α 1 subunit of the GABA receptor can 
prohibit the correct communication between the TM domain and the EC domain, which 
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further affect the channel conductivity 136. Halothane prefers to interfering with the loop 
regions in Mistic, which suggests that anesthetic act on the protein through modulating 
the residues having important function such as loop residues. The significance of this 
finding lies not only in revealing the nature of anesthetic interaction sites, but also in 
suggesting potential anesthetic modulation to protein regions at the water-lipid interface 
that play critical roles in protein functions.  
4.2.4 Halothane had minimal anesthetic effect on Mistic structure 
The structure of Mistic in DPC micelles was obtained through refinement of Mistic 
structure in LDAO 47 by using the RDC constraints of Mistic in DPC. The generated 
structure of Mistic in DPC has a similar folding as original Mistic in LDAO. 
The addition of halothane into Mistic in DPC micelle did not change the overall 
structure of Mistic. The comparison of the CSIs of Cα, Cβ, and Hα chemical shifts in the 
absence and presence of 10 mM halothane indicates that general anesthetics do not 
alter the secondary structure of Mistic, shown in Fig. 4.2.4. Halothane effect on Mistic 
tertiary structure was examined via measuring backbone RDCs of Mistic in the absence 
and presence of 5 mM halothane. Only a small change observed after addition of 
halothane, shown in Fig.4.2.5. It suggests that the overall tertiary structure of Mistic is 
well preserved upon the addition of halothane. 
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Fig. 4.2.4. Halothane effects on the secondary structure of Mistic. The similarity of 
13
Cα CSI of Mistic residues in the absence (top) and presence (bottom) of 10 mM 
halothane indicated that halothane does not interfere the secondary structure of Mistic. 
The Cα chemical shifts were referenced with respect to random coil values at 0 ppm. 
This figure was reproduced from J Phys Chem B 112, 14312-14318, (2008) 
 
 
 
 
Fig. 4.2.5. Refined structure of Mistic in DPC on the basis of RDC NMR 
measurements. The RMSD (Å) of Mistic structure in the absence and presence of 10 
mM halothane is presented using a color scale. Residues that showed the largest RMSD 
are labeled. This figure was reproduced from J Phys Chem B 112, 14312-14318, (2008) 
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Previously studies 24,40,42 show that structures of TM peptides remained 
unchanged in the presence of general anesthetics. It has been also reported that the 
overall structures of several globular proteins do not change with general anesthetics at 
low millimolar concentrations 28,125,137,138. Mistic in micelles shares the same structural 
motif, four TM domains, with a subunit in the Cys-loop receptors. Therefore, the 
structure of Mistic insensitivity to anesthetics may also exist in the Cys-loop receptors. It 
suggests that anesthetic action on these Cys-loop receptors is unlikely through 
significantly altering receptor structures. 
4.2.5 Halothane had profound effects on MISTIC motion 
Halothane-induced changes in Mistic motion were confirmed by at least two 
experimental evidences. First, in HSQC experiment, some residues showed profound 
changes in their peak intensities (or line widths) after adding halothane. Second, in 15N 
relaxation dispersion experiments indicated that halothane can modulate the motion on 
the microsecond-millisecond time scale in some regions of Mistic. 
As shown in Fig. 4.2.2, residues S58, Q66, and A40 peak intensities increased 
(peak line width decreased) in the 1H−15N HSQC NMR spectra in the presence of 
halothane. It is also happened to several Cα resonance peaks such as loop residues 
S58−L67, which changed from weak to strong after the addition of halothane, as shown 
in Fig. 4.2.4. In contrast, I52 peak intensity decreased significantly after the addition of 
halothane (Fig.4.2.2). Backbone dynamics in the picosecond-nanosecond time scale, 
longitudinal (R1) and transverse (R2) relaxation rates, as well as 1H−15N heteronuclear 
NOE, show that they are not sensitive to anesthetics. It indicates that anesthetics have 
almost no effect on the motion of protein in the picosecond-nanosecond time scale. 
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However, the peak intensities for several residues were observed, which suggests that 
anesthetics may modulate on the motion of the protein in different time scale such as 
microsecond-millisecond time scale. In this case, anesthetic protein interaction may 
interfere with the conformational exchange process in Mistic. In order to know whether 
anesthetics potentiate or inhibit the exchange process, quantitative measurements were 
achieved through 15N R2 CPMG relaxation dispersion experiments.  
For the majority of Mistic residues, their transverse relaxation rates were not 
affected by a systematic variation of CPMG pulse. This indicates that most residues do 
not involve the motion on the microsecond-millisecond time scale. However, R2 
dispersion curves were observed for a number of residues located at the loop 23 (S58, 
D61, Q66, and D68), loop12 (V29), helix α2 (T39 and N45), and loop34 (Y82). The R2 
dispersion profiles for two representative residues, D61 and N 45, in the absence and 
presence of 10 mM halothane was shown in Fig. 4.2.6. It is clear that halothane inhibited 
the exchange contribution to R2 on residue N45 and suppressed the exchange on D61. It 
is consistent with what we concluded based on the changes of peak intensities and line 
widths. The R2 relaxation dispersion experimental data was fitted to Eq. 4.1.1 by using a 
two-site exchange model, which provided us estimated exchange parameters, including 
the difference of chemical shifts between two exchanging sites (Δω), the exchange rate 
(kex), the relative population of a conformation (pa or pb), and the intrinsic transverse 
relaxation rate (R2o). Table 4.2.7 summarizes these fitting parameters in the absence 
and presence of 10 mM halothane. The population of the major conformation, pa, was 
close to, or over, 90% and it increased 0−3% after the addition of halothane. Δω 
remained the same for most residues, which is consistent with the result that Mistic 
structure remained the same in the presence of halothane. 
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Table 4.2.7. 
15
N Relaxation Dispersion Parameters
a
 of Exchanging Residues of 
Mistic in the Absence and Presence of 10 mM Halothane 
Residues  Rex (s
−1
)
b
 R
20
 (s
−1
) k
ex
 (s
−1
) p
a
 Δω (s
−1
) 
V29 − 7.8 16.4±0.7 532±290 0.97±0.02 508±59 
  + 4.2 16.9±0.2 154±22 0.97±0.02 523±69 
T39 − 3.9 20.7±0.3 1455±296 0.98±0.08 588±65 
  + NA
c
         
N45 − 5.2 27.3±0.4 635±197 0.92±0.02 258±28 
  + NA         
I52 − 6.2 23.7±0.4 722±200 0.90±0.02 241±30 
  + ND
d
         
S58 − 6.4 15.8±0.3 217±83 0.91±0.03 205±12.5 
  + 4.8 17.2±0.5 551±270 0.91±0.03 189±33 
D61 − 26.7 13.5±0.9 468±144 0.89±0.02 529±26 
  + 17.9 13.2±0.5 199±22 0.90±0.01 550±50 
Q66 − 12.9 17.0±0.7 376±99 0.90±0.03 362±18 
  + 12.0 17.1±0.6 174±33 0.92±0.01 486±74 
D68 − 3.5 17.9±0.2 279±120 0.97±0.02 317±25 
  + 3.3 16.3±0.1 482±84 0.97±0.02 300±15 
Y82 − 11.5 25.0±1.1 267±148 0.87±0.17 244±24 
  + NA         
a Equation 1 was used for fitting of these parameters. 
b R
ex
 = R
2
(ν
cp
 → 0) − R
2
(ν
cp
 → ∞). 
c NA: no relaxation dispersion. 
d ND: the signal was too weak to determine relaxation dispersion parameters. 
Absence (−) and presence (+) of halothane 
This table was reproduced from J Phys Chem B 112, 14312-14318, (2008) 
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Fig. 4.2.6. Backbone
15
N relaxation dispersion curves of Mistic. Two representative 
residues, N45 and D61, were shown in the absence () and presence (●) of 10 mM 
halothane. This figure was reproduced from J Phys Chem B 112, 14312-14318, (2008) 
 
 
The exchange rate kex varied to a different extent on different residues. Because 
these residues resided in the specific joints connecting a rigid region with a flexible 
region, they likely experienced the chemical exchange on the microsecond−millisecond 
time scale in the absence of halothane, as shown in Table 4.2.7. For example, both 
residues T39 and N45 reside in the middle part of helix α2, where a helical kink is 
located between these two residues. Residue Y82 resides at the end of helix α3. 
Interestingly, the exchange disappeared in the presence of halothane. In these cases, 
the anesthetic halothane inhibited the conformational exchange process. For residue 
V29 located at the end of helix α1, the Rex value of V29 was reduced almost by half, 
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and the exchange rate kex became less than 1/3 of its original value after addition of 
halothane. Residue I52, at the end of helix α 2, experienced fast exchange in the 
absence of halothane, since kex is much greater than Δω  (Table 4.2.7). It makes I52 
give a relatively strong peak in 1H−15N HSQC (Fig. 4.2.2). However, the resonance peak 
of I52 vanished as a result of addition of halothane.  
Residue Q66 is located at the beginning of helix α3 or end of the loop connecting 
α2 and α 3, whose side chain is a few angstroms away from the side chain of Q66. 
Therefore, both Q66 and D61 can have similar exchange rates that became much 
slower after the addition of halothane. It is a similar case for residue S58 and D68. S58 
resides at the middle of the loop 23 close to D68 at the beginning of helix α3. For these 
two residues, they also show very similar kinetic parameters. By comparing the fitting 
results between Q66 and D61 with D68 and S58, we can find that these two pairs show 
opposite trends of rate changes in the presence of halothane. A close inspection of 
Mistic structure revealed that the pair of D68 and S58 is oriented inward to helices, while 
the pair of Q66 and D61 is directed outward in the loop and pointed to the water phase. 
This phenomenon is also observed in the previous study on the kinetics of SH2 protein 
139. The residues near to ligand binding sites show distinctive kinetics, similar to what we 
found in Mistic. 
Our previous study 32 shows that the dynamical changes due to the addition of 
halothane may not necessarily result from direct halothane interaction with individual 
residues. Allosteric effect may play an important role in term of the mechanism of 
anesthesia. In Mistic, most of the residues listed in Table 4.2.7 showed significant 
chemical shifts due to halothane titration, while neither I52 nor Y82 demonstrated 
obvious changes in their chemical shifts. It suggests that both I52 and Y82 had no close 
or direct interaction with halothane molecules. Therefore, the dynamical alternation of 
these residues may result from halothane allosteric modulation. The present study in 
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Mistic confirmed that anesthetic molecules could induce changes in protein motions on 
the microsecond−millisecond time scale either through direct interaction with specific 
residues or through allosteric modulation. 
4.2.6 Conclusion 
In the present study, we confirmed what we found in the previous study on the water-
soluble anesthetic-binding model protein, the four-α-helix bundle 32. In this work, it was 
found that inhaled general anesthetics were bound to the designed amphipathic pocket 
and anesthetics could modulate protein slow dynamics. Similar to the four-α-helix 
bundle, Mistic, a real membrane protein with a similar structural motif to the TM domain 
of Cys loop receptors, also served as a model protein for the study of anesthetic 
mechanism. What we found is that inhaled general anesthetics can also modulate its 
motion on the microsecond-millisecond time scale and especially motion close to the 
flexible loops. These loops are usually located in the surface of the detergent micelles, 
which is also considered as the amphipathic environments. Additionally, the inhaled 
general anesthetics perturb Mistic slow dynamics not only to residues that might interact 
directly with halothane molecules, but also to residues that may be remote from 
halothane. Allosteric effect may also play an important role. By collecting more 
experimental data demonstrating anesthetic modulation on protein dynamics, we can 
significantly advance our understanding of molecular mechanisms of general 
anesthesia. 
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 4.3 ANESTHETIC EFFECTS ON THE TM2 DOMAIN OF nAChR 
α4β2 
This section has been published in Biochim Biophys Acta 1798, 161-166, (2010) as a full 
article. I am the first author. The language was directly taken from the paper. 
4.3.1 Significance 
nAChRs belong to a superfamily of ligand gated ion channels involving the rapid 
chemical transmission of nerve impulses at synapses. Previous studies found that some 
subtypes of nAChRs might be potential targets of general anesthetics and their normal 
channel functions could be inhibited by general anesthetics 140-146. Neuronal α4β2 
nAChR is one of the subtypes sensitive to general anesthetics 35,143-145. It is also one of 
the most abundant nAChR subtypes in the brain 147. Despite ample evidence showing 
that general anesthetics could alter α4β2 nAChR functions 35, it remains largely unclear 
how anesthetics perturb the protein structures and dynamics that ultimately affect the 
protein functions. Therefore, the insights of anesthetic modulation on the structure and 
dynamics of the α4β 2 nAChR are valuable to resolve a long time mystery of the 
molecular mechanisms of general anesthesia 21,30. 
A comprehensive understanding of anesthetic action on α4β2 nAChR or other 
nAChR subtypes has often been restricted by limited available structural information of 
nAChRs in the past. The structural models of the closed- and open-channel α4β2 
nAChR have been generated 49 recently via computations using the known structure of 
the Torpedo nAChR as a template 8. More recent X-ray structures of pentameric ion 
channels in closed- and open-channel forms from Erwinia chrysanthemi and 
Gloeobacter violaceus provide high-resolution structural information relevant to nAChRs 
9,10,49. These new developments certainly facilitate the understanding of anesthetic action 
on α4β 2 nAChR, but experimental studies of structural and dynamic effects of 
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anesthetics on α4β2 nAChR may lead directly to insights into how anesthetics act on 
α4β2 nAChR and alter the protein function. 
Solid-state NMR spectroscopy is a powerful technique for the characterization of 
membrane protein structures and dynamics and for the investigation of ligand–protein 
interactions 148-156. The polarization Inversion and Spin Exchange at the Magic Angle 
(PISEMA) experiment 53 is particularly useful for the determination of topological 
structures and dynamics of helical proteins in a well-oriented lipid environment 157-160. 
Ligand binding to the Torpedo nAChR was comprehensively analyzed using static 2H 
and cross polarization magic angle spinning (CPMAS) 13C solid-state NMR experiments 
161,162. The structures of the TM domains of the Torpedo nAChR were also examined by 
various solid-state NMR methods 48,163,164, including PISEMA 48. However, no solid-state 
NMR study on neuronal nAChR has been reported previously. In the present study, we 
embedded the TM2 domains  of α4β2 nAChR in lipid bicelles, which served as 
membrane mimetic media and magnetically aligned the protein. The structural and 
dynamic properties of the TM2 α4β2 nAChR in the absence and presence of anesthetics 
halothane or isoflurane were investigated using solid state NMR, especially PISEMA 
experiments. Anesthetics were found to affect both helical tilting and rotational motions 
that have been identified computationally as critical elements for ion channel functions. 
This study suggested that anesthetics could alter these motions to modulate channel 
functions. 
4.3.2 Materials and methods 
Sample preparation 
The TM2 domains of the human nAChR were obtained by solid phase synthesis 
40,82. The α 4 and β2 TM2 domains have the sequences of EKITLCISVLLSLTVFLLLITE 
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and EKMTLCISVLLALTVFLLLISK, respectively. In order to simplify the studies, only 
seven leucine residues in α4 TM2 domain, as indicated in bold letters, were 15N labeled. 
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL). A conventional 
protocol of bicelle preparation 165 was followed. 1,2-dimyristoyl-sn-glycero-3-
phosphocoline (DMPC) and 1,2-dihexyl-sn-glycero-3-phosphocholine (DHPC) were 
mixed in a desired molar ratio (q=3.2). Lipid concentration was 28% of sample volume 
(typically 220µL). To extend sample stability for samples containing the nAChR TM2 
domains, 1,2-O-ditetradecyl-sn-glycero-3-phosphocoline (14-O-PC)) and 1,2-O-dihexyl-
sn-glycero-3-phosphocholine (6-O-PC) replaced DMPC and DHPC, respectively. A small 
amount of deuterated DMPCd54 (~1mg) was added to each sample for 2H NMR. The α4 
or β2 TM2 was dissolved in 100µL trifluoroethanol and added to the 6-O-PC-chloroform 
solution. The organic solvents were removed under a stream of nitrogen gas, followed 
by further evaporation under high vacuum overnight. The aqueous solutions were 
prepared by adding 110µL of deuterium-depleted water to dried 14-O-PC and 6-O-
PC/peptide. The 14-O-PC suspension was vortexed extensively followed by three 
freeze/thaw cycles (liquid nitrogen/42°C). The 14-O-PC suspension at 42°C was then 
added to the 6-O-PC/peptide, followed by vortexing and three freeze/thaw cycles. Slow-
speed centrifugation was sometimes necessary to remove air bubbles in the sample. A 
transparent solution was obtained that was viscous at 38°C and fluid at 4°C. Parallel-
oriented peptide-containing bicelles were prepared by adding 100 mM YbCl3·6H2O to the 
peptide-bicelle solution to reach a final lanthanide concentration of 3 mM. The sample 
was transferred to a 5-mm OD glass tube (New Era Enterprises, Newfield, NJ) using a 
pre-cooled pipette tip at 4°C. The glass tube was sealed with a tight fitting rubber cap 
and further sealed with hard bees wax. The α4-TM2 concentration was 7.4 mM in the α4 
samples and 3 mM in the α4β2 samples. The molar ratio of β2 to α4 was 1.5 in the α4β2 
samples to ensure a formation of (α4)2(β2)3. The peptide to lipid ratio is ~1:60. 
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Anesthetics halothane (2-bromo-2-chloro-1,1,1-trifluoro-ethane) and isoflurane (2-chloro-
2-(difluoromethoxy)-1,1,1-trifluoro-ethane) were added directly to the NMR tube (pre-
cooled in an ice bath) and mixed thoroughly with the samples. The anesthetic 
concentrations were determined using 19F NMR with 5 mM trifluoroacetic acid (TFA) as a 
reference. 
NMR spectroscopy 
All solid state NMR experiments were performed at 40°C on a Bruker Avance 
600MHz NMR spectrometer equipped with a 1H/31P/15N(2H) Bruker flat-coil probe. 19F 
NMR experiments were performed on a Bruker Avance 600 spectrometer with a Bruker 
TXO probe. The 1-D 15N cross-polarization experiments were conducted using a 1H 90° 
pulse of 5.1µs, a 49kHz 1H-decoupling field, 1ms contact time, 3s recycle delay, and 
10,000 scans. The same cross-polarization parameters were used in the 2-D 15N-1H 
PISEMA 166. Other parameters included ±35kHz frequency jumps for the Lee-Goldberg 
condition, 400–1000 scans, and 6–8 s recycle delay. The 1H carrier frequency was set at 
4.5 ppm on parallel oriented bicelle samples. The 15N chemical shift frequencies were 
referenced to solid ammonium sulfate at 26.8 ppm (relative to liquid ammonia at 0 ppm). 
The 2H NMR experiments were performed using a solid echo sequence ((π/2) − τ − (π/2) 
− τ). The 90° pulse length was 2 µs and τ values were 40µs (perpendicular bicelle) and 
20µs (parallel bicelle). The recycle delay of 0.5 s and the scans of 256 to 10,000 were 
used. 
NMR data processing 
All NMR spectra were processed using NMRPipe 167 and analyzed using Sparky 
73. The data from PISEMA experiments were fitted to the PISA (Polarity Index Slant 
Angle) 168,169 wheels using the program developed by Veglia's group 158. The tilt angle (θ) 
of the helix axis with respect to the bicelle normal, rotation angle (ρ) of the helix around 
its axis, the angle between the N-H bond and helix axis (δ), and the dipolar coupling 
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constant (KDD) were determined via fittings. The principal values of the 15N chemical shift 
tensors 53 for non-glycine residues, σ11=64 ppm, σ22=77 ppm, and σ33=217 ppm, were 
adopted for the fittings. These values were multiplied uniformly by a factor of 0.95 to 
accommodate reduced 15N chemical shift anisotropy of proteins in bicelles, as reflected 
in the reduction of spectral span of the same proteins in bicelles in comparison to those 
in mechanically aligned lipids. 
The TM2 chemical shift assignments were accomplished by combining several 
sources of information, including the previous assignments of δ –TM2 nAChR 48, the 
solution NMR structure of β2-TM2 nAChR 82, and the best fitting of PISA wheel. L19 is 
distinctly separated from the rest of leucine residues in a top view of the NMR structure 
(pdb code: 2K59) 82. L19 also has weaker NMR signal than other leucines, presumably 
because it is located at the lipid-water interface and has less protection from solvent 
exchange. The distinct location and intensity of L19 convinced us to assign L19 to the 
most downfield peak in the α4-TM2 PISEMA spectra. Once L19 is defined, the rest of 
peaks were assigned automatically by PISA wheel fitting. The final assignment of our 
α4-TM2 PISEMA spectra matches very well with a 2-D projection of the leucine 
distribution along helical axis from N- to C-terminus in the solution NMR structure 82. The 
assignment also agrees well with that for δ–TM2 nAChR 48. 
The orientational order parameter, SiCD, of the ith CD bond vector can relate to 
the residual quadrupolar splitting, ΔνiQ, in a 2H NMR spectrum using the equation 170  
€ 
ΔvQi = 32 AQ
3cos2θ −1
2 Si
CD                               (4.3.1) 
where AQ=e2Qq/h=167kHz is the static deuterium quadrupolar coupling constant for 
aliphatic CD bonds, θ is the angle between the bilayer normal and the magnetic field. 
Na+ flux assay and confocal fluorescence microscopy 
The Na+ flux assay, as measured by the enhancement of Sodium Green™ dye 
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(Invitrogen, Carlsbad, CA) fluorescence due to Na+ entry into vesicles through open 
nAChR channels, is an effective way to assess nAChR activity macroscopically. We 
prepared 30 mM large lamellar vesicles with 250µM α4β2. The vesicles contain 
phosphatidylcholine (PC) and phosphatidylglycerol (PG) in a 4:1 molar ratio 41. PC and 
PG were mixed in chloroform. α4 and β2 were mixed in a molar ratio of 2:3 and 
dissolved in TFE. The dissolved lipids and α4β2 were mixed and dried to a thin film. 
Residual organic solvent was removed by vacuum overnight. The lipid–protein mixture 
was hydrated with a buffer solution at pH 7.5 containing 20 mM Tris, 50 mM CaCl2, and 
6 uM membrane impermeable Sodium Green™. The vesicles were obtained by 
incubating the lipid–protein solution at 42°C overnight and subsequent multiple cycles of 
freeze and thaw. An extensive dialysis was performed to remove Sodium Green™ dye 
outside the vesicles. 
The Na+ flux assay was performed using an Olympus Fluoview300 Confocal 
Laser Scanning head with an Olympus IX70 inverted microscope (Olympus, Melville, 
NY). Sodium Green™ was excited by the 488nm argon laser line and the emission was 
detected using sharp cutoff 510IF long-pass and BA530RIF short-pass filters. For each 
measurement, 50µL vesicles containing α4β2 were added into a tray coated with poly-
lysine that facilitated vesicle adhesion due to the interactions between negatively 
charged PG and positively charged poly-lysine. The image acquisition began before the 
addition of an isotonic 100 mM NaCl solution to the media outside the vesicles and 
continued for 200 s after the exposure to Na+. The program MetaMorph was used for 
analyzing the image data. 
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4.3.3 Anesthetic effects on the bicelles 
Solid-state 2H NMR spectra of bicelles with deuterated DMPCd54, as shown in Fig. 4.3.1, 
provided insight of lipid alignment and dynamics. The high-resolution 2H NMR spectra 
with distinguished quadrupolar splittings in Fig. 4.3.1A and B attested that the bicelles, 
without incorporating proteins, were well oriented. The quadrupolar splitting of individual 
2H peaks corresponding to carbon positions close to the tail of the aliphatic chains 
showed little difference in Fig. 4.3.1A and B, suggesting that anesthetic halothane 
molecules had no access to the hydrophobic tail region. However, halothane diffused to 
the carbon positions close to the glycerol group, as evidenced by significantly broadened 
2H signals of the region in Fig. 4.3.1B. The order parameters of individual C-2H bonds of 
DMPCd54, SCD, were calculated using Eq. 4.3.1 in the presence and absence of 6 mM 
halothane. SCD normally contains information on (a) collective motions of lipids, including 
bicelle wobbling, (b) trans-gauche isomerizations around C-C bonds of lipids, and (c) the 
anisotropic reorientation of a whole lipid molecule. Collective motions of lipids were small 
in our systems, in which a 72% hydration level was remained and bicelles were well 
magnetically oriented. A recent comprehensive NMR analysis also suggested a good 
bicelle alignment at such a hydration level 171. The contribution of anisotropic lipid 
reorientation to SCD was expected to be uniform for all C–2H bonds linked to a rigid 
structure. Therefore, a small increase in SCD values in the presence of halothane in Fig. 
4.3.2 predominately resulted from orientation of the C–2H bonds with respect to the 
principal axis of motion of individual lipid molecule. However, since only the readable 
quadrupolar splitting was used for SCD calculations, the disordered component reflected 
in the broader peaks might be underestimated in Fig. 4.3.2. 
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Fig. 4.3.1. 2H NMR spectra of perdeuterated DPMCd54 phospholipids. The DPMC 
phospholipids were embedded in (A) a pure DMPC/DHPC (q = 3.2) bicelle system; (B) 
after adding 6 mM halothane to the system in (A); (C) the 14OPC/6OPC bicelle system 
incorporated with (α4)2(β2)3 nAChR TM2 domains; (D) after adding 6 mM halothane to 
the system in (C). The bicelle normal was perpendicular to the magnetic field in (A) and 
(B), parallel to the magnetic field in (C) and (D) due to the addition of 3 mM lanthanide. 
The spectra were acquired with the solid echo pulse sequence at 40 °C. The spectrum 
center was arbitrarily set to 0 Hz. This figure was reproduced from Biochim Biophys Acta 
1798, 161-166, (2010) 
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Fig. 4.3.2. C-2H order parameter SCD as a function of DPMCd54 carbon positions. 
The absence () and presence () of 6 mM anesthetic halothane were investigated. 
This figure was reproduced from Biochim Biophys Acta 1798, 161-166, (2010) 
 
 
Fig. 4.3.1C and D shows the solid-state 2H NMR spectra of the bicelles 
incorporated with the (α4)2(β2)3 TM2 in the absence and presence of 6 mM anesthetic 
isoflurane, respectively. The bicelles were flipped 90° by YbCl3 so that their quadrupolar 
splittings were double of that in Fig. 4.3.1A and B. The presence of the (α4)2(β2)3 TM2 
made the 2H peaks much broader, presumably because the lipid bilayer was severely 
disturbed by the insertion of the TM2 domains. A small amount of lipids were in isotropic 
phase after incorporating TM2 domains into the bicelles and the amount increased upon 
addition of 6 mM isoflurane, as reflected in the peak at zero frequency. The degree of 
anesthetics-induced 2H peak broadening in Fig. 4.3.1D seemed to be more severe than 
that in Fig. 4.3.1B, especially to the carbon positions at the middle of DMPC aliphatic 
chains. Formation of the (α4)2(β2)3 channels might facilitate anesthetic diffusion into the 
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deep bilayer where anesthetics normally have less access. Direct interactions between 
anesthetics and TM proteins were observed previously 25,31,40,44. Anesthetics could 
modulate protein dynamics directly and allosterically 31. Such changes in protein motions 
could affect lipids surrounding proteins and contribute to the observed lipid peak 
broadening in Fig. 4.3.1D. 
4.3.4 TM2 domain in channel and non-channel forms 
The α4 and β2 subunits of nAChR need to be in 2:3 stoichiometry to form pentameric 
channels 172. Our Na+ flux experiments confirmed that ion channels could be formed by 
combining the α4 and β2 TM2 domains in a 2:3 molar ratio, but not by the α4 TM2 
domain alone. As shown in Fig. 4.3.3, large vesicles made of phosphatidylcholine (PC) 
and phosphatidylglycerol (PG) with (α4)2(β2)3 TM2 could be easily identified. A time-
dependent increase of sodium green fluorescence intensity upon injection of 10µl 100 
mM NaCl signaled channel formation. Control vesicles without channels showed no 
increase in fluorescence intensity, nor did the channel-containing vesicles when isotonic 
CaCl2 was added instead of the NaCl solution. The same experiment was also 
performed on the PC-PG vesicles containing the α4 TM2 domain alone and found no 
indication of channel formation, suggesting different topology and dynamics of the α4 
and (α4)2(β2)3 TM2 assemblies. 
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Fig. 4.3.3. Functional assay of TM2 domains of α 4β2 nAChR. (A) Confocal 
fluorescence images of large unilamellar vesicles (LUV) made of phosphatidylcholine 
and phosphatidylglycerol containing α4β2 nAChR channels after exposure to 100 mM 
NaCl solution at different time points. Membrane-impermeable Sodium Green 
fluorescent dyes were enclosed and trapped inside the LUVs to indicate intra-vesicle 
Na+ concentration. The fluorescence intensity of the vesicles with α4β2 channels 
increased significantly within a short period of time after exposure to extra-vesicle NaCl, 
indicating an influx of Na+ through the channels. (B) The intensity changes in the circled 
vesicles over time after the exposure to extra-vesicle Na+. The background refers to the 
region without vesicles. The control refers to vesicles without channels, whose 
fluorescence intensity remained constant before and after exposure to extra-vesicle Na+. 
This figure was reproduced from Biochim Biophys Acta 1798, 161-166, (2010) 
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4.3.5 PISEMA: Effect of β2 TM2 on α4 TM2 
The solid state 1H-15N dipolar /15N chemical shift correlation PISEMA spectra of the 15N-
Leu labeled α4 TM2 in Fig. 4.3.4 demonstrated distinct differences in the absence and 
presence of the unlabeled β2 TM2. Wheel-like patterns in the PISEMA spectra of parallel 
14-O-PC/6-O-PC bicelles confirmed the TM helical structure of the TM2 domains 82. Six 
out of seven total leucine residues of the α4 TM2 showed amide 15N resonances 
between 180 and 200 ppm. Their resonance patterns are similar to those composed by 
the TM2 of the δ nAChR 48. Leu 5 at the N-terminus of the TM2 did not show up in this 
region of PISEMA spectra, confirming our early solution NMR finding that Leu 5 was not 
part of the TM2 helix 82. Leu 19 resides close to the C terminus of the TM2. Its relatively 
weak intensity in the PISEMA spectra is probably due to a conformational exchange and 
less efficient cross-polarization in the dynamic C-terminal region. The most downfield 15N 
chemical shift in the PISEMA spectra is 12 ppm smaller than the conventional value of 
σ33 (217 ppm), suggesting a more dynamical environment in bicelles. 
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Fig. 4.3.4. PISEMA spectra of the 15N-Leu labeled α4 TM2 in the absence (Black) 
and presence (Green) of unlabeled β2 TM2. Best fit simulations to the PISEMA data 
reveal the helical tilt angles of 12 ± 1° and 16 ± 1° of the α4 TM2 and the (α4)2(β2)3 TM2, 
respectively. The notable difference between two PISEMA spectra suggests that the α4 
TM2 must have experienced the existence of the β2 TM2 in the (α4)2(β2)3 TM2 sample. 
This figure was reproduced from Biochim Biophys Acta 1798, 161-166, (2010) 
 
 
Although the α 4 TM2 had a single set of 15N-Leu resonances in the PISEMA 
spectrum in Fig. 4.3.4, the presence of unlabeled β2 TM2 brought up several minor 
resonances for the (α4)2(β2)3 TM2. Leu10, Leu17, and Leu13 showed almost the same 
15N chemical shifts in both major and minor resonances, but their dipolar couplings were 
about 1kHz greater in the minor resonances. Although it was almost impossible to 
accurately define topology of the minor conformation due to too few numbers of 
resonances, the chemical shift and dipolar coupling data suggested that the helix tilt 
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angle relative to the bicelle normal must be smaller in the minor conformation than in the 
major population 168,169. The minor peaks might also result from a sub-population α4 TM2 
in a slightly different motional environment. 
A more noticeable difference between the α4 and (α4)2(β2)3 spectra in Fig. 4.3.4 
is the shift of the amide resonances along both 15N chemical shift and 1H-15N dipolar 
coupling axis. Leu11 and Leu18 of the α4 TM2 experienced relatively small shifts before 
and after mixing with the β 2 TM2, but Leu10, Leu13, Leu17 and Leu19 had more 
profound changes. It is plausible that Leu11 and Leu18 have experienced little 
interaction with residues in other helices. The best fitting of all downfield resonances to 
ideal PISA wheels revealed the helical tilt angles of 12 ±1° and 16 ±1° of the α4 TM2 
and the (α4)2(β2)3 TM2, respectively. The rotation angle, ρ, was 65° for both α4 and 
(α4)2(β2)3. The tilt angle of 12° for the α4 TM2 in bicelles agrees with the result of the δ 
nAChR 48, where the δ TM2 helix was also tilted 12° relative to the normal of 
mechanically oriented DMPC bilayers. Neither α4 nor δ subunit could form nAChR 
channels without partitioning of other subunit types 172. The tilt angle of 16 ± 1° of the 
(α4)2(β2)3 TM2 is comparable to the tilt angle of 15 ± 2° found for the GABAA receptor 
TM2 domain, an anion channel-forming peptide, by a recent solid-state NMR study 151. 
It is worth mentioning that all the resonances in our PISEMA spectra resulted 
solely from the 15N-Leu residues of the α4 TM2. The unlabeled β2 TM2 did not generate 
15N NMR signals. If the α4 TM2 was isolated from the β2 TM2, the (α4)2(β2)3 TM2 would 
give the same PISEMA spectrum as the α4 TM2. The notable difference between the 
two spectra in Fig. 4.3.4 prove that the α4 TM2 must have interacted with the β2 TM2 in 
the (α4)2(β2)3 TM2 sample. A thorough NMR characterization of oligomerization states of 
2H selective labeled TM peptides in oriented lipid bilayers was demonstrated previously 
173. The same method can also be applied to the α4 and β2 TM2 if proper labeled 
samples become available. Nevertheless, the data in Fig. 4.3.4 indicate that interaction 
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between α4 and β2 subunits that might be the driving force for assembling a functional 
channel. The larger helix tilt angle found in the (α4)2(β2)3 TM2 supported the previous 
prediction that channel opening might involve tilting of pore lining helices 10,49,81,121. 
4.3.6 PISEMA: Anesthetic effect on TM2 domains 
Fig. 4.3.5 displays an overlay of the PISEMA spectra of the α4 TM2 in the absence and 
presence of 6 mM halothane. Halothane lowered 1H-15N dipolar coupling and 15N 
chemical shift of six leucine residues noticeably. The data fitting into PISA wheels 
provided a helical tilt angle of 14° in the presence of halothane. The dipolar coupling 
constant, KDD, decreased from 8700 to 8100 KHz, but the rotational angle (ρ=65°) and 
the angle between N-H bone and helix axis (δ=13°) remained the same in the absence 
and presence of 6 mM halothane. 
 
 
 
 
Fig. 4.3.5. Overlay of PISEMA spectra of the α4 TM2 in the absence (Black) and 
presence (Red) of 6 mM halothane. PISA wheel fitting of the α4 TM2 in the presence 
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of 6 mM halothane reveals an increase in tilt angle from 12° ± 1° to 14° ± 1°. This figure 
was reproduced from Biochim Biophys Acta 1798, 161-166, (2010) 
 
 
In comparison to the α4 TM2, the (α4)2(β2)3 TM2 seemed less susceptible to 
anesthetics. Fig. 4.3.6 shows the PISEMA spectra of the (α4)2(β2)3 TM2 before and after 
adding 12 mM anesthetic isoflurane. The helix tilt angle of the (α4)2(β2)3 TM2 with 
respect to the bicelle normal changed less than 1° (θ =16.5°). The KDD value changed 
from 8400 to 7900 KHz. The other two parameters, ρ=65° and δ=13°, remain 
unchanged. To the majority of the (α4)2(β2)3 TM2 in the sample, anesthetic isoflurane 
had a subtle but real impact on their helical orientation in bicelles. The anesthetic-
induced changes in the major resonance pattern also implicate the possibility of a 
wobbling motion of the helix axis with respect to the bicelle normal 174. Those 
aforementioned minor resonances of Leu10, Leu13, and Leu17 shown in Fig. 4.3.4 
disappeared after adding 6 mM isoflurane to the sample (see the on-line supporting 
information). However, another subset of minor resonances appeared upon further 
increasing the isoflurane concentration to 12 mM, as shown in Fig. 4.3.6. The new minor 
peaks, labeled as L19′, L11′, L13′ L17′, and L19′ in Fig. 4.3.6, appeared as if they 
resulted from corresponding major resonances rotating 50° counterclockwise around the 
helical axis. Distinct major and minor resonances signify that the helix rotational motion 
was on a time scale slower than 10–4 s 175. Both tilting and rotational motions of the TM2 
helices are critical elements for channel functions 49. Our data reveal that anesthetic 
molecules are able to alter motions of the TM2 helices that could account, at least 
partially, for anesthetic inhibition effects on the α4β2 nAChR 35. 
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Fig. 4.3.6. Overlay of PISEMA spectra of the (α4)2(β2)3 TM2 in the absence (Black) 
and presence (Red) of 12 mM anesthetic isoflurane. Notice the appearance of subset 
resonance peaks (a, b, c in black and L19′, L11′, L18′, L19′, L13′, L17′ in red). The minor 
resonance peaks in red seem to result from rotating corresponding major resonances 
50° counterclockwise around the helical axis. This figure was reproduced from Biochim 
Biophys Acta 1798, 161-166, (2010) 
 
 
It is not surprising to observe different responses of the α4 TM2 and the 
(α4)2(β2)3 to anesthetics, considering that one might exist as monomer but the other 
could form channels. Without the presence of the β2 TM2, the α4 TM2 interacted loosely 
with other α4 TM2 helices so that individual helix orientation was affected by anesthetics 
more severely. In a pentameric (α4)2(β2)3 TM2, the helix tilting in respect to the bicelle 
normal became less sensitive to the addition of anesthetics, presumably due to stronger 
interaction between the α4 TM2 and its adjacent β2 TM2. One may wonder if small 
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changes in helix orientation induced by anesthetics, either through tilting or rotational 
motion, are significant enough to alter channel functions. The X-ray structures of 
pentameric ion channels from bacterial demonstrated that the pore-lining TM2 domains 
in closed- and open-channel conformations differ by merely 9° rotation around an axis 
that is parallel to the membrane normal 9-11, suggesting that a small change in the TM2 
orientation could elicit a sizable change in channel functions. Although further structural 
and dynamical investigations on integral α4β2 nAChR are necessary to define a final 
answer, the present study highlights the possibility that anesthetics may modulate the 
channel function via altering the motion as well as orientation of the pore-ling domain. 
4.3.7 Conclusion 
Several key findings emerged from the current study. First, TM proteins could facilitate 
anesthetic diffusion into deep membrane bilayers even though anesthetics normally 
prefer amphiphilic lipid-water interface region 43. Consequently, anesthetics affected lipid 
alignment and conformation more severely in bicelles containing proteins. Secondly, the 
α4 TM2 could not form channels unless it had been mixed with the β 2 TM2. The 
interactions between the α4 and β2 TM2 subunits do exist and such interactions may be 
essential to drive channel formation. Thirdly, general anesthetics could perturb 
orientations of the TM helices in lipid bilayers and introduce changes in helical motions. 
The observed anesthetic effects on the tilt and rotational angles of pore lining TM2 
helices reveal a potential pathway for anesthetic inhibition of channel functions. A more 
challenging question has arisen based on the current study: how do anesthetics make 
changes in TM protein orientations and motions that are related to protein functions? 
This is certainly a question worth further investigation. 
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CHAPTER 5  
FUNCTIONAL STUDIES AND 
INHALATIONAL ANESTHETIC 
EFFECTS ON TRANSMEMBRANE 
PROTEINS 
5.1 PROTEIN FUNCTIONAL STUDY BY 35Cl NMR 
SPECTROSCOPY 
5.1.1 Significance 
The structural study of proteins by high resolution NMR is often limited by the protein 
size. GlyRs belong to a superfamily of ligand-gated ion channels, involving in rapid 
inhibitory chemical transmission of nerve impulses at synapses. These receptors are 
typically pentameric ion channels formed by either one or a combination of various 
subunits. Each subunit is comprised of a large EC domain, a four-helix TM bundle, and 
an IC domain region. The GlyR’s molecular mass is ~240-290 kDa and each subunit is 
~48 (α-subunit)-58 (β-subunit) kDa 176.  
Taking into consideration the presence of the detergent to solubilize the 
receptors for NMR study, the molecular mass is increased to ~80 kDa, even for a single 
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subunit. The larger the protein size, the weaker the NMR signals are detected and the 
more severe peak overlaps are observed. Therefore, it is very challenging to study 
proteins with such large molecular mass by NMR. Not only the protein size but also the 
dynamic properties in the protein are critical in NMR studies. The dynamics could be 
wildly different among different domains in a protein. These inhomogeneous dynamic 
properties also weaken the NMR signals and cause additional peak overlaps.  
A feasible approach is to use the reductionist approach. In order to study a large 
complicated system such as GlyRs or nAChRs, we decompose the complex into several 
small units. As a consequence, each unit with a smaller molecular mass and 
homogeneous motion is suitable for structural studies. In the present study, the EC 
domains were truncated, and the specific TM domains were isolated with the IC domain 
replaced by a glycine linker. The legitimate question is whether in the reduced system, 
TM domains themselves can still represent the large complicated system. In other 
words, whether the TM domains by themselves form a correct channel with the relevant 
biology is critical for this reductionist approach. The truncated GlyR TM domain, 
GlyRα1TM-5G (where 5G indicates five glycine linker in place of the long IC loop), was 
selected and its channel activity was studied using 35Cl NMR. By using magnetization 
inversion transfer (MIT) experiments, the transport of chloride ion across the truncated 
GlyR channel was investigated 177,178 
 
 
5.1.2 Materials and sample preparation 
L-α phosphatidylcholine (PC) and L-α phosphatidylglycerol (PG) were purchased from 
Avanti Polar Lipids (Alabaster, AL). The vesicles contained PC and PG in a 3:1 molar 
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ratio 41. Approximately 25 mM large lamellar vesicles (LUV) with ~26 uM GlyRα1TM-5G 
were prepared. The lipid to channel ratio was ~4800:1. It was optimized based on the 
sample stability and MIT signal intensity. PC and PG were mixed in chloroform first and 
the GlyRα1TM-5G was dissolved in TFE. The dissolved lipids and GlyRs were mixed 
and dried to a thin film under N2 gas. Residual organic solvent was removed by high 
vacuum overnight. Large unilamellar vesicles were prepared based on the previous 
protocol 179. The lipid–protein mixture was first hydrated with 5 mM Tris-HCl buffer 
solution (buffer A) at pH 7.2 in 1/5 the final volume. After thoroughly vortexing and 
sonicating, the ion strength was increased to a concentration of 0.4 M by adding buffer A 
in the presence of 0.5 M KCl. This new high salt buffer was added into the vesicle 
sample in two successive steps. 1/5 the final volume of high salt buffer was first added 
into the vesicle sample and thoroughly vortexing and approximately sonicating was 
done. This was repeated using 3/5 of the final volume of high salt buffer. The 
reconstituted vesicles were frozen slowly in an -80°C freezer for more than 30 min. The 
frozen vesicles were then thawed at room temperature without agitation. This “freeze 
and thaw” procedure was done twice. In order to achieve expanded larger vesicles, the 
concentrated vesicles were further diluted 2-fold by very carefully adding buffer A. The 
final KCl concentration was 200 mM in 5 mM Tris-HCl. 
Picrotoxin (PTX) was purchased from Tocris Bioscience. A 50-mM PTX stock 
solution in pure DMSO was prepared. In the experiment of PTX effect on GlyRs, two-
microliter PTX solution was first titrated into the mixture of the GlyRα1TM-5G and the 
lipid PC/PG in chloroform solution. The dissolved PTX, lipids and GlyRs were well mixed 
and then dried to a thin film under N2 gas. Residual organic solvent was further removed 
by high vacuum overnight. Unilamellar vesicle preparation was the same as above. 
 The chloride chemical shift reagent (Co(II)(gly)3-) was prepared as previously 
described 180. Cobalt chloride was mixed with Gly in a ratio 1:3 in buffer A. The sample 
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pH after the addition of 20 mM chemical shift reagent changed to pH ~4.3. For higher pH 
experiment, the sample pH was adjusted to pH 7.2 by titrating 1 M KOH solution. 
5.1.3 NMR measurements 
The NMR experiments were performed at 30°C using a 4-mm MAS probe on Bruker 
Avance 600 MHz spectrometer. The resonance frequency for 35Cl is 58.8 MHz at 14.4T. 
In the absence of the chloride chemical shift reagent, there was only one peak and it 
was manually assigned to 0 ppm. In the presence of 20 mM Co(II)(gly)3- shift reagent, 
the 35Cl peak outside the vesicles (35Clout), which experienced the shift reagent, was 
separated from the peak inside the vesicles (35Clin). The chemical shift difference is ~25 
ppm between 35Clout and 35Clin. The normal 90° pulse is ~5 us and the power level is 0 
dB. The duration t1 is equal to the reciprocal of twice the chemical shift difference 
between 35Clout and 35Clin. The mixing time t2 was set from 10 us to 0.5 ms and a total of 
13-14 mixing times were used in the MIT experiments. The recycle delay d1 was 0.5 s 
with 256 scans for 1D 35Cl experiments and 1 s with 512/1024 scans for MIT 
experiments. The resulting MIT spectra were further deconvoluted by using the software, 
MestReNova NMR (mestrelab reseach). 
The Solomon equation was modified to fit the MIT results as previously described 
178. 
 
where I and S are inside and outside spins, respectively, T1 and T1’ are the longitudinal 
relaxation for the spin I and S, respectively. ke and ki are the apparent unidirectional 
efflux and influx rate with the boundary condition keI0 = kiS0 (5.1.3) based on the thermal 
(5.1.1) 
(5.1.2)	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equilibrium relationship. From Eq. (5.1.1), (5.1.2) and (5.1.3), we can get the solutions: 
 
 
Here, spin S was selected to invert and 
€ 
T1 ≈ T ' was assumed, which was measured from 
the conventional inversion-recovery experiments with the control sample (no proteins). I0 
and S0 were measured by the fully recovered spectra. Other parameters were 
determined by non-linear fitting, using Eq. (5.1.4) and (5.1.5). 
 5.1.4 1D 35Cl experiment 
In the presence and absence of GlyRα1TM-5G, the 35Clout and 35Clin peaks were 
examined by a 1D 35Cl NMR experiment.  
Fig. 5.1.1 shows a typical micrograph of a LUV sample used in the NMR 
experiments. In the absence of GlyRα1TM-5G, the addition of 20 mM chemical shift 
reagent (SR) (Co(II)(gly)3-) separated the 35Cl peak into two peaks, 35Clout and 35Clin, 
which were overlapped in the absence of SR, shown in Fig. 5.1.2A. In the presence of 
SR, the 35Clout peak became broader and the chemical shift difference between 35Clout 
and 35Clin peaks was ~25 ppm. In the above experiment, the sample pH was changed to 
pH 4.3 instead of the original pH 7.2, after the addition of SR. The KOH solution was 
then titrated into the same sample to bring pH back to 7.2. Two separated 35Cl peaks 
were still observed. Due to the pH effect on the SR, the 35Clout became sharp and was 
shifted to the highfield, while the 35Clin was unchanged, as shown in Fig. 5.1.2B. 
 
(5.1.4) 
(5.1.5)	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Fig. 5.1.1. Bright field phase-contrast image of a typical large vesicle sample. The 
vesicles contained PC and PG in a 3:1 molar ratio. The large lamellar vesicles with ~26 
uM GlyRα1TM-5G in approximately 25 mM lipid were prepared. A 10um scale was label 
in red. 
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Fig. 5.1.2. 1D 35Cl spectra in the absence of GlyRα1TM-5G. The 35Clin peak was 
manually assigned to 0 ppm. (A) In the absence of chemical shift reagent SR (Brown), 
the 35Clout and 35Clin peaks were overlapped together at 0 ppm. At low pH, the chemical 
shift of 35Clout ion in the presence of SR (Cyan) was shifted to downfield, comparing to 
35Clout ion in the absence of SR (Brown), while the chemical shift of 35Clin ion remained 
the same at 0 ppm. The brown peak was scaled down ~2.5-fold for clarification. (B) At 
high pH (Cyan), the 35Clout peak became sharp and was shifted to highfield, comparing to 
the low pH result (Brown). The sample pH was adjusted to high pH by titrating KOH 
solution into the sample. The 35Clin remain untouched.  
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Interestingly, in the presence of GlyRα1TM-5G, only one 35Cl peak can be 
detected at high pH in Fig. 5.1.3B. Based on its chemical shift, peak intensity and peak 
width, this peak was assigned to both 35Clout and 35Clin. This indicates that the truncated 
GlyR with the TM domain alone (GlyRα1TM-5G), likely formed a large open channel, 
which allowed the 35Clin to experience very fast exchange with 35Clout. In this case, only 
one peak 35Cl was detected on the NMR timescale. In our previous study with gramicidin 
178, two separated peaks, 23Naout and 23Nain, were always present, regardless of the 
channel formation by the gramicidin. The different phenomena between the GlyRα1TM-
5G and the gramicidin may suggest that the GlyRα1TM-5Gs oligomerized in the open 
conformation and may form a much large pore in the vesicle, while the gramicidin can 
form a small pore or a transit channel. This large pore formed by the GlyRα1TM-5G may 
be the intrinsic large conductance property of GlyR channel, or due to the truncation of 
the EC and IC domains.  
The pH effect on the 35Cl transport across the GlyRα1TM-5G channel was 
investigated. In order to observe two peaks, lower concentration of GlyRα1TM-5G (thus, 
less channels per vesicle) was reconstituted on the vesicles at pH ~4.3. In Fig. 5.1.3A, 
two distinct peaks for 35Clin and 35Clin were observed. This pH dependence may be due 
to the conserved Arg-252 residing in the terminus of the TM2 domain of the GlyRα1TM-
5G. At low pH, the Arg-252 was always protonated with positive charges. A ring of 
positively charged side chains, formed by the Arg-252 from each subunit, might be 
essential to the pH dependence of the channel conductance. The charged ring creates a 
deep energy well to trap Cl–, thus the transport slows down. In the slow exchange state, 
it allowed us to observe two distinct 35Cl peaks by NMR. In contrast, partial 
deprotonation at high pH allows Cl– to leave the region at the fast rate. In such a case, 
only one peak was detected shown in Fig. 5.1.3B. 
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Fig. 5.1.3. 1D 35Cl spectra in the presence of GlyRα1TM-5G with (Cyan) and without 
SR (Brown). (A) At low pH, two individual peaks were observed in the presence of SR. 
The chemical shift splitting between 35Clout and 35Clin is ~25 ppm. It indicated that they 
were in the slow exchange state. The brown peak was scaled down for the clarification. 
(B) At high pH, one single peak was observed in the presence of SR (Cyan). It indicated 
that a fast exchange occurred between 35Clout and 35Clin.  
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5.1.5 MIT experiments 
At low pH, in the case of slow exchange, the flow rate of the 35Cl transport across the 
GlyRα1TM-5G channel can be estimated by MIT experiments. Fig. 5.1.4 shows two 
stack plots of 35Cl NMR spectra of MIT experiments and their fitting results. In the 
absence of the channel protein, the 35Clin peak was not affected (Fig. 5.1.4.A), while the 
35Clout was selectively inverted and gradually returned to its thermal equilibrium state. 
This suggested that the 35Cl transport was negligible on the NMR time scale when there 
were no channels formed in the vesicles. Basically, the MIT cure was flat (Fig. 5.1.4C). 
However, in the presence of the GlyRα1TM-5G, the 35Clin peak was modulated by the 
inverted 35Clout peak, which strongly suggested the channel formation, shown in Fig. 
5.1.4B. The apparent rate constants ki and ke were estimated to be 562.2±292.4s-1 and 
1345.9±464.2s-1, by using Eq. 5.1.4, shown in Fig. 5.1.C. Here, in the fitting, T1 was fixed 
to 21.3 ms, which was independently measured from MIT experiment of the vesicles in 
the absence of GlyRα1TM-5G. The relatively large fitting error was due to sample 
stability and experimental errors. Therefore, the values for the apparent rate constants 
are more qualitative than quantitative. If comparing these results with the previous study 
with gramicidin, the apparent rate constants of the channels formed by GlyRα1TM-5G 
were much larger. The apparent rate constants for the gramicidin channels were 
182±15.4 (ki) and 149.7±7.2 (ke) 178.  
Picrotoxin (PTX) is a 1:1 mixture of picrotoxinin and picrotin. It is a poisonous 
crystalline compound that is used as a stimulant in the central nervous system (CNS). It 
has been reported that PTX is a non-competitive channel blocker, which interacts with 
the TM2 domain of the receptors and thereby inhibit ion flows of the α homo-oligomeric 
GlyRs 181. In our experiments, 1 mM PTX was added to over saturate the GlyRα1TM-5G 
sample. The presence of PTX successfully blocked 35Cl ion flow in the MIT experiments, 
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shown in Fig. 5.1.4C. These results indicated that the quaternary association of 
GlyRα1TM-5G monomers is essentially the same as in the authentic channel. 
 
5.1.6 Conclusion 
The channel functions of the truncated GlyR, GlyRα1TM-5G, were examined by using 
35Cl NMR. GlyRα1TM-5Gs themselves do form a channel in the vesicles. Cryo-EM 
experiments with these TM segments also confirmed the formation of oligomers with 
pentamers being dominant. The transport rates were measured by the MIT experiments. 
PTX, a channel blocker for the GlyRs, can also inhibit the Cl- ion flows of GlyRα1TM-5G. 
This indicated that GlyRα1TM-5G channel has the correctly folded quaternary structure. 
More interestingly, we found that this specific GlyR channel formed by the TM domain 
alone is pH dependent. At low pH, the transport rate is lower than at high pH.  
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Fig. 5.1.4. Stack plots of 35Cl magnetization inversion transfer spectra. The 
absence (A) and presence (B) of GlyRα1TM-5G channels were investigated 
respectively. 35Clin and 35Clout were separated by 20 mM Co(II)(gly)3- shift reagent. (C) 
The peak intensity profiles of 35Clin were plotted as a function of the inversion recovery 
time, τ. In the presence of GlyRα1TM-5G (Filled circles), the peak intensity profile was 
best fit using Eq. 5.1.4. The fitting result was a V-shaped curve. The apparent influx rate 
ki was estimated to be 562.2±292.4 s-1 and the apparent efflux rate ke was 1345.9±464.2 
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s-1. T1 was fixed to be 21.3 ms as determined under the control condition. In the absence 
of GlyRα1TM-5G (Open Circles), no V-shaped curve was observed. In the GlyRα1TM-
5G sample, the presence of 1 mM picrotoxin (Red triangles) eliminated the V-shaped 
curve and a relatively flat curve was observed. This indicated that there were no 35Cl 
ions across the membranes of the vesicles. Error bars show the standard error of the 
mean. 
 
 
5.2 PROTEIN FUNCTIONAL ASSAY AND FUNCTIONAL STUDY 
OF ANESTHETIC EFFECT ON THE TM DOMAINS OF nAChR BY 
FLUORESCENCE MICROSCOPY 
5.2.1 Significance 
Fluorescence microscopy is also a straightforward method to address whether 
reconstituted proteins still retain their native function. nAChRs are made of five subunits 
with a molecular mass of ~290 kDa 12. This receptor is in the same superfamily as the 
GlyRs. The large molecular mass and various dynamics in each domain also complicate 
the structural study of nAChRs. Using the reductionist approach, the TM domain of 
nAChR was isolated and studied independently. Whether the reduced nAChR is 
functionally relevant is addressed by fluorescence microscopy. In the present study, the 
channel activities of nAChRα4β2ΤΜ-5Gs and nAChRα7TM-5Gs were studied by 
fluorescence microscopy. 
Cys-loop receptors have been proposed as the main targets for general 
anesthetics. In previous studies from our group 31-33, anesthetic effects on the TM 
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domain of the nAChRs and their analogues have been intensely studied on the 
molecular basis, such as the preferred binding sites of anesthetics and the effects of 
anesthetics on the structure and dynamics of the protein targets. In these studies, the 
reductionist approach was applied. Whether the results from the various studies on the 
reduced nAChR are functionally valid still need to be addressed.  
Electrophysiology studies show that the different types of full-length nAChRs 
respond differently to general anesthetics. The full-length nAChR α4β2 is sensitive to 
general anesthetics and they can be inhibited by general anesthetics, whereas the full-
length nAChR α7 is insensitive to volatile anesthetics 35. In the present study of TM 
domains, the anesthetic effect on the channel functions was investigated by 
fluorescence microscopy. Similar results to the full-length proteins were observed, 
suggesting that the previous studies of the anesthetic effects on the TM domains are 
physiologically relevant. This finding also suggested that the TM domains of nAChRs 
were the main targets of general anesthetics, since their responses to the general 
anesthetics were in the same trends as with the full-length nAChRs.  
 5.2.2 Materials and sample preparation 
Sample preparation has been described in the previous chapters. Briefly, we prepared 
the vesicles with 30 mM lipids and 150 µM receptors. The ratio between the lipid and 
receptors was 200:1 and the PC/PG ratio was 4:1 for the nAChR 41. For the TM domains 
of nAChR, the purified samples, α 4 and β 2 in the lauryldimethylamine-oxide (Ldao) 
micelles, were first mixed in a molar ratio of 2:3 and dialyzed against the water to 
remove the detergents. The precipitated proteins were re-dissolved in the 
tetrafluoroethylene (TFE) organic solvent. The dissolved protein sample in TFE was 
mixed with the lipid in chloroform and dried to a thin film. The dried mixture of the lipids 
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and proteins were further re-hydrated in 200 mM NaCl buffered at 20 mM Tris buffer pH 
7.5. Basically, the same protocol as described before was followed to prepare the 
vesicles for fluorescence microscopy. The same protocol was followed to prepare the 
nAChR α7 sample. 
 For the anesthetic studies, 2 ul net isoflurane solution was equilibrated with 1ml 
200 mM NaCl at 20 mM Tris buffer pH 7.5. The vesicle sample was pre-mixed with an 
equal volume of the above isoflurane solution for 0.5 h before the measurements. The 
final isoflurane concentration in the vesicles was ~0.2 mM, confirmed by 19F NMR. 
In order to observe the correct fluorescence signal that corresponds to the 
channel function, specific dyes were selected. The nAChRs form cation channels, which 
allow the positively charged Na+ ion to pass through the channel. Sodium Green 
(Invitrogen, Carlsbad, CA) is a sodium enhancement dye, which increases the 
fluorescence intensity as the Na+ concentration rises inside the vesicles. 5 uM Sodium 
Green dyes were added into the samples during the rehydration process. The dyes 
outside the vesicles were removed by overnight dialysis. 
5.2.3 Vesicle-channel activity assay 
Fig. 5.2.1A shows that, when 10 mM NaCl was carefully replacing the extra-vesicle 100 
mM Na+ ion in the nAChR samples, the fluorescence intensities decreased rapidly, 
suggesting that the truncated nAChRs formed the functional channels to allow the intra-
vesicle Na+ to flow out. For the control experiment, the intensity kept constant during the 
experiment (Fig. 5.2.1B). This indicated that the intensity decay observed in Fig. 5.2.1A 
was not due to fluorescence bleaching. Fig. 5.2.1C shows the typical curves of the 
fluorescence intensities as a function of time. The fluorescence data were best fitted to 
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Eq. 5.2.1 and the average transport rate can be determined as ~2 s-1 for the nAChR 
α4β2. 
€ € 
F(t) = A1⋅ exp(−k⋅ t) + A2                                                             (5.2.1) 
where F is the fluorescence intensity, t the experimental time in sec, and k the apparent 
transport rate, respectively, and A1 and A2 are constants. 
 
 
 
 
Fig. 5.2.1. Functional assay of TM domains of α4β2 nAChR. (A) Zoom-in confocal 
fluorescence images of unilamellar vesicles containing α4β2 nAChR channels, after 
rapidly exchanging extra-vesicular Na+ concentration from 100 mM to 10 mM at different 
time points. Membrane-impermeable Sodium Green fluorescent dyes were enclosed and 
trapped inside the vesicles to indicate intra-vesicle Na+ concentration. The fluorescence 
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intensity of the vesicles with α4β2 channels decreased significantly within a short period 
of time after dilution of extra-vesicle NaCl, indicating an enflux of Na+ through the 
channels. (B) A control experiment to show that the intensity decay observed in (A) was 
not due to fluorescence bleaching. (C) The intensity changes in the vesicles over time 
after the exposure to extra-vesicle Na+.  
 
 
The flow rates determined by nonlinear fitting on the fluorescence intensity 
profiles show the difference along the channel types. The flow rate determined by a 
single event is only valid for that particular sample under that particular experimental 
condition because the flux depends on the channel density in the vesicles. Therefore, 
based on a single experiment, we cannot tell the difference between the α7 channel and 
the α4β2 channel with regard to the flow rates. In order to compare them, the average 
flow rates were obtained through using the histogram method to analyze multiple 
independent experiments. Fig. 5.2.2 shows the histogram of Na+ efflux rates for α4β2 
and α7 nAChR channels. In general, the efflux rates were similar to each other. The flow 
rate of the nAChR α7 may be smaller than the nAChR α4β2. 
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Fig. 5.2.2. Vesicle-channel activity assay of nAChR α4β2 and α7. (A) Histogram of 
apparent Na+ efflux rate constants in α4β2 TM1234 channels. (B) Histogram of apparent 
Na+ efflux rate constants in α7 TM1234 channels. 
 
 
The flow rates determined by fluorescence microscopy are expected to be much 
slower than the transport rates measured by the MIT experiments. In the MIT 
experiment, the 35Cl ions were in the equilibrium state. Therefore, the changes 
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measured by NMR must be due to the 35Cl ion across the channel. However, in the 
fluorescence experiment, when the extra buffer was added into the sample, the 
equilibrium state was broken and needed a rebuilt. During this time, the fluorescence 
intensity started to change correspondingly. It resulted that the flow rates determined by 
fluorescence microcopy combined both the time for rebuilding the equilibrium and the 
time for the ions to cross the channel.  
5.2.4 Isoflurane effects on the TM domain of nAChR α4β2 and α7 
The vesicle samples of nAChR α 4β2 and α 7 were prepared as previously described. 
Similar experiments, using fluorescence microscopy, were performed for both α4β2 and 
α7 in the presence of isoflurane. The flow rates were determined by fitting the data using 
Eq. 5.2.1. The histogram method was further used to analyze the distribution of the flow 
rates. 
 For the TM domains of nAChR α4β2, in the absence of isoflurane, the apparent 
flow rates were distributed between 0.5 s-1 and 3.5 s-1, as shown in Fig. 5.2.2A. In the 
presence of ~2 mM isoflurane, the histogram bars shifted to the left. The flow rates were 
obviously decreased by the addition of the isoflurane (Fig. 5.2.3A). This suggested that 
the general anesthetics inhibited the channel activities. However, for the TM domains of 
nAChR α7, we did not observe the same trend in the presence of the isoflurane (Fig. 
5.2.3B). The TM domains of α7 are insensitive to the isoflurane. These findings are 
consistent with previous studies based on the full-length nAChR α4β2 and α7. Without 
the EC domain and IC domain, the TM domains of nAChR themselves can resemble the 
native nAChR responses to the general anesthetics, therefore the TM domains may be 
the main targets for the anesthetic. Our studies based on the truncated nAChR are valid 
and functionally important. 
CHAPTER 5 FUNCTIONAL STUDIES AND INHALATIONAL ANESTHETIC EFFECTS ON TM 
PROTEINS 
 166	  
 
  
 
 
Fig. 5.2.3. Anesthetic effect on the TM domains of nAChRs. Histogram of apparent 
Na+ efflux rate constants in α4β2 (Α) and α7 (Β) channels in the presence of ~0.2 mM 
isoflurane. 
 
 
CHAPTER 5 FUNCTIONAL STUDIES AND INHALATIONAL ANESTHETIC EFFECTS ON TM 
PROTEINS 
 167	  
5.2.5. Conclusion 
The vesicle-channel activities of nAChR α4β2 and α7 were examined by fluorescence 
microscopy. The fluorescence intensity reduction in response to the decreases of the 
Na+ concentrations outside the vesicles indicated the channel formations of nAChR α4β2 
and α7. The flow rates were estimated to be 0.5~3.5 s−1 for α4β2 and 0.5~2.2 s−1 for α7. 
In the presence of isoflurane, the observed flow rate of nAChR α4β2 was decreased to 
0~2 s−1, while it remained the same for nAChR α7. These results were consistent with 
the responses of full-length nAChR α4β2 and α7 to the anesthetic. nAChR α4β2 is 
sensitive to isoflurane and α7 is not. Therefore, our previous anesthetic studies on the 
TM domains of nAChR α4β2 and α7 were functionally relevant.  
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CHAPTER 6 
 SUMMARY OF CONCLUSIONS AND 
FUTURE DIRECTIONS 
6.1 STRUCTURAL STUDIES OF nAChR AND FUTURE 
DIRECTIONS 
6.1.1 Structural studies 
The TM domains of a water-soluble acetylcholine receptor (WSA), human nAChR TM 
domains with and without the IC domain (nAChRα7TM-IC and nAChRα7TM-5G, 
respectively) were successfully constructed and heterologously over-expressed in E. 
coli.  
 The monomer structure of WSA and the secondary structure of nAChRα7TM-5G 
were determined by NMR. Both WSA and nAChRα7TM-5G show a secondary structure 
more similar to the bacterial analogues of the pentameric channels, GLIC and ELIC, 
than to the cryo-EM structure model of the parent nAChR, on which WSA was designed. 
The monomer structure of WSA was resolved to the backbone RMSD of ~1.1 Å. The 
overall tertiary structure of WSA is also more similar to the X-ray structures of GLIC and 
ELIC than to the cryo-EM structure of nAChR. The dynamics of WSA, nAChRα7TM-5G 
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and nAChRα7TM-IC, which provided more detailed information about protein motion, 
were investigated by NMR. The dynamics of the IC domain was first characterized using 
our newly developed histogram method. It revealed that the presence of the IC domain 
dramatically affects the intrinsic dynamics of the TM domains. 
6.1.2 Future directions 
This thesis has focused on the monomeric WSA, nAChRα7TM-5G and nAChRα7TM-IC. 
However, based on our previous study on WSK3 and several lines of other evidence in 
the thesis, we believe that these water –solubilized proteins might exist in a channel-like 
oligomeric state. The structure determination for them will be very critical to the 
understanding of the channel gating mechanism of Cys-loop receptors. 
For the membrane proteins used in this thesis, we used a novel water 
solubilization approach. We mutated putatively lipid-facing residues to hydrophilic ones 
for the entire TM domains in order to make the target protein water-soluble. However, 
fewer mutation sites than we reported here may be sufficient to make the protein over-
express in E.coli and yield a sufficient mount of proteins for the structure determination. 
 The IC domains are intrinsically flexible, making it hard to be characterized 
structurally. Because IC domains are usually involved in downstream signal transduction 
by interacting with other soluble protein in the cytoplasm, such interactions may facilitate 
the structure determination or crystallization. 
CHAPTER 6 SUMMARY OF CONCLUSIONS AND FUTURE DIRECTIONS 
 
 170	  
6.2 INHALATIONAL ANESTHETIC MECHANISMS AND FUTURE 
DIRECTIONS 
6.2.1 Anesthetic mechanism 
In this thesis, we focused on the mechanism of general anesthesia by studying a water-
soluble dimeric protein, (Aα2-L1M/L38M)2, a membrane protein, Mistic, and TM2 
domains of nAChR. It revealed that general anesthetics always prefer amphipathic 
environments. Compared to the effect on the structures of proteins, general anesthetics 
show stronger effect on the dynamics. The effects on the dynamics of proteins can 
manifest directly or allosterically. 
6.2.2 Future directions 
In the thesis, we investigated several model proteins and the TM2 domain of nAChR by 
NMR. WSA, nAChRα7TM-5G and nAChRα7TM-IC are all larger and more complete 
domains of nAChR. General anesthetic effects on these proteins will further advance our 
understanding of the mechanism of the general anesthesia. 
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APPENDIX 
See blow for the four published papers. 
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Four-a-Helix Bundle with Designed Anesthetic Binding Pockets. Part II:
Halothane Effects on Structure and Dynamics
Tanxing Cui,* Vasyl Bondarenko,* Dejian Ma,* Christian Canlas,* Nicole R. Brandon,* Jonas S. Johansson,§{
Yan Xu,*y and Pei Tang*yz
*Department of Anesthesiology, yDepartment of Pharmacology, and zDepartment of Computational Biology, University of Pittsburgh
School of Medicine, Pittsburgh, Pennsylvania 15260; §Department of Anesthesiology and Critical Care, and {Johnson Research
Foundation, Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104
ABSTRACT As a model of the protein targets for volatile anesthetics, the dimeric four-a-helix bundle, (Aa2-L1M/L38M)2, was
designed to contain a longhydrophobic core, enclosedby four amphipathica-helices, for specific anesthetic binding. The structural
and dynamical analyses of (Aa2-L1M/L38M)2 in the absence of anesthetics (another study) showed a highly dynamic antiparallel
dimer with an asymmetric arrangement of the four helices and a lateral accessing pathway from the aqueous phase to the
hydrophobic core. In this study, we determined the high-resolution NMR structure of (Aa2-L1M/L38M)2 in the presence of
halothane, a clinically used volatile anesthetic. The high-solution NMR structure, with a backbone root mean-square deviation of
1.72 A˚ (2JST), and the NMR binding measurements revealed that the primary halothane binding site is located between two side-
chains of W15 from each monomer, different from the initially designed anesthetic binding sites. Hydrophobic interactions with
residues A44 and L18 also contribute to stabilizing the bound halothane. Whereas halothane produces minor changes in the
monomer structure, the quaternary arrangement of the dimer is shifted by about half a helical turn and twists relative to each other,
which leads to the closure of the lateral access pathway to the hydrophobic core. Quantitative dynamics analyses, including
Modelfree analysis of the relaxation data and the Carr-Purcell-Meiboom-Gill transverse relaxation dispersion measurements,
suggest that themost profound anesthetic effect is the suppression of the conformational exchange both near and remote from the
binding site. Our results revealed a novel mechanism of an induced fit between anesthetic molecule and its protein target, with the
direct consequence of protein dynamics changing on a global rather than a local scale. This mechanism may be universal to
anesthetic action on neuronal proteins.
INTRODUCTION
A diverse range of molecules, from structurally featureless
noble gases to complex steroids, can render people into a state
of mind commonly known as general anesthesia. The molec-
ular processes underlying this phenomenon remain unclear
(1–7). Although modulation of neuronal protein functions
through nonspecific anesthetic perturbation to the lipids in the
central nervous system remains a distinct possibility, the cur-
rent consensus is that anesthetic molecules, despite their struc-
tural diversity, interact specifically with proteins (5). Extensive
investigations, particularly with biophysics, electrophysiol-
ogy, and mutagenesis approaches, have centered on the hy-
pothesis that anesthetics occupy the hydrophobic pockets or
cavities in the proteins to change the protein function. How
exactly such a change is achieved, however, is still a mystery.
The dimeric protein, (Aa2-L1M/L38M)2, was engineered
by de novo design to create a long hydrophobic core within
a common four-a-helix bundle scaffold (8,9). This four-
a-helix bundle has an anesthetic binding affinity in the anes-
thetizing concentration range of clinical volatile anesthetics
(9,10) and thus is regarded as a suitable model for the protein
targets of general anesthetics. In our Part I article in this issue
(11), we presented the NMR structural and dynamical anal-
ysis of (Aa2-L1M/L38M)2 in the absence of anesthetic
binding. The apoprotein backbone structure was resolved to a
root mean-square deviation (RMSD) of 1.77 A˚. As originally
designed, two monomers of the helix-turn-helix motif form
an antiparallel dimer. The dimeric structure shows that two
helices from the N-terminus to the linker (helix 1 and helix
19) are held together by the ring stacking of F12 and W15
along the hydrophobic core and by a leucine zipper from
complementary pairs of L4, L11, L18, and L25 at the heptad
e position of each monomer. The high-resolution structure
also shows a lateral access pathway near K47 between the
two second helices in the dimer (helix 2 and helix 29) such
that the amphipathic anesthetic molecules can enter the hy-
drophobic core directly from the aqueous phase. Departing
from the initial design, however, is the number of anesthetic
binding pockets identifiable within the hydrophobic core.
Whereas the original design intended to create two sites with
mirror images of each other between W15 and M38 of each
monomer (9), the NMR structure suggests only one primary
anesthetic binding site between the aromatic rings of W15 in
the dimer, and two possible minor binding sites between the
ring stacking of F12 and F52 (11).
In this study, we experimentally measured the halo-
thane binding to (Aa2-L1M/L38M)2 and determined the
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high-resolution structure of (Aa2-L1M/L38M)2 in the pres-
ence of halothane. Comparison of the structures and dy-
namics of (Aa2-L1M/L38M)2 in the presence and absence of
a bound halothane molecule revealed an interesting change in
protein quaternary structure and in the overall dynamics of
the protein. These results shed new light on how volatile
anesthetics might potentially produce functional changes in
proteins in general.
MATERIALS AND METHODS
(Aa2-L1M/L38M)2 expression and purification, NMR sample preparation,
and all NMR methods for structure determination have been described in
detail in Part I (11). Briefly, the conventional suite of two-dimensional (2D)
and three-dimensional (3D) heteronuclear, filtered experiments for spectral
assignment, TALOS dihedral angle constraints, and NOESY distance con-
straints were carried out using the standard pulse sequences from the Bruker
sequence library. 15N- and 13C-filtered NOESYwas measured with a mixing
time of 120 ms. The NOESY assignment was done initially using the Cyana
program (12) and then improved manually. Because of the high helical
content in (Aa2-L1M/L38M)2 and the characteristic short- and mid-range
NOE connectivity to define the helix regions in the structure, the long-range
intersubunit NOEs from residues on the opposite ends of the helices can be
distinctively and positively identified by the chemical shift matching with an
exclusion strategy, without resorting to mixing labeled and unlabeled sam-
ples and using specific filtering or purging pulse sequences. In the halothane
titration experiments, the (Aa2-L1M/L38M)2 concentration was 500 mM in
10%D2O/90%H2O with 0.4% 2,2-dimethyl-2-silapentane-5-sulfonic acid
(DSS) and 0.02% NaN3. Neat halothane was added in 0.3 ml increments
using a Hamilton microsyringe. Because evaporation during the repeated
titration procedure could not be controlled, the halothane concentrations in
the NMR sample were measured by the halothane 1H intensities after each
titration step and then calibrated against the final titration point, at which both
1H and 19F intensities were measured, with the 19F intensity calibrated
against known concentrations of trifluoroacetate solutions (13,14). Based on
this calibration, the halothane concentrations in the titration experiment
ranged from 0 to 2.2 mM, at which point the chemical shift change started to
plateau. At very low halothane concentrations, the halothane peak was too
weak to be accurately measured. This technical difficulty prevents the site-
specific Kd values from being accurately quantified. Therefore, the chemical
shift change as a function of halothane titration is used in this study only as a
qualitative indication of the halothane binding site(s). To estimate the
magnitude of Kd at the binding site, nonlinear regression with the following
equation (15,16) was used to fit the chemical shift changes as a function of
halothane concentration, including the point with zero halothane:
Dobs ¼ Dmax
2½P#0
KD1 ½A#01 ½P#0
! "#
$
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
KD1 ½A#01 ½P#0
! "2$4½A#0½P#0q %; (1)
where [A]0 and [P]0 are the anesthetic and protein concentration, respec-
tively, and Dmax is the limiting chemical shift difference.
Except for temperature dependent amide proton exchange measurements,
for which HSQC experiments were performed at 25, 30, 35, and 40!C to
determine the temperature coefficient for hydrogen bonding constraints, all
other NMR experiments were conducted at 35!C. Most of the NMR ex-
periments were carried out using a Bruker Avance 600 spectrometer. For
selected experiments, Avance 700 and 800 spectrometers were used.
Two different types of experiments were conducted to determine the
halothane binding to (Aa2-L1M/L38M)2 by measuring the intermolecular
NOE. The conventional 2D 1H-1HNOESYwas used to measure the coherent
NOE build-up, whereas selective saturation transfer was used to measure the
noncoherent cross relaxation between the two interacting molecules. The 1H
saturation transfer NOE experiments used tr-HSQC-based pulse sequence.
Selective saturation of halothane proton resonance was achieved using an
IBURP2 pulse train (80-ms shaped pulses with an interpulse delay of 4 ms
and a total duration of 1.6 s) preceding the tr-HSQC sequence. Interleaving
on-resonance and off-resonance (–5000 Hz) spectra were acquired to de-
termine the saturation-transfer effects between halothane and individual
residues.
The halothane effects on backbone dynamics were measured in the
presence of 2.2 mM halothane and compared with the results obtained
without halothane as described in Part 1 (11). The 15N R1 and R2 relaxation
and 15N-{1H} heteronuclear NOE (hetNOE) data were analyzed using the
Lipari-Szabo model-free approach (17,18) with the Modelfree program (19).
The R2 relaxation dispersion spectra were acquired at 35!C on Bruker 800
MHzNMR spectrometers with 15N operating frequencies of 81.09MHz. The
spectra were recorded with 1024 t2 and 128 t1 data points, with spectral
widths of 10 ppm for 1H and 24 ppm for 15N dimensions. The relaxation-
compensated constant-time Carr-Purcell-Meiboom-Gill (CPMG) sequence
was used (20,21). The total CPMG constant-time delay was set to TCPMG ¼
60 ms (two 30 ms CPMG periods). The spectra were collected with 10 dif-
ferent CPMG field strengths, measured by nCPMG of 33.33, 66.67, 100.00,
133.33, 200.00, 266.67, 333.33, 400.00, 500.00, and 666.67 Hz, where
nCPMG ¼ 1/(4tCPMG), and the separation between the centers of successive
refocusing 180! pulses equals 2tCPMG. An additional reference spectrumwas
collected by removing the CPMG periods in the pulse sequence. A relaxation
delay of 2.5 s was used. The 1H chemical shifts were referenced to DSS
resonance at 0 ppm, and the 15N chemical shifts were indirectly referenced
(22).
To analyze transverse relaxation dispersion, the intensities of crosspeaks
in 2D R2 relaxation dispersion spectra with a given CPMG field strength
were measured and then converted into the 15N transverse relaxation rate
constant R2 and associated uncertainties according to the well-established
relations (23):
R2ðnCPMGÞ ¼ $ 1
TCPMG
ln
IðnCPMGÞ
I0
& '
(2)
and
dR2ðnCPMGÞ ¼ 1
TCPMG
dIðnCPMGÞ2
IðnCPMGÞ2
& '
1
dI20
I20
& '( )1=2
; (3)
where I(nCPMG) and I0 are the intensities for a given crosspeak, and
dI(nCPMG) and dI0 are the noise levels in the dispersion spectra with and
without the CPMG pulse trains, respectively. Three exchange parameters,
R20, Fex/kex and kex were calculated using the fast exchange limit approx-
imation (Dv ¼ va $ vb , kex) with two exchanging sites to fit the R2
dispersion profile R2(nCPMG) by (24):
R2ðnCPMGÞ ¼ R201Fex
kex
1$ 4nCPMG
kex
tanh
kex
4nCPMG
& '& '
; (4)
in which R20 is the R2 without exchange (in the limit of nCPMG ¼N),Fex ¼
(va $ vb)2papb, pi and vi are the populations and Larmor frequencies for the
nuclear spin in site i; and kex is the exchange rate. It should be noted that kex
describes exchange rate on the ms-ms timescale and is not the same as the
phenomenological Rex term used in the Modelfree approach (24,25).
RESULTS
Site-specific anesthetic binding
Two independent NMR methods were used to determine
possible site-specific interactions between anesthetics and
(Aa2-L1M/L38M)2. The first was an anesthetic titration ex-
Four-Helix Bundle II: Anesthetic Effects 4465
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periment, in which the dependence of chemical shifts of in-
dividual residues in (Aa2-L1M/L38M)2 was measured as a
function of halothane concentration. Fig. 1 A depicts the
representative overlaps of HSQC contour plots for four res-
idues where the backbone amide 1H or 15N chemical shifts
are profoundly affected by varying concentration of halo-
thane. Nonlinear fitting with Eq. 1, including the point
without halothane, yield an estimate of Kd atW15 to be 2.66
1.7 mM (R2 ¼ 0.996). To visualize the overall halothane
effects on HSQC chemical shifts, the normalized changes in
the weighted average of the 1H and 15N chemical shifts with
and without 2.2 mM halothane are color coded onto the
protein structure (see below for structural determination), as
shown in Fig. 1 B. Clearly, the most sensitive region is near
W15. To further confirm that the concentration-dependent
chemical shift changes are indeed a result of halothane
binding instead of other nonspecific effects, a second, inde-
pendent NMR method was used to measure the saturation
transfer (26) between halothane and various residues. The
percentage change in tr-HSQC peak intensity from the sat-
uration transfer difference spectroscopy is mapped on the
structure (Fig. 1 C), showing again the specific interaction
between halothane and the protein near W15, A22, and A44.
Neither chemical shift titration nor the saturation transfer
difference spectroscopy showed significant halothane effects
on M38, confirming the prediction from a computer simu-
lation (27) and our own structural study (Part I (11)) that M38
is not directly involved in the halothane binding. Thus, the
3.5-fold enhancement in the halothane binding affinity due to
L38M mutation must result from allosteric effects.
High-resolution structures with a
bound halothane
Parallel to the studies without anesthetics as described in Part
I (11)), the same batch of the expressed proteins was used in
this study to determine the (Aa2-L1M/L38M)2 structure in
the presence of halothane. The same suite of heteronuclear,
multidimensional NMR experiments was performed for as-
signment and structure determination. The NOE connectivity
and chemical shift index (CSI) pattern resemble those shown
in Fig. 3 of Part I (11)). Again, two helical segments, from R5
to E27 and from E36 to R58, are readily identifiable in the
NOE connectivity and CSI. The two termini and the glycine
linker between the two helices appear to be unstructured
based on the CSI and dynamics results (see below). The
statistics of the 20 structures with the lowest target function is
given in Table 1. The overall backbone RMSD is 1.72 6
0.39 A˚; the backbone RMSD of the helical regions is 1.056
0.28 A˚. The insignificant difference in RMSD between the
apo- and halothane-bound protein structures is likely due to
the difference in the spectral quality and the different num-
bers of total constraints available for the structural calcula-
tion. In the presence of halothane, at least two intermolecular
NOE peaks were positively identified in 2DNOESY between
halothane and L18 and A44 (Fig. 2). Structural calculations
with the inclusion of a halothane molecule clearly define the
halothane binding pocket, which is shown to be bordered by
the aromatic side chains of W15 and the hydrophobic side
chains of L18 and A44 in the dimeric form (Fig. 3 E). Fig. 3,
A and B, show the superposition of the structures with and
without halothane in the monomer and dimer forms, re-
spectively, exhibiting nearly the same secondary and tertiary
monomer structures and pronounced quaternary structural
changes after the addition of halothane. The side-chain ar-
rangements surrounding the primary halothane binding site
FIGURE 1 Halothane binding to the four-a-helix bundle (Aa2-L1M/
L38M)2. (A) Overlap of HSQC contour plots for residues F12, E14, W15,
and A44 in response to halothane titration, which was done by adding neat
halothane to the NMR sample in 0.3-ml increments. The same contour scale
is used for all peaks in each plot to show relative intensities. The peak colors
in the order of red, orange, green, blue, and purple indicate increasing
concentrations of halothane from 0 to 2.2 mM. In the contours for W15 and
A44, the shifted A44 peaks (blue and purple) overlap with the unshifted
W15 peak (red). Notice that W15 shows a large chemical shift jump at the
first titration point and greatly increased intensities at higher halothane
concentrations. (B) Individual residues in the NMR-determined structure are
color-coded according to their normalized chemical shift sensitivities to
halothane titration, with blue to red representing the least to most sensitive,
respectively. (C) Normalized saturation transfer NOE is mapped onto the
NMR structure of (Aa2-L1M/L38M)2 using the blue-white-red color code.
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without and with a bound halothane are depicted in Fig. 3, C
and D, respectively, and the packing details of halothane
interaction with the protein at the binding site are shown in
Fig. 3 E. Whereas the halothane orientation in the pocket is
not fixed, there is a clear orientation preference in binding
interaction in the bundle of structures (Fig. 4) because of
cation-pi type of interaction between the partial positive
charge on the hydrogen atom of halothane (28) and the aro-
matic ring of W15. Among the 20 lowest-energy structures,
12 have a halothane orientation as shown in Fig. 3 E, with
halothane’s Br and Cl each interacting with one of the two
hydrophobic side chains of L18, and the hydrogen and the
–CF3 moiety orienting toward the W15 aromatic ring and the
A44 side chain, respectively. In the remaining 8 structures,
the halothane flips;180! to point the proton to the aromatic
ring of the other W15.
FIGURE 2 A contour plot of a 1H-1H 2D NOESY spectrum showing
unambiguous crosspeaks between halothane resonance at;6.4 ppm and the
side chains of L18 and A44.
FIGURE 3 Comparison of high-resolution NMR structures of (Aa2-L1M/
L38M)2 determined with and without halothane. (A) The monomer structure
determined in the presence of halothane (purple) is superimposed onto the
structure of the apoprotein (yellow). (B) Superposition of the dimer struc-
tures. Notice the quaternary structural changes and supercoiling of the
helices in the presence of halothane. (C) Side view of hydrophobic core of
the four-a-helix bundle in the absence of halothane. (D) Side view of
hydrophobic core of the four-a-helix bundle with a halothane bound in the
primary binding site. (E) Detailed interactions between halothane and the
residues surrounding the anesthetic binding pocket. In C, D, and E,
important side chains are shown in licorice representation: W15 (orange);
K47 (cyan); E43 (pink); F12 (green); and A22 and A44 (lime). The
halothane molecule is shown in VDW spheres: C (cyan); H (white); Cl
(blue); Br (red); and F (pink).
TABLE 1 Structural statistics of 20 (Aa2-L1M/L38M)2 structures
with halothane
NMR structure Statistic
Restraints per monomer
NOE distances
Intraresidue 144
Short range (i-j ¼ 1) 128
Medium range (1, i-j # 4) 96
Long range (i-j . 4) 15
Dimer (intermonomer) 6
Dihedral angles 72
Hydrogen bonds 20
Residual upper limit constraints violations number
. 0.5 A˚
0
Residual dihedral angle constraints violations
number . 5!
0
Backbone RMSD
Residues 5-27, 36-58, 205-227, 236-258 1.05 6 0.28 A˚
All residues (1-62, 201-262) 1.72 6 0.39 A˚
Heavy atom RMSD
Residues 5-27, 36-58, 206-226, 236-258 1.56 6 0.32 A˚
All residues (1-62, 201-262) 2.07 6 0.36 A˚
Ramachandran plot
Residues in most favored regions 91.0%
Residues in allowed regions 8.9%
Residues in disallowed regions 0.2%
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Anesthetic effects on backbone dynamics
The backbone dynamics was determined by analyzing the R1,
R2, and hetNOE of the backbone amide
15N with and without
halothane using the Modelfree approach (17,18). In addition,
the conformation exchange on the ms-ms timescale was ex-
amined using the CPMG R2 dispersion measurements. The
effects of halothane binding on the local and global dynamics
are depicted in Figs. 5 and 6. Fig. 5 shows the conventional
Modelfree analysis, depicting the generalized order param-
eter, the correlation time of the fast local motion (te), the
exchange contribution to the relaxation (Rex) (29), and the
model number used to fit the data. As in the case without
anesthetics, the two termini and the loop regions are signif-
icantly more flexible, with order parameters lower than 0.5.
The loop region does not meet the basic Lipari-Szabo as-
sumption and can only be fitted with Model 5. In the presence
of halothane, the residues in the immediate vicinity of the
binding site showed slightly elevated order parameters, be-
coming more ordered than without halothane. The most
profound changes are seen in the global distribution of the
Rex term in the helical regions. Overall, Rex is reduced upon
halothane binding, suggesting a lesser degree of conforma-
tional exchange. The involvement of nonzero Rex terms in
many residues is confirmed by the R2 dispersion measure-
ments, which are independent of the model selection or the
spectral density mapping. As shown in Fig. 6, many residues
exhibit the R2 dependence on the CPMG frequencies. The
DR2 values, which are estimated from the R2 values at the
two extreme CPMG frequencies achievable with our NMR
hardware, display the same distribution pattern as Rex along
the protein sequence (Fig. 6 B). It should be noted that the
DR2 measured by the relaxation dispersion underlies the
phenomenological nonzero Rex term in the Modelfree anal-
ysis, albeit the two are not expected to be identical (25) be-
cause the two experimental methods are sensitive to motions
on different timescales. Nevertheless, the overall trend is
clear, and the binding of halothane reduces the conforma-
tional exchange on the global scale. The significance of this
reduction in Rex (or DR2) will be discussed below. As in the
case without halothane, two residues, M38 and C41, still
show a larger Rex than other residues, albeit halothane re-
duced the Rex values by a factor of 2. Exchange parameters,
R20, Fex/kex, and kex, determined for several residues using
the fast exchange limit approximation (Eq. 4) to fit the
R2 dispersion data, are shown in Supplementary Material,
Table S1. There seems to be also a slight tendency that hal-
othane binding makes the loop region more ordered as shown
in the S2 values. This is supported by the slightly elevated R2
values for some of the loop residues in the R2 dispersion
measurements (e.g., G30 in Fig. 6 A). However, since the R2
dispersion method is prone to artifacts when R2 is not sig-
nificantly larger than R1 (30), which is indeed the case for the
loop residues, the small difference in the R2 dispersion with
and without halothane should be taken with caution for the
loop and terminal residues. Using the same method as in Part
FIGURE 4 Orientations of halothane molecules in the binding pocket. A
bundle of 20 halothane molecules (C-C bond (cyan); C-H bond (white) is
depicted in relation to the bundle of W15 side chains (orange) in the 20
lowest energy structures. Although the halothane orientation is not fixed, the
hydrogen, with partial positive charge, has the tendency to point to the
aromatic ring of W15 due to cation-pi type of interaction.
FIGURE 5 Comparison of (Aa2-L1M/L38M)2 dynamics in the presence
and absence of halothane binding. (A) The squared order parameter (S2), (B)
the local correlation time (te), (C) the exchange contribution (Rex), and (D)
model number used in the model-free analysis are plotted as a function of the
residue numbers of the four-a-helix bundle, depicting the dynamics in the
absence (s) and presence (d) of 2.2 mM of halothane. Notice that halothane
stabilizes overall protein motion as evidenced by the increased S2 in the
immediate vicinity of W15 and the globally reduced Rex terms at many
residues.
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I (11) to search for the best-fitted tm value, the Modelfree
calculations yielded the global tumbling time of 5.006 0.08
ns, in agreement with the global tumbling time of the apo
protein.
DISCUSSION
Primary anesthetic binding site in the
four-a-helix bundle
Four-a-helix bundle is a common scaffold found in many
important functional proteins. For example, the transmem-
brane domains of anesthetic-sensitive superfamily of Cys-
loop receptors are composed of pseudosymmetric pentamers
of four-a-helix bundles. Serving as a model for anesthetic
protein targets, (Aa2-L1M/L38M)2 was designed with a few
iterations of design changes aimed at improving the binding
affinity for volatile anesthetics (8,9). Our structural studies of
(Aa2-L1M/L38M)2 in the absence of a bound anesthetic, as
detailed in Part I (11) suggested a primary binding site be-
tween the twoW15 side chains in a dimer and an amphipathic
lateral access pathway from the aqueous phase through the
flexible C-terminal helix interface into this binding site.
These findings are somewhat unexpected because the in-
tended binding sites by design are closer to the two ends of
the hydrophobic core of the four-helix bundle, and thus there
should be two sites that are mirror images of each other. In the
present structural study with halothane, we confirmed that the
main halothane binding site is indeed sandwiched between
the two W15 residues. The chemical shift changes in re-
sponse to titration with varying concentrations of halothane,
the saturation transfer experiment, and 2D NOESY experi-
ment all indicate that the preferred halothane interaction site
are in the middle section of the four-helix bundle, instead of
between W15 and M38 as the latest iteration of design had
intended. The apparent dissociation constant for halothane
binding to (Aa2-L1M/L38M)2 is estimated to be in the
submillimolar range based on the fluorescence quenching on
(Aa2-L38M)2 (9). Our chemical shift titration experiments,
which measure the halothane influence on the protein back-
bone amide nitrogen and proton chemical shifts, probe the
relative involvement of individual residues in the anesthetic
binding. Since the side chains at the binding site are more
directly involved in the interaction than the backbone, the
site-specific Kd determined from the backbone chemical
shifts does not necessarily reflect the true binding affinity at
the interaction site. Nevertheless, the approximate Kd value
obtained from the chemical shift titration measurements is
consistent with the apparent Kd from the fluorescence
quenching experiments (9).
It is interesting to note that when the experimental struc-
tures were used in a docking search for potential halothane
binding sites, we found that the site between two W15 side
chains is highly preferred (;98%) but not exclusive in the
apoprotein. In contrast, with the lowest energy structure de-
termined in the presence of halothane, Autodock (31) found
the halothane binding site to be exclusively between W15
side chains. The estimated free energy of binding from Au-
todock is –3.35 kcal/mol (4.89 mM), which is in agreement
with the experimental titration data.
An induced fit for anesthetic binding
Detailed structural analysis revealed that the monomeric
helix-turn-helix fold is very similar in the two structural
bundles with and without a bound anesthetic, as shown in
Fig. 3 A. When fitting the helical regions of the monomers,
the RMSD between the two structural bundles is ;1.5 A˚,
which is only slightly larger than the RMSD of the monomers
FIGURE 6 (A) Representative plots of the 15N transverse relaxation rate,
R2, as a function of the CPMG field strength, nCPMG, for L4 (e), G30 (D),
M38 (h), C41 (s), and E50 (=) in (Aa2-L1M/L38M)2 without (open
symbols) and with (solid symbols) 2.2 mM halothane at 18.8 T (800 MHz).
Uncertainties in R2 were determined from the signal/noise ratio using Eq. 3.
The R2(nCPMG) dispersion profiles for L4, M38, C41, and E50 demonstrate
the contribution of conformation exchange to the 15N transverse relaxation
rate. The solid and dash lines are the best fit to the data for the protein in the
absence and presence of the anesthetic, respectively, using Eq. 4. G30 shows
no conformation exchange and is presented here as a reference. (B) Values of
DR2¼ R2(nCPMG¼33.3Hz) – R2(nCPMG¼ 666.7Hz) are plotted as a function
of residue numbers in (Aa2-L1M/L38M)2 without (s) and with (d)
halothane at 18.8 T. Most residues show a decreased DR2 in the presence
of halothane, indicating that halothane suppresses the global conformational
exchange in the protein.
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among the 20 lowest-energy structures of each bundle. Thus,
halothane binding did not greatly affect the monomer (sec-
ondary and tertiary) structure. As shown in Fig. 3 B, the most
significant structural change upon halothane binding is the
quaternary association of the four helices in the dimer. There
is a vertical shift of the monomers relative to each other by
approximately half a helix turn and a super-coil twisting of
the helices when a halothane molecule is bound at the site
between the two W15s. These quaternary structural changes
removed the asymmetry found in the apoprotein due to wider
separation between helix 2 and helix 29. The halothane-in-
duced quaternary changes led to a better fitting between
halothane and the amphipathic cavity of the binding site.
Measured by the Q-SiteFinder program (32), the binding
cavity bordered primarily by the side chains of W15, L18,
and A44 (Fig. 3, D and E) reduces its size from ;381 A˚3 in
the structures without halothane to;162 A˚3 in the structures
determined with halothane (after removing halothane from
the structure). The latter value better matches the molecular
volume of halothane (;130 A˚3 (33,34)). Thus, our structural
data suggest an induced fit between halothane and its binding
site. The high structural flexibility of the apoprotein, the
lateral opening between helix 2 and helix 29 for direct access
to the binding site from the aqueous phase, and the quaternary
structural re-arrangement for an induced fit can all contribute
to an increase in the binding on-rate. As evidenced in the
packing between the halothane molecule and the residues
surrounding the binding pocket (Fig. 3 E), the interaction at
the binding site is both hydrophobic and electrostatic in na-
ture. Optimization of the fitting in the binding site and the
closure of the lateral pathway as a result of the twisting of
helices 2 and 29 relative to helices 1 and 19 will likely de-
crease the binding off-rate, thereby achieving the high-af-
finity specific binding of halothane in this designed protein.
Implications of anesthetic effects on local and
global dynamics
In addition to the structural changes, halothane binding to the
four-a-helix bundle also resulted in profound changes in the
protein dynamics, not only locally but also globally at resi-
dues remote from the binding site. This finding is important
because protein function always involves protein motion.
Thus, the four-a-helix bundle offers more than just a struc-
tural model. The characteristics of halothane effects on the
dynamics of (Aa2-L1M/L38M)2 may have universal impli-
cations on how anesthetic binding to protein ultimately leads
to changes in protein functions (1–3,7,35–37).
In the absence of halothane, (Aa2-L1M/L38M)2 appears
extremely dynamic on the NMR timescale (11). Model-free
analysis showed that many residues in the helical regions
contain the Rex contribution to the backbone amide
15N re-
laxation, suggesting the presence of a conformational ex-
change process at these residues (18,28,38). This finding is
confirmed in this study by the R2 dispersion measurements.
By comparing the model-free analyses of the relaxation data
with and without halothane as shown in Fig. 5 and of the R2
dispersion data as shown in Fig. 6, it is clear that halothane
binding not only stabilizes the residues in direct contact with
halothane, but also reduces the Rex (orDR2) on a global scale.
The most noticeable Rex changes in (Aa2-L1M/L38M)2 are
atW15 and near M38 and C41. In the apoprotein, W15 signal
is relatively weak (hence precluding the R2 dispersion mea-
surement), presumably due to an intermediate exchange.
Indeed, when the site is not occupied, there is a large degree
of orientation freedom for the W15 side chains within the
hydrophobic core. The NMR structure of the apoprotein
suggests that W15 side chains tend to swing toward F12 to
form an aromatic ring stack within the long stretch of hy-
drophobic core, leaving a large space between the W15 side
chains to accept halothane. When the site is occupied, the two
W15 side chains are locked into a parallel configuration (Fig.
3, D and E) with reduced local flexibility, as indicated by the
increased order parameter at W15 and nearby residues. This
not only changes the chemical shift but also increases the
intensity of W15 in HSQC (Fig. 1 A). One of the direct
consequences of the reduced W15 side chain flexibility—in
addition to the induced fitting for high-affinity halothane
binding as discussed above—is the largest decrease of the Rex
term associated with W15 (Fig. 3 E).
As discussed in Part I (11), another dynamic hotspot in
(Aa2-L1M/L38M)2 is located near M38 and C41. Both of
these residues showed a large Rex term compared to the rest
of the protein when no halothane is bound. It is known that a
point mutation at residue 38 from Leu to Met can result in a
3.5-fold increase in halothane binding. Such an increase
could be due to changes in either structure or dynamics, or
both. Structurally, Leu-Met mutation has been shown to be
well tolerated by numerous studies. Because M38 (or L38) is
not even part of the halothane binding site according to the
NMR structure, local steric effects in a structural sense are
unlikely to be the cause of the increased binding affinity after
the mutation. In searching for other possible explanations, we
believe that global dynamics is an obvious candidate, given
the unusual dynamics property near the mutation site. The
allosteric coupling between W15 and M38 is clearly evident
in the large reduction of the Rex term at M38 and C41 on
halothane binding at W15. This suggests that residue 38 is
situated at a pivotal point to control the global dynamics of
the protein. Although Leu and Met are close on the hydro-
phobicity scale (39), methionine’s side chain is longer and
narrower than leucine’s side chain. Residue 38 is at the first
heptad g position in the first turn of helix 2 after the flexible
glycine linker. From the apoprotein structure, it can be seen
clearly that the M38 side chain is sandwiched between the
adjacent L37 and the more distant E27 and A23, all of which
congregate at the two ends of the flexible glycine loop. The
long and linear M38 side chain can either point toward the
glycine loop or toward the lateral aqueous phase, depending
on the glycine loop orientation. If L38 resumes the same local
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structure as M38, its side chain has predictably less orienta-
tion freedom relative to the glycine loop due to its bulkier
branching methyl groups. Therefore, it is conceivable that the
mobility at residue 38 in relation to the flexible linker is
critical to the opening and closing of the lateral pathway
between helix 2 and helix 29. The higher halothane binding
affinity found in the L38M mutation can be explained by the
increased on-rate, whereas the off-rate should be dictated by
the W15 ring stacking and induced fit after halothane has
occupied the binding site, which would be similar irre-
spective of L38 or M38.
In support of this viewpoint is the dynamics change at E43
and K47, where sizeable Rex terms can be seen when halo-
thane is absent. After halothane binding, the high-resolution
NMR structures reveal that the quaternary structural changes
shift E43 of one monomer to almost the same level as K47 of
the other monomer. The super-coil twisting brings E43 at
heptad b position closer to K47 at heptad e position of the
opposing helix. The electrostatic interaction stabilizes E43
and closes the interface (and thus the lateral access pathway)
between helices 2 and 29. As a consequence, both E43 and
K47 show a significantly reduced Rex term after halothane
binding.
Our results suggest an interesting interplay between
structural fitting and dynamical contribution to anesthetic
binding at protein targets. From a pure structural viewpoint
without considering protein mobility, the space between two
W15 side chains in the apoprotein would not seem ideal for
halothane binding. As discussed above, there is a large dis-
crepancy between the cavity size (381 A˚3) and the volume of
the anesthetic molecule (130 A˚3) for a snug structural fit.
However, the opening between helices 2 and 29 and their
conformational flexibility create an easy access directly from
the aqueous phase to this site. The intrinsic global mobility of
this dimeric protein and the interaction-induced structural
fitting between halothane and the key residues at the binding
site make this site more favorable than other potential sites.
For example, the minor sites found by the Autodock program
in the apoprotein between F12 and F52 would be theoreti-
cally suitable for halothane binding. These minor sites,
however, are not occupied with high affinity due to diver-
gence of the structural and dynamical factors at these sites. As
discussed in Part I (11), the side chain of F52 seems to be
‘‘out of place’’ in the aqueous phase. Although the local
rotational freedom of F12 and F52 side chains would allow
halothane to bind, the absence of a consequent structural
change to secure the binding would render any halothane
occupancy between F12 and F52 short-lived. Similarly,
Q-SiteFinder revealed two amphipathic pockets bordered
mainly by A8, F12, L51, L54, and R58 of one monomer and
L26, E27, L37, M38, and C41 of the other monomer, along
with three residues from the glycine loop. These pockets have
a volume of 303 A˚3 but show no interaction with halothane
experimentally and yield no population by flexible docking.
The controlling factor in this later case is likely to be the
protein dynamics. Thus, when searching for important an-
esthetic interaction site or sites in neuronal proteins to un-
derstand the molecular mechanisms of general anesthesia,
one must analyze and differentiate the structural and dy-
namical contributions to the functional consequences of an-
esthetic-protein interactions.
In conclusion, we identified a novel anesthetic binding site
in the designed four-a-helix bundle (Aa2-L1M/L38M)2 by
solving its high-resolution structure in the presence of halo-
thane. Different from the designed locations, this site be-
comes preferred over other potential sites, including the two
designed sites, for anesthetic binding after the interaction
between the anesthetic and protein has occurred. The intrinsic
global dynamics characteristics of this protein make the in-
duced fitting possible, and the induced structural fitting upon
anesthetic binding, in turn, modifies the local and global
dynamics of the protein. For neuronal proteins, the latter
aspect is likely to account for functional change of the pro-
teins, ultimately leading to the anesthetizing effects. It should
be pointed out also that we proposed more than a decade ago,
based on the analysis of xenon (6), that some molecules
would not normally be classified as general anesthetics due to
their lack of basic properties found in common anesthetizing
agents, but they nevertheless can produce anesthesia by
gaining these properties after interactions with their targets
takes place (e.g., induced dipole in xenon). We now show an
example of a related phenomenon, namely, that the protein
targets can be turned into relevant to anesthetic action only
after the interaction between anesthetic and protein has taken
place. The value of the designed four-a-helix bundle as a
model for anesthetic targets lies not only in its structural re-
semblance to the ubiquitous scaffold found in many func-
tional proteins, but also in its dynamics characteristics that
are perhaps more relevant to the functional response to an-
esthetics (1,2).
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Four-a-Helix Bundle with Designed Anesthetic Binding Pockets. Part I:
Structural and Dynamical Analyses
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ABSTRACT The four-a-helix bundle mimics the transmembrane domain of the Cys-loop receptor family believed to be the
protein target for general anesthetics. Using high resolution NMR, we solved the structure (Protein Data Bank ID: 2I7U) of a
prototypical dimeric four-a-helix bundle, (Aa2-L1M/L38M)2, with designed specific binding pockets for volatile anesthetics. Two
monomers of the helix-turn-helix motif form an antiparallel dimer as originally designed, but the high-resolution structure exhibits
an asymmetric quaternary arrangement of the four helices. The two helices from the N-terminus to the linker (helices 1 and 19)
are associated with each other in the dimer by the side-chain ring stacking of F12 and W15 along the long hydrophobic core and
by a nearly perfect stretch of hydrophobic interactions between the complementary pairs of L4, L11, L18, and L25, all of which
are located at the heptad e position along the helix-helix dimer interface. In comparison, the axes of the two helices from the
linker to the C-terminus (helices 2 and 29) are wider apart from each other, creating a lateral access pathway around K47 from
the aqueous phase to the center of the designed hydrophobic core. The site of the L38M mutation, which was previously shown
to increase the halothane binding affinity by ;3.5-fold, is not part of the hydrophobic core presumably involved in the anesthetic
binding but shows an elevated transverse relaxation (R2) rate. Qualitative analysis of the protein dynamics by reduced spectral
density mapping revealed exchange contributions to the relaxation at many residues in the helices. This observation was
confirmed by the quantitative analysis using the Modelfree approach and by the NMR relaxation dispersion measurements. The
NMR structures and Autodock analysis suggest that the pocket with the most favorable amphipathic property for anesthetic
binding is located between the W15 side chains at the center of the dimeric hydrophobic core, with the possibility of two
additional minor binding sites between the F12 and F52 ring stacks of each monomer. The high-resolution structure of the
designed anesthetic-binding protein offers unprecedented atomistic details about possible sites for anesthetic-protein interac-
tions that are essential to the understanding of molecular mechanisms of general anesthesia.
INTRODUCTION
Recent mutagenesis and biophysics investigations have led to
the belief that general anesthetics, although structurally di-
verse, can interact with proteins in a specific manner (1–7).
Among the proteins that are essential for neurological func-
tions, a superfamily of neurotransmitter-gated postsynaptic
receptors, known as the Cys-loop receptors, has been shown
to be particularly sensitive to volatile anesthetics (8). The
Cys-loop receptors are ion channels that, on activation by
neurotransmitter binding, respond to fast synaptic transmis-
sions in the central and peripheral nervous systems (9). These
ion channels are formed by association of five subunits, each
of which has four transmembrane (TM) domains, traversing
the membrane four times as a four-a-helix bundle. Point
mutations in the TM domains of the Cys-loop receptors have
been found to significantly alter the receptors’ sensitivity to
volatile anesthetics (10), implicating certain specific inter-
actions between the anesthetics and the TM four-a-helix
bundles.
Despite numerous functional investigations, the current
knowledge on the structure-function relationship of anes-
thetic-protein interactions is limited. This is largely because
of the technical difficulties in studying membrane proteins.
Although significant progress has been made in recent years
(11–17), no structure at the atomistic resolution is currently
available for the four-a-helix bundle TM domains of the Cys-
loop receptors.
To understand the structural basis of anesthetic-protein
interactions, de novo designs of prototype four-a-helix bun-
dles with specific anesthetic binding pockets have been pro-
posed (18,19). The original design, denoted as (La2)2, was
composed of a Leu-rich hydrophobic core as part of an an-
esthetic binding pocket. The pocket was later modified with
six Leu-to-Ala mutations (denoted as (Aa2)2), leading to a
factor of 4.4 improvement in the halothane binding affinity.
Further optimization with an additional 3.5-fold binding af-
finity increase was achieved in (Aa2)2 with the L38M point
mutation (19). This newer generation four-a-helix bundle
protein has a halothane dissociation constant, Kd, of 0.2 mM,
which is essentially the same as the clinical concentration for
halothane. Thus, (Aa2-L38M)2 is considered one of the most
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suitable models for the volatile anesthetic binding targets in
the four-a-helix bundle scaffold proteins.
Because of the size difference between the Leu and Ala
side chains, the improvement in anesthetic binding due to the
Leu-to-Ala mutations in (Aa2)2 was interpreted intuitively as
the result of the steric effects, namely, a possibly better fit
between anesthetic molecules and their binding pockets.
Nearly the same degree of improvement seen in the L38M
mutation, however, was not expected fully by design. Mo-
lecular dynamics simulations of a structure model for (Aa2-
L38M)2 showed thatM38was not even part of the hydrophobic
core (20), suggesting that factors other than simple geometric
fitting or steric restrictions between anesthetic molecules and
protein pockets might be at play in determining the anesthetic
binding affinity. To better understand these factors, we de-
termined the high-resolution structure and dynamics of the
bacterial-expressed (Aa2-L1M/L38M)2, which has compat-
ible anesthetic-binding properties to the early chemically
synthesized (Aa2-L38M)2 (21). The sequence of this 62-
residue peptide and the heptad repeat assignments used to
design the amphiphilic a-helices are shown in Fig. 1. We
present here the results of our investigation in the absence of
any anesthetic binding and emphasize the intrinsic structural
and dynamical properties of this designed anesthetic-binding
protein. The parallel studies of the same protein in the pres-
ence of halothane are presented in our Part II article in this
issue (22).
MATERIALS AND METHODS
Sample preparation
(Aa2-L1M/L38M)2 was expressed using BL21 codon plus (DE3)-RP com-
petent Escherichia coli cells in M9 minimal media and purified using re-
versed-phase HPLC, as described previously (21). The L1M mutation was
required for the bacteria to express the protein without a fusion protein. The
M9medium contained (15NH4)2SO4 and
13C-glucose as the sole 15N and 13C
sources for uniform 15N and 13C labeling, respectively. The purified protein
was lyophilized and stored at –20!C until use. NMR samples were prepared
by dissolving lyophilized protein in a 10% D2O/90% H2O solution to a
monomer concentration of 0.5 mM in a total volume of 300–400 mL. Ap-
proximately 1 mL of 100 mM 2,2-dimethyl-2-silapentane-5-sulfonate (DSS)
sodium salt was added as an internal chemical shift reference. Typically, the
unbuffered sample has a pH of 4.5. Samples prepared in this way have been
stable for several months if stored at 4!C.
NMR experiments
A suite of two-dimensional and three-dimensional (3D) NMR experiments
for spectral assignment, including 1H-15N HSQC, HNCO, HNCA,
HN(CO)CA, HNCACB, CBCA(CO)NH, HBHANH, and HBHA(CO)NH,
was performed at 35!C using a Bruker Avance 600 MHz spectrometer
equipped with a cryoprobe (Bruker Instruments, Billerica, MA). The 13C-
decoupled 1H-15N HSQC was acquired in 1024 (1H) 3 128 (15N) complex
points, with a spectral width of 10 ppm for 1H and 23 ppm for 15N, and
averaged for 16 scans. TheHNCACBwas acquired in 512 (1H)3 24 (15N)3
64 (13C) complex points, with spectral widths of 10 ppm (1H), 22 ppm (15N),
and 64 ppm (13C), and 32 scans. The CBCA(CO)NH, HNCO, HNCA, and
HN(CO)CA were each acquired in 512 (1H)3 30 (15N)3 64 (13C) complex
points, with spectral widths of 10 ppm (1H) and 22 ppm (15N), and 16 scans.
The 13C spectral widths were 64 ppm (CBCA(CO)NH), 20 ppm (HNCO and
HNCA), or 24 ppm (HN(CO)CA).
The 3D HCCH-TOCSY was acquired at 35!C on a Bruker Avance 700
MHz spectrometer with a cryoprobe using the following parameters:
1024(1H)3 64(13C)3128(1H-indirect) points, spectral widths of 10 ppm for
1H and 75 ppm for 13C, carrier at H2O resonance for
1H and 41.65 ppm for
13C, and 16 transients for each time increment. To assist with manual as-
signments and to obtain distance constraints for the structure calculation,
15N-edited 3D NOESY (mixing time of 120 ms and 150 ms) and 13C-edited
3D NOESY (mixing time of 75 ms and 150 ms) were performed. All four
NOESY experiments had 512 (1H) 3 30 (15N) 3 64 (13C) complex points
and 16 scans. The spectral widths were 10 ppm for 1H, 22 PM for 15N, and 40
ppm for 13C.
To measure the temperature effects, a series of 1H-15N HSQC experi-
ments were performed at 25, 30, 35, and 40!C. The same sample as the one
for the assignment experiments was used. The experiments were performed
on a Bruker Avance 600MHz spectrometer with a TXI probe. At least 30min
were given between each temperature change for the sample to equilibrate
before proceeding with the experiment. HSQC at 35!Cwas repeated to verify
that the protein had not irreversibly changed at different temperature steps.
Each 1H-15N HSQC was acquired with 16 scans in 512 (1H) 3 64 (15N)
complex points and spectral widths of 10 ppm (1H) and 22 ppm (15N).
The four-a-helix bundle dynamics was measured at 35!C using 15N R1
and R2 relaxation and
15N-{1H} heteronuclear NOE experiments. A Bruker
FIGURE 1 (A) The primary structure of (Aa2-L1M/L38M)2 four-a-helix
bundle protein with the heptad position a and d positions highlighted in
boldface. (B) Wheel diagram showing a single cycle of the heptad repeat.
The left two helices belong to a monomer (gray) with the linker below the
plane of the page, and the right two helices belong to another monomer
(black) with the linker above the plane of the page. The direction of the
helices is indicated by the1 and – signs. The a and d positions on the helices
form the hydrophobic core of the four-a-helix bundle.
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Avance 600 MHz spectrometer with a TXI probe and the Bruker standard
pulse sequences were used. In the R2 measurements, the interpulse delay
between two adjacent 15N 180 pulses in the CPMG sequence was 1000 ms
(including a 100-ms pulse width), and thus the field strength of the CPMG
refocusing pulses was 1.0 kHz. 512 (1H) 3 128 (15N) complex points were
taken, interleaving with and without 1H saturation. The spectral widths were
10 ppm for 1H and 22 ppm for 15N, with 88 scans for hetNOE and 24 scans
for R1 and R2 measurements. The R1 was determined using 8 delay values:
20, 50, 100, 200, 400, 600, 1100, 2000 ms. The R2 experiments used eight
delay values: 17, 34, 51, 68, 85, 119, 153, 221 ms. The relaxation rate
constants were obtained by exponential fitting. The hetNOE values were
defined as the ratios of peak intensities with and without proton saturation.
The uncertainties of hetNOE values, DNOE, were calculated using the well-
established method (23):
DNOE
NOE
¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
DIsat
Isat
" #2
1
DIunsat
Iunsat
" #2s
; (1)
where Isat and Iunsat are the peak intensities with and without proton
saturation, respectively. Their uncertainties were determined from the root
mean-square noise in the background regions.
Data processing and structure calculations
Data were processed using NMRPipe (24) and analyzed with NMRView
(One Moon Scientific, Westfield, NJ) (25) or Sparky (26). Because of the
repetitive nature of the designed amino acid sequence, the backbone spectral
assignments were done semimanually with the aid of the automatic spectral
assignment software packages AutoAssign (27) and MONTE (28,29).
Structure calculations were performed using CYANA v2.1 (30) based on
NOE restraints and Talos dihedral angle restraints from CSI (31). Hydrogen
bonding restraints were added for those residues that showed not only slow
exchange with water based on the small amide proton chemical shift de-
pendence on temperature (32), but also the helical 13C CSI as well as the
helical backbone NOE connectivities. To calculate the dimeric structures, the
restraints were duplicated for the two monomers, including 15 intermonomer
long-range NOEs observed in the 15N- or 13C-edited NOESY spectra. The
intermonomer NOEs were assigned by matching chemical shifts using an
exclusion strategy. A total of 100 structures were initially calculated by
CYANA. A bundle of 20 structures with the lowest target function is pre-
sented. Structures were analyzed using VMD (33) and Molmol (34).
The reduced spectral density mapping method (35) was used to qualita-
tively evaluate the dynamic characteristics of the protein. The reduced
spectral density functions at three frequencies, J(0), J(vN), and J(0.87vH),
were calculated from 15N R1, R2, and
15N-{1H} hetNOE by the following
matrix conversion (35):
where
1
B
¼ g
2
H
N 3 g2N3 h
2
43 r6NHN 3 4p
23
m0
4p
$ %
; (3)
and
1
F
¼ 3
B
1
D23v2N
3
: (4)
The 15N-1H internuclear bond distance (rNH) of 1.02 A˚ and the
15N chemical
shift anisotropy (D) of –160 ppm were assumed in the calculation of the
matrix elements (35). General classification of the spectral densities was
done by comparing the experimental spectral density values with the
theoretical curves for the single Lorentzian motion (36):
Jð0Þ3 JðvÞ ¼ Jð0Þ
2
11 5
2
3v3 Jð0Þ& '2: (5)
Deviations from the single Lorentzian motion were used to determine
qualitatively whether there is an exchange contribution to the relaxation at
each residue. In addition, we also employed a similar qualitative method
proposed earlier (37) to use R1 3 R2 to effectively discriminate chemical
exchange contribution from the motional anisotropy contribution in the R2
relaxation. This method takes the advantage of the fact that the anisotropy
effects on correlation times are greatly attenuated in R13 R2 when vt$ 1.
After calculating the theoretical curve of R13 R2 as a function of R2/R1 using
the full spectral density expressions for R1 and R2, we compared the
experimental data with the theoretical curve in the R1 3 R2 dimension.
Any residues with excess R1 3 R2 values above the theoretical curve would
suggest a nonzero Rex term for those residues. To quantitatively analyze the
15N relaxation parameters and 15N-{1H} heteronuclear NOE, the model-free
approach (38–41) and the Modelfree program (41) were used. The model
selection was first done based on the F-statistics in the R2/R1 diffusion
analysis. Because qualitative R1 3 R2 vs. R2/R1 analysis suggests that many
residues have nonzero Rex contribution in the R2 relaxation (see Results), the
global tumbling correlation time (tm) was determined by extensive search for
the tm value that gives the minimum reduced x
2 value and the least number
of nonfitted residues in the Modelfree data fitting, instead of estimating from
the R2/R1 ratio.
RESULTS
Spectral assignments
As shown in Fig. 1, this designed protein has 14 Es, 12 Ks, 11
Ls, 9 As, 8 Gs, 2 Fs, 2 Ms, 2 Rs, and one C and W, with a
significant amount of segment repetitiveness (e.g., 3 EEAAK
segments, 7 KL pairs, 6 EE pairs, etc.). Such sequence de-
generacy made the NMR spectral assignment difficult. Fig. 2
shows a typical 1H-15N HSQC spectrum of (Aa2-L1M/
L38M)2. A total of 115 peaks can be found in this spectrum,
nearly twice as many as expected. It is clear that the peaks can
be classified into two sets based roughly on the intensities,
corresponding to two different conformations. From a suite
of triple-resonance NMR experiments, 61 out of the 62 res-
idues (except M1) for the major conformation could be
positively identified and assigned (see Supplementary Ma-
terial, Table S1). The final assignments were marked in Fig.
2. Approximately 90% of the side-chain resonances in the
major conformation were assigned by using the 3D HCCH-
TOCSY. Because many peaks in the 3D spectra for the minor
conformation are too weak to be measured, only ;50% of
Jð0Þ
JðvNÞ
Jð0:87vHÞ
0@ 1A ¼ %0:753F 1:53F %0:93FF 0 %1:43F
0 0 0:23B
0@ 1A3 R1R2gN3 ðNOE% 1Þ3R1
gH
0BB@
1CCA; (2)
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reliable assignments for the second set of signals can be
made. Therefore, the current NMR data set does not allow a
complete structure and dynamics characterization of the
minor conformation. Possible sources of some of the minor
peaks include residual impurity in the protein preparation, a
very small population of the four-a-helix in the monomer
state, or different forms of dimers (e.g., parallel instead of
antiparallel dimers). In this study, we focus only on the major
conformation.
High-resolution structures of four-a-helix bundle
The sequential and midrange NOE connectivity in the major
conformation, the chemical shift indices (CSI), and the
temperature dependence of amide proton chemical shift are
summarized in Fig. 3. Similar to using line segments for
short- andmid-range NOEs, long-range NOEs (ji – jj. 4) are
also indicated by lines connecting the two interacting resi-
dues. Solid and dashed lines are used to distinguish the intra-
and inter-monomer long-range NOEs, respectively. Two
helical segments, from E7 to E27 and from E36 to R58, are
clearly discernible from the NOE connectivity. The Ca and
Cb CSI confirms that at least the segments from E6 to K24
and from E36 to E57 are helical. The first 5 residues from the
N-terminus, the last 5 residues to the C terminus, and 11
residues in the center from L25 to G35 have Ca and Cb
chemical shifts not significantly different from the random-
coil values. The CSI data also suggest a certain degree of
disruption in the a-helicity near F52.
Fig. 4 A shows a bundle of 20 structures calculated using
the restraints derived from the NMR peaks in the major
conformation. The atomic coordinates of the structures have
been deposited in Protein Data Bank (PDB: 2I7U). The sta-
tistics of the structural calculation are given in Table 1. The
overall backbone RMSD, including the flexible and less-
FIGURE 2 [1H, 15N]-HSQC of 13C/15N-labeled four-a-helix bundle in
90% H2O/10% D2O with a monomer concentration of 0.5 mM at 35!C and
pH 4.5. Sixty-one of 62 backbone resonances of the major conformation are
assigned with the exception of M1. F12 is visible when the contour level is
lowered. On addition of anesthetics, these resonances become stronger,
which allows their assignments to be easily confirmed in 3D experiments.
Assignments of the major conformation are labeled using the one-letter
amino acid code and the sequence number.
FIGURE 3 (A) Summary of NMR restraints determined for (Aa2-L1M/
L38M)2 four-a-helix bundle. Sequential and midrange NOE connectivity is
linked by the line segments, with the line thickness proportional to the
crosspeak intensity. For the long-range NOE [dij(ji–jj . 4)], the solid lines
represent intramonomer NOEs, and the dashed lines represent intermonomer
NOEs. The chemical shift index obtained from combining Ca and Cb shifts
is also shown. The amide proton chemical shift dependence on temperature
is marked under the sequence. Solid circle, solid star, and open circle
represent slow, medium, and fast exchange, respectively. (B) An example of
intersubunit NOESY assignment. Shown here are strip plots from 13C-edited
3D NOESY showing intersubunit NOE crosspeaks between G28 and L4.
Such crosspeaks cannot arise from the same subunit.
Four-Helix Bundle: Structure & Dynamics 4457
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structured terminal and linker regions, is 1.776 0.24 A˚. The
backbone RMSD for all four helical regions combined is
0.826 0.17 A˚. Further improvement of backbone RMSD by
residual dipole coupling (RDC) was not attempted because
high sequence redundancy and spectral overlap in the IPAP-
type spectra would not provide the needed accuracy in the
RDC frequency difference measurements.
Several features are readily apparent in the calculated
structures: 1), Because of the random-coil structures at the
two termini, the helical segments are somewhat shorter than
initially designed. 2), The dimer is antiparallel based on the
long-range NOEs between the two monomers (Fig. 3, dashed
lines). 3), There is a super-helical twist (coiled-coil) leading
to slight deformation of the helices (Fig. 4 B). 4), As origi-
nally designed, the first helix from the N-terminus to the
linker (helix 1) is associated with the other first helix (helix
19) in the dimer in an antiparallel fashion (likewise, helix 2
and helix 29 are associated with each other), such that the
hydrophobic surfaces composed of the a and d positions in
the helical heptad are facing each other in the hydrophobic
core. 5), The tertiary and quaternary arrangements of the four
helices are not completely symmetrical (Fig. 4 C). Helices
1 and 19 are closer to each other than helices 2 and 29. As will
be discussed later, this feature might be essential for creating
a lateral pathway for amphiphilic anesthetics to enter the
designed hydrophobic core.
Changes in chemical shifts of the amide protons at dif-
ferent temperatures are consistent with both the NOE con-
nectivity and the CSI result. As expected, the slope of
chemical shift change with temperature is small for residues
in the helical regions, indicating the existence of backbone
hydrogen bonding (32), whereas those with large chemical
shift changes with temperature are in the glycine linker re-
gion. Among the residues associated with the helices, those
whose chemical shifts are least sensitive to temperature tend
to be in the hydrophobic core of the protein. These data
further validate the spectral assignments and confirm that the
four-a-helix bundle is a dimer with hydrophobic faces of the
monomers associating with each other to exclude the water in
the hydrophobic core.
Backbone dynamics
The R1, R2, and hetNOE data for the backbone amide
15N of
(Aa2-L1M/L38M)2, the reduced spectral density mapping
results, the R2/R1 ratio, and the graphical analyses of J(vN) as
a function J(0) and R13 R2 as a function of R2/R1 are shown
in Fig. 5. The dynamics in the two termini and the loop re-
gions are significantly different from that in the helices. The
R1 values cluster in the 1.8–2.3 s
!1 range throughout the
sequence, with only small variations in the loop region and
near the termini. In contrast, R2 and hetNOE values are sig-
nificantly smaller in these regions (3.0–6.3 s!1) than in the
helices (10.1–13.7 s!1), suggesting considerable backbone
flexibility in the loop and the termini. Two residues, M38 and
C41, have noticeably higher R2 values than their adjacent
residues (17.5 and 17.3 s!1, respectively), indicating con-
siderable contributions from exchange in the R2 relaxation
for these residues. The hetNOE values are above 0.7 for all
residues in the a-helical regions. Initial estimates of the tm
value of the four-a-helix bundle, based on the R2/R1 ratio and
averaged over the residues in the a-helical regions, is 5.6 6
0.5 ns at 600 MHz. Because many residues have nonzero Rex
contributions to the R2 relaxation (see below). The tm value
should be determined independent of the R2/R1 ratio.
FIGURE 4 (A) The backbones of 20 lowest-energy structures of (Aa2-
L1M/L38M)2, fitted from E6 to E27 and from E36 to E57. Two monomers
are colored gray and black for distinction. (B) Side view of (Aa2-L1M/
L38M)2 structure in ribbon representation, showing distortion in helix 2 and
helix 29. (C) Top view of (Aa2-L1M/L38M)2 structure in ribbon represen-
tation. Notice the overall asymmetry in the arrangement of the four helices.
The N-terminal helices are labeled as 1 and 19, and the C-terminal helices as
2 and 29.
TABLE 1 Statistics of 20 NMR structures with the lowest
target functions
NMR structure Statistic
Restraints per monomer
NOE distances
Intraresidue 168
Short range (ji–jj ¼ 1) 133
Medium range (1 , j i–jj # 4) 82
Long range (ji–jj . 4) 17
Dimer (intermonomer) 15
Dihedral angles 90
Hydrogen bonds 40
Residual upper limit constraint
violations . 0.5 A˚
0
Residual dihedral angle constraint
violations . 5!
0
Backbone RMSD
Residues in helical regions only (6–27, 36–58) 0.82 6 0.17 A˚
All residues (1–62) 1.77 6 0.24 A˚
Heavy atom RMSD
Residues in helical regions only (6–27, 36–58) 1.38 6 0.20 A˚
All residues (1–62) 2.22 6 0.27 A˚
Ramachandran plot
Residues in most favored regions 92.8%
Residues in allowed regions 6.5%
Residues in disallowed regions 0.7%
4458 Ma et al.
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Qualitative analysis of the relaxation data using the re-
duced spectral density mapping method clearly indicates a
complex dynamics profile of the dimeric (Aa2-L1M/L38M)2.
The points within the dashed ellipse in Fig. 5 H are those
from the loop and terminal residues, which are less structured
and highly flexible. Many residues in the helices exhibit a
rightward shift from the theoretical single Lorentzian J(vN)
vs. J(0) curve, which is equivalent to the case of isotropic
tumbling in the model-free analysis. The rightward shift is an
indication that other motions, either anisotropic motion and/
or chemical and conformational exchange, contribute to the
R2 relaxation in addition to the global tumbling and internal
local motion. Since J(vN) is dominated by R1 and hetNOE
and is independent of Rex (see Eq. 2), the intersection be-
tween the single Lorentzian curve and the average J(vN)
values (horizontal line in Fig. 5 H) yields a J(0) value cor-
responding to an apparent correlation time should the protein
tumble isotropically. This estimate also gives a tm value of
;5.6 ns. To distinguish exchange from anisotropy contri-
butions, we compared experimental R1 3 R2 with the cor-
responding theoretical values (Fig. 5 I). If Rex ¼ 0, the
experimental R1 3 R2 would be smaller than the theoretical
values by a factor of S4, where S2 is the generalized order
parameter. A nonzero Rex would displace the experimental
values vertically by R1 3 Rex. As shown in Fig. 5 I, many
residues have nonzero Rex contributions to R2, with M38 and
C41 being distinctly different from the others. We confirmed
the presence of exchange contribution to relaxation by the R2
dispersion measurements, in which the relaxation-compen-
sated, constant-time Carr-Purcell-Meiboom-Gill (CPMG)
sequences (42,43) were used to determine the R2 dependence
on the CPMG frequency. Detailed analyses of the relaxation
dispersion data and of the anesthetic effects on the confor-
mational exchange are discussed in Part II (22). Quantitative
analyses using the Lipari-Szabo model-free approach with
the NMR structure and the relaxation data as input are
depicted in Fig. 6. The model selection criteria based on
F-statistics suggested that the isotropic tumbling model fit the
relaxation data of the apo protein better than the anisotropic
model. In agreement with the qualitative assessment, the
majority of residues in the helical region can be fit best with
FIGURE 5 Dynamics analysis of the backbone amide 15N
of (Aa2-L1M/L38M)2 in H2O at 35!C. Longitudinal and
transverse relaxation rate constants, R1 andR2, and
15N-{1H}
NOE values are shown in A, B, and C, respectively. The
reduced spectral density functions, J(0), J(vN), and
J(0.87vH), are shown in D, E, and F, respectively. R2/R1
ratio and the correlation between J(vN) and J(0) and between
R1 3 R2 and R2/R1 are shown in G, H, and I, respectively.
The relaxation data were acquired at 600MHz. Error bars are
either the standard errors in the least-squares fit to the
exponential decay function (for R1 and R2) or the calculated
uncertainties (forNOE). (H) residues inside the dashedellipse
are from the loop region and the termini. The solid green
curves describe the dependence of J(vN) on J(0) in the
limiting case of single Lorentzian motion. Points to the right
of the green curve suggest the presence of exchange and/or
anisotropic contribution to the relaxation. (I) the contribution
of exchange and anisotropy can be effectively isolated
because the dependence of R1 3 R2 on correlation times is
greatly attenuated. Experimental data above the theoretical
curve (solid green curve) suggest the presence of Rex contri-
bution to the R2 relaxation.
FIGURE 6 Quantitative model-free analyses of the dynamics of (Aa2-
L1M/L38M)2 using Modelfree program: (A) the generalized squared-order
parameter (S2); (B) the local correlation time (te), (C) the exchange term
(Rex), and (D) the models used to fit the data for each residue. Error bars are
standard errors from the fitting.
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Model 3, which includes a nonzero Rex term indicative of
exchange contribution to the dynamics. Again, the most
noticeable dynamical hotspot is the large Rex term for resi-
dues M38 and C41, suggesting that the L38M mutation that
renders a 3.5-fold increase in halothane binding affinity is at
an intrinsically dynamic site of the protein. Note also that the
entire loop region can be described only by Model 5, which
assumes internal backbone motions on multiple timescales.
Thus, the basic assumption for the model-free approach does
not strictly apply to the residues in the loop region. By
searching for the tm value that gives the minimum reduced x
2
value and the least number of nonfitted residues, Modelfree
calculations yielded a global tumbling time of 5.1 6 0.1 ns,
corresponding to a protein size of 11–12 kDa. Because the
(Aa2-L1M,L38M) monomer has a molecular mass of 6.86
kDa, the dynamics data confirm that the major peaks used
for the model-free calculations indeed arise from the dimeric
form of the four-a-helix bundle.
DISCUSSION
We have solved the high-resolution structure of a designed
dimeric four-a-helix-bundle protein that was found previ-
ously to interact specifically with volatile anesthetics with
relatively high binding affinities. Since the four-a-helix
bundle is a ubiquitous scaffold in functional proteins, our
designed protein is considered to be a suitable model for
anesthetic binding targets. The high and specific anesthetic
binding affinity to (Aa2-L1M/L38M)2 suggests that certain
intrinsic structural and dynamical features of this particular
protein are essential for volatile anesthetic-protein interac-
tion. Our NMR structure and the dynamics data have re-
vealed some of these features that might be important for
anesthetic-protein interaction in general.
Spatial asymmetry of the four helices
An unexpected feature in the high-resolution structure is the
overall asymmetry in the spatial arrangement of the four
helices. Although the final structures show a two-fold sym-
metry, which is consistent with the fact that the NMR peaks
in the helical region give a tumbling rate of a dimer and that
each peak arises from the same residue in the two monomers,
the quaternary arrangement of helices 1 and 19 is different
from that of helices 2 and 29, as shown in Fig. 4 C. Careful
examinations of the detailed side-chain packing of helices
1 and 19 shows a stack of aromatic rings from two F12 and
twoW15 residues in the hydrophobic core, as shown in Fig. 7A.
Moreover, there is excellent steric complementarity of eight
leucine residues (L4, L11, L18, and L25), all of which oc-
cupy the heptad e position at the interface of helices 1 and
19 (Fig. 7 A). The accumulation of van derWaals interactions,
in addition to the hydrophobic interactions, holds helices
1 and 19 together in an antiparallel fashion. In contrast, he-
lices 2 and 29 are wider apart from each other. The comple-
mentarity between the hydrophobic side chains of helices 2
and 29 is disrupted in the middle of the helical interface be-
cause K47 is at the heptad e position. The side chains of the
two K47 collide at nearly the same level (see Fig. 7). The
electrostatic repulsion of the charged side chains forces helix
2 to distort slightly. Deformation of helix 2 is also clearly
evident in the CSI result in Fig. 3.
Lateral accessibility to binding site
It is very likely that the two K47 in the middle of helix 2 play
an important role in the high-affinity anesthetic binding in
this designed four-a-helix bundle. One of the most essen-
tial properties of general anesthetics is their tendency to
preferentially interact with amphipathic molecular targets
(4,44,45). As shown in Fig. 7, two K47 residues in the di-
meric (Aa2-L1M/L38M)2 are at the level midpoint to the two
W15 side chains. This creates an ideal amphipathic envi-
ronment. Most importantly, the opening in the middle of the
helices 2 and 29 interface creates a lateral access pathway for
anesthetics from the aqueous phase to enter the site between
the two W15 side chains in the center of the long hydro-
phobic core without passing through either end of the four
helix bundle. Thus, the predominant anesthetic binding site,
which has now been confirmed experimentally (see Part II
(22)), is between the twoW15 aromatic side chains, bordered
additionally by A44 and A48 at the heptad a and e positions
at the same level. A closer examination of this particular
binding pocket also predicts that among the six L-to-A mu-
tations to convert (La2)2 to (Aa2)2 (18), the two L44A and
the two L48A are the most crucial ones responsible for the
increase in the halothane binding affinity. The bulkier side
chains of leucine would require significantly larger distortion
FIGURE 7 Side view (A) and top view (B) of the (Aa2-L1M/L38M)2
structure in ribbon representation, showing the relationship of important
side chains. Helices 1 and 19 are colored in yellow and helices 2 and 29 are
colored in purple. The complementary L4, L11, L18, and L25 are depicted in
gray in van der Waals spheres representation. F12, F52, W15, M38, and K47
are shown in licorice representation. F12 and F52 are shown in green, W15
in orange, M38 in red, and K47 in cyan.
4460 Ma et al.
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of helix 2 to accommodate a halothane molecule in this
pocket.
Importance of aromatic side chains
It is interesting to further analyze the orientations of aromatic
side chains from F12,W15, and F52 in the structure. All three
residues are located in the helical region. The intensities of
these residues in the HSQC spectrum are significantly weaker
than other resonances in the major conformation, indicative
of intermediate conformational exchange. It is likely that, in
response to helix-2 global movement at the level of K47,
W15 side chains adapt different orientations in the hydro-
phobic core when the cavity between the two W15 side
chains is not occupied, as suggested previously by a fluo-
rescence quenching study (21). This re-orientation of the
bulky W15 side chains will inevitably affect W15 backbone
dynamics. As we have found in the study with halothane (see
Part II (22)), the presence of a bound halothane stabilizes the
W15 side chains, resulting in not only halothane concentra-
tion-dependent shift of W15 backbone amide 1H and 15N
resonance, but also an increase in peak intensity for W15 in
the HSQC spectrum with halothane. The increases in peak
intensity after halothane binding strongly suggest that the
weak intensity of W15 in the absence of halothane is indeed
the result of intermediate conformation exchange.
In the NMR structure, F52 seems to be ‘‘out of place’’.
Although it is designed to be at the heptad g position, which is
supposed to be at the interface between helix 1 and helix 2 of
the same monomer, the F52 side chain is extended outward,
pointing into the aqueous phase. This is the direct conse-
quence of the helix 2 distortion from K47 to the C-terminus.
Having a highly hydrophobic side chain oriented into the
aqueous phase is energetically unfavorable. Hence, it is ex-
pected that the F52 side chain experiences a tremendous
amount of fluctuations, which leads to greatly reduced F52
resonance in HSQC.
Because of its ‘‘odd’’ location, the F52 side chain can only
be stabilized by the ring stacking with the side chain of F12 in
the same monomer. This affords the possibility of another
two plausible anesthetic binding sites in (Aa2-L1M/L38M)2,
namely, the space sandwiched by the F12 and F52 side
chains. However, because of the extremely hydrophobic
rather than amphipathic nature of the phenylalanine residues,
these two additional anesthetic binding sites would be not as
favorable as the major binding site between the twoW15 side
chains.
Implications of dynamics in anesthetic binding
(Aa2-L1M/L38M)2 exhibits a very interesting motional
profile as measured by the 15N backbone dynamics. As
shown in Fig. 6, our designed four-a-helix bundle is a very
dynamic protein in the absence of a bound anesthetic. Judged
by the nonzero Rex terms, it can be concluded that neither of
the two helices behave like a rigid rod. Instead, as discernible
in the NMR structure, the well known coiled-coil structural
twist commonly found in four-a-helix bundles might result
from the underlying superhelical twist motion. Indeed, when
we subject the NMR structure of (Aa2-L1M/L38M)2 to
normal mode analysis using ElNemo (46,47), we found that
the global mode (the first nonzero mode) is dominated by a
large-amplitude winding and unwinding helical twist motion.
Such coiled-coil twist may prove to be the universal dynamic
characteristic of four-a-helix bundles. The fact that so many
structurally diverse anesthetics can interact with so many
proteins in a similar way suggests the possibility of an ‘‘in-
duced fit’’ between small volatile anesthetic molecules and
their protein targets. The protein’s intrinsic ability to be
flexible enough to accommodate necessary conformational
changes upon anesthetic binding is exemplified in (Aa2-
L1M/L38M)2. It is tempting to speculate that the coupling
between the supercoil twisting global dynamics and the
structurally defined amphipathic lateral pathway leading to
the binding pocket will facilitate the binding on-rate when the
binding site(s) are empty. As will be shown in the study with
anesthetics (see Part II (22)), the presence of halothane in the
binding site reduces the dynamics of (Aa2-L1M/L38M)2,
thus decreasing the off-rate of the bound halothane. Our
structural and dynamic data on the apo protein seem to sug-
gest the possibility of interplay between structural and global
dynamics as contributing factors for anesthetic-protein in-
teractions. This possibility is further explored in Part II (22).
In conclusion, to our knowledge, we have solved the first
high-resolution structure of a designed anesthetic-binding
protein having the common four-a-helix bundle scaffold. In
the apo form, the protein is highly dynamic, with a clear
indication of conformational heterogeneity on the NMR
timescale. The major conformation is an antiparallel dimer
showing two helices from the N-terminus to the linker packed
neatly with a long stretch of eight complementary leucine
side chains at the heptad e positions and four aromatic rings
in the hydrophobic core. The two helices from the linker to
the C-terminus are less well packed because of two charged
K47 side chains being too close to each other. The distortion
of the second helix from a straight helix creates a lateral ac-
cess pathway for general anesthetics to reach the amphipathic
binding site between the two W15 side chains. The global
protein dynamics, coupled with the mobility near the flexible
glycine linker, seems to contribute to the specific anesthetic
binding affinity to this designed protein.
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Mistic (membrane integrating sequence for translation of integral membrane protein constructs) comprises
the four-R-helix bundle scaffold found in the transmembrane domains of the Cys-loop receptors that are
plausible targets for general anesthetics. Nuclear magnetic resonance (NMR) studies of anesthetic halothane
interaction with Mistic in dodecyl phosphocholine (DPC) micelles provide an experimental basis for
understanding molecular mechanisms of general anesthesia. Halothane was found to interact directly with
Mistic, mostly in the interfacial loop regions. Although the presence of halothane had little effect on Mistic
structure, 15N NMR relaxation dispersion measurements revealed that halothane affected Mistic’s motion on
the microsecond-millisecond time scale. Halothane shifted the equilibrium of chemical exchange in some
residues and made the exchange faster or slower in comparison to the original state in the absence of halothane.
The motion on the microsecond-millisecond time scale in several residues disappeared in response to the
addition of halothane. Most of the residues experiencing halothane-induced dynamics changes also exhibited
profound halothane-induced changes in chemical shift, suggesting that dynamics modification of these residues
might result from their direct interaction with halothane molecules. Allosteric modulation by halothane also
contributed to dynamics changes, as reflected in residues I52 and Y82 where halothane introduction brought
about dynamics changes but not chemical shift changes. The study suggests that inhaled general anesthetics
could act on proteins via altering protein motion on the microsecond-millisecond time scale, especially motion
in the flexible loops that link different alpha helices. The validation of anesthetic effect on protein dynamics
that are potentially correlated with protein functions is a critical step in unraveling the mechanisms of anesthetic
action on proteins.
Introduction
The molecular mechanism of general anesthesia remains
unsolved. The current consensus is that inhaled anesthetics act
on the central nervous system (CNS) and affect neural networks.
A wealth of molecular biology and electrophysiology data has
demonstrated that neurotransmitter-gated ion channels, particu-
larly Cys-loop receptors,1,2 are plausible targets for general
anesthetics. These ion channels are sensitive to volatile anesthet-
ics at clinically effective concentrations. The channel functions
could be inhibited or potentiated significantly by general
anesthetics in the excitatory (nicotinic acetylcholine and sero-
tonin type 3) or inhibitory (GABAA and glycine) receptors,
respectively.1,2 It is, however, still debatable where anesthetic
binding sites reside and whether the traditional lock-and-key-
binding paradigm is applicable for anesthetics interacting with
proteins. We have recently proposed a hypothesis of anesthetic
action based on protein global dynamics3 and contend that the
necessary and sufficient condition for general anesthetics, as
well as other low-affinity drugs, to exert their action on proteins
is to disrupt the modes of motion essential to protein functions.
Experimental evidence, in addition to computational studies, is
critical to further validate the hypothesis.3,4
Directly obtaining information with atomic resolution con-
cerning anesthetic modulation on the structures and dynamics
of neuronal proteins is often prohibited by technical obstacles,
such as limitations of protein size for nuclear magnetic resonance
(NMR) spectroscopy or challenges regarding crystallization of
membrane proteins for X-ray crystallography. As an alternative
approach, model proteins that mimic certain properties of
neuronal ion channels have been used to understand the
structural basis of anesthetic-protein interaction. Proteins of
four-R-helix bundle structural motif are useful models because
binding pockets of inhaled anesthetics are presumed to be within
transmembrane four-R-helix bundles of Cys-loop receptors.5 A
de novo designed prototype four-R-helix bundle with specific
anesthetic binding pockets6-8 and a natural soluble four-R-helix
bundle protein (ferritin)9 served previously as models for
investigating the structural basis of inhaled anesthetic binding
in proteins with such a special structural motif. The knowledge
gained from these studies could be applicable for understanding
molecular insight on anesthetics in much more complex
neurotransmitter-gated ion channels.
Our recent NMR studies7,8 on a water-soluble, de novo
designed, prototype four-R-helix bundle indicated that the
motion of the four-R-helix bundle could be modulated by
halothane, an inhaled general anesthetic. This inspired us to look
into similar anesthetic effects on other four-R-helix bundle
proteins and to investigate whether there are any common
anesthetic effects on four-R-helix bundle proteins. Mistic was
chosen for the present study because it could naturally fold into
a four-R-helix bundle motif in micelles. The structure of this
110-amino acid (13 kD) Bacillus subtilis protein was previously
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determined with NMR in lauryl dimethylamine oxide (LDAO)
micelles.10 High-quality NMR spectra of Mistic (membrane
integrating sequence for translation of integral membrane protein
constructs) allow for exploring molecular details of anesthetic
and Mistic interaction at atomic resolution. Conformational
flexibility of Mistic offers a possibility to assess potential
structural and dynamical changes as a consequence of the
interaction with halothane. The working hypothesis of our study
on Mistic is that volatile general anesthetics act on proteins via
altering protein motions, especially motions in the flexible loops,
which link different R helices.
Materials and Methods
Sample Preparation. The gene-encoded Mistic was cloned
from the B. subtilis into the expression vector pTBSG1 (a gift
from Prof. Timothy A. Cross’ laboratory at Florida State
University). The Mistic was expressed in strain BL21(DE3)
CodonPlus cells using the Marley protocol.11 Typically, the
expression was induced with 0.2 mM isopropyl !-D-1-thioga-
lactopyranoside (IPTG) and kept in M9 minimal medium at 12
°C for about 80 h. The protein was purified using published
procedures.10 A yield of ∼120 mg of purified Mistic was
obtained from each liter of M9 minimal media.
Mistic is insoluble in water. The presence of detergent is
essential for solubilizing Mistic. Mistic is stable in LDAO for
∼5 days, but for more than 5 months in dodecyl phosphocholine
(DPC). The exchange of DPC for LDAO was performed at the
protein elution from the Ni-NTA resin in order to extend the
stability of Mistic samples.
The samples for NMR experiments typically contained 0.5
mM of either 15N-labeled or 13C/15N-labeled Mistic, 30 mM
DPC, 0.2 mM dithiotreitol (DTT), 50 mM KCl, and 10 mM
potassium phosphate buffer at pH 6.0.
NMR Experiments. All 1H, 15N, and 13C NMR experiments
were performed at 30 °C on Bruker Avance 600 or 700 or 800
MHz NMR spectrometers equipped with cryoprobes (Bruker
Instruments, Billerica, MA). The 1H chemical shifts were
referenced to the 2,2-dimethyl-2-silapentene-5-sulfonate reso-
nance at 0 ppm, and the 15N/13C chemical shifts were indirectly
referenced. 19F NMR experiments were performed on a Bruker
Avance 600 spectrometer with a Bruker TXO probe to determine
halothane concentrations in reference to a solution with 10 mM
trifluoroacetic acid (TFA). Although the chemical shifts assign-
ments of Mistic in LDAO were done previously10 and the
1H-15N TROSY-HSQC spectra of Mistic in DPC showed high
similarity to that in LDAO, we repeated the same two-
dimensional (2D) and three-dimensional (3D) NMR experi-
ments10 for the 13C and 15N chemical shift assignments of Mistic
in DPC. A series of 1H-15N TROSY-HSQC spectra were
collected on samples with five different halothane concentra-
tions, ranging from 0 to 13 mM, to determine site-specific
dissociation constants. The CBCA(CO)NH and HBHA(CO)NH
spectra were acquired in the absence and presence of halothane
so that the chemical shifts of CR, C!, HR, and H! at these two
different conditions were obtained for comparison. 1H-15N
residual dipolar couplings (RDCs) of Mistic were measured
using a TROSY-IPAP-HSQC pulse sequence with 1024 (1H)
× 256 (15N) complex points. A weak alignment of 15N-labeled
Mistic in DPC micelles was achieved in both compressed and
stretched charged polyacrylamide gel.12 The degree of alignment
for each sample was checked using one-dimensional (1D) 2H
NMR experiments.
To confirm anesthetic direct interaction with Mistic, 1H
saturation transfer difference (STD)13 NMR was performed on
a 0.5 mM 15N-labeled Mistic sample in 30 mM DPC in the
presence of 10 mM halothane. As a control, the same experiment
was also performed on a similar sample but without Mistic.
The spectra were obtained in an interleaved manner using
irradiation of 50 ms Gaussian pulses applied on-resonance at
0.58 ppm, corresponding to Mistic methyl protons, and off-
resonance at 40 ppm. The pulse sequence utilized the WATER-
GATE water suppression and spoil sequence to destroy un-
wanted magnetization.14 A series of STD spectra were acquired
within a range of saturation times: 0.5, 1, 3, 5, 10, 20, and 40 s.
Each spectrum had 64 scans with a relaxation delay of 40 s.
The STD (∆I ) Ioff - Ion) was calculated by subtraction of the
intensities of the on-resonance peak (Ion) from those of the off-
resonance peak (Ioff).15,16
To characterize the dynamic property of Mistic, spin-lattice
(R1) and spin-spin (R2) 15N relaxation rate constants were
measured with 512 (1H) × 128 (15N) complex points using
standard pulse sequences with echo-antiecho gradient selec-
tion.17 Nine (ranging from 10-1800 ms) or 10 (16-160 ms)
variable delays were used for the R1 or R2 measurements,
respectively. The effective transverse relaxation rate was also
measured using relaxation-compensated Carr-Purcell-Mei-
boom-Gill (CPMG) experiments as a function of CPMG field
strength (νCPMG).18,19 The 15N R2 relaxation dispersion data are
suited to determine Mistic’s conformation exchange on the
microsecond-millisecond time scale in the presence and
absence of halothane. The R2 relaxation dispersion profiles were
recorded at two different magnetic field strengths corresponding
to 1H frequencies of 600 and 800 MHz. The experiments were
performed in a constant time manner (TCP ) 60 ms) on
uniformly 15N-labeled Mistic samples. The CPMG field strength,
νCPMG, was varied to 33.33, 66.67, 100.00, 133.33, 200.00,
266.67, 333.33, 400.00, 500.00, and 666.67 Hz.
Data Process and Structure Refinement. All NMR data
were processed using NMRPipe20 and analyzed with Sparky.21
The chemical shift assignments were accomplished with the aid
of AutoAssign22 and manual comparison to the assignments of
Mistic in LDAO.10
The structure of Mistic in DPC micelles was obtained through
refinement of the lowest-energy structures (PDB: 1YGM) of
Mistic in LDAO micelles10 using dihedral angle restraints
obtained from CR and C! chemical shift index (CSI)23 processed
using Talos24 and RDC data of helical regions obtained from
two different alignment mediums. The refinement used the slow
cooling simulated annealing protocol in Xplor-NIH.25 The axial
(Da) and rhombic (R) components of the alignment tensor in
RDC experiments were determined using the histogram
method,26 producing Da ) -10.8 and R ) 0.23 for samples in
compressed gel and Da ) -10.0, R ) 0.27 for samples in
stretched charged gel, respectively. A total of 100 structures
were produced in the refinement, and half of them with lower
energies were used for an averaged structure. The best-fit
comparison between experimental RDCs and the refined struc-
tures were performed using the program MODULE 1.0.27
15N relaxation dispersion data were analyzed using eq 1,
which encompasses all chemical exchange timescales:28
R2(νCPMG)) [R20+ (kex ⁄ 2)-
νCPMG cosh
-1(D+ cosh(η+)-D- cos(η-))] (1)
where D( ) 1/2((1 + (ψ + 2∆ω2)/(ψ2 + &2)1/2), η( ) (νCPMG/
2(2)1/2)((ψ + (ψ2 + &2)1/2)1/2, ψ ) kex2 - ∆ω2, & )
-2∆ω(pakex - pbkex), R20 is the intrinsic transverse relaxation
rate, kex is the exchange rate, ∆ω is the difference of chemical
shifts between exchange sites a and b, the population of site a
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is denoted by pa ) (1 - pb), νCPMG ) 1/(2τ), and τ is the time
between centers of successive 180° pulses in the CPMG pulse
sequence.
Results and Discussion
For increased readability, we present here only the primary
results that are intimately related to our discussion. Other
supporting data are provided in the Supporting Information as
references.
Halothane Interaction Sites in Mistic. Direct halothane
interaction with Mistic was evidenced in the STD experiments
based on the nuclear Overhauser effect between bound halothane
proton and Mistic protons. As shown in Figure 1A, a halothane
signal became observable in STD spectra when the on-resonance
saturation frequency was set at 0.58 ppm, a frequency far away
from halothane proton but near Hδ of Leu and Ile. The halothane
signal in Figure 1A critically depended on the presence of
Mistic. Under the same NMR experimental condition (0.58 ppm
for the on-resonance saturation), but without Mistic, there was
no observable halothane signal (Figure 1B), indicating that direct
interaction between halothane and Mistic certainly exists. The
halothane interacting sites in Mistic were examined by monitor-
ing chemical shift changes of Mistic backbones and sidechains
in response to halothane titrations. Figure 2 shows a representa-
tive overlay of Mistic’s 1H-15N TROSY-HSQC spectra in the
presence and absence of halothane. A number of residues
showed profound chemical shift changes after the addition of
halothane. Some residues, such as A40 and Q66, had changes
not only in their chemical shifts, but also in their signal
intensities. After the addition of halothane, the S58 signal
became much stronger, but the I52 peak intensity became much
weaker. The peak intensity signified plausible dynamics alterna-
tion in the region where the residue resided. Figure 3 highlights
Mistic residues that experienced obvious changes in chemical
shift (HN > 0.05 ppm, CR and C$ > ( 1 ppm, HR and H$ >
( 0.1 ppm) upon halothane titration. The R2 helix had several
residues in the middle of the helix that were sensitive to
halothane. The location of residues affected by halothane
coincided with the helix kink near A40 and M44, suggesting
the possibility that the helical kink acted as a pocket for
halothane binding. The chemical shifts of residues in other
helices were largely insensitive to anesthetics, except for some
residues adjacent to or in loop regions. In contrast to helical
residues, all loop residues were more or less perturbed by
halothane. These loop residues were located at the micelle
headgroup region, as evidenced by high sensitivity of their
chemical shifts to the headgroup changes in micelles from 100%
DPC to 40% LDAO/60% DPC (see Figure 1S in the Supporting
Information). Most helical residues or N- and C-terminal
residues maintained the same chemical shifts when DPC was
partially replaced by LDAO, confirming that they were embed-
ded in the micelle hydrocarbon regions or exposed to bulk water.
Halothane dissociation constants in the loop regions were
estimated in the range of a few millimolars (Figure 2S in the
Supporting Information). The observation of halothane attraction
to Mistic loop residues at the micelle-water interface is
consistent with the notion that general anesthetics prefer
amphipathic water-lipid interfaces.15,29,30 The significance of
this idea lies not only in revealing the nature of anesthetic
interaction sites, but also in suggesting potential anesthetic
modulation to protein regions at the water-lipid interface that
play critical roles in protein functions. Anesthetics could disrupt
normal residues’ interactions within the same loop or between
different loops. Anesthetic disruption on residues interactions
between different loops can be more vital. Proper couplings of
loop residues in agonist-binding extracellular and transmembrane
domains at the water-lipid interface are often crucial for
functions of plausible anesthetic targeting channels.1,2 Modifica-
tion of interfacial electrostatic interactions by point mutations
induced profound changes in channel functions.31 Because of
their preferred interaction with residues at an interface, it is
conceivable that anesthetics could also affect receptor interfacial
interactions and ultimately alter functions of Cys-loop receptors.
Such a possibility will be discussed further in the following
sections.
The halothane concentration of ∼10 mM was suitable for
observing halothane effects in our NMR experiments, but
one might wonder if this concentration is pharmacologically
relevant. A clinically relevant concentration of volatile
general anesthetics is often quoted as being in the submil-
limolar (∼0.1-1 mM) range. The strict meaning of this range
refers to what is measured in saline. For volatile anesthetics
administered in patients, the only entity that is constant
throughout the body under equilibrium is partial pressure. The
concentration in any given compartment depends on the partition
coefficient in that compartment. Under the same partial pressure,
a 100 µM concentration of halothane in saline translates as ∼12
mM concentration in lipids, given a 1:124 saline/lipid partition
coefficient of halothane at 30 °C.32 Note that our reported
concentration was measured in an excess amount of detergent
for stabilizing Mistic. Therefore, the halothane concentration
of 10 mM used in our NMR measurements is not as high as it
appears and is pharmacologically relevant.
Halothane Had Minimal Effects on Mistic Structure. The
structure of Mistic in DPC micelles was obtained through
refinement of Mistic structure in LDAO10 using our RDC data
attained on Mistic in DPC. We found that Mistic had virtually
the same folding in DPC and LDAO. Details of the structure
refinement are provided in the Supporting Information (Figure 3S).
The introduction of halothane to Mistic in DPC did not change
the overall structure of Mistic. The CSIs of CR, C$, and HR,
characterizing the secondary structures of Mistic, were largely
unchanged in the absence and presence of 10 mM halothane,
especially in helical regions. Figure 4 displays a comparison of
the CR CSI before (top) and after (bottom) the addition of
halothane, showing that halothane had a minute impact on the
secondary structure of Mistic. Halothane effects on Mistic
Figure 1. 1H STD NMR spectra of 10 mM halothane (resonance at
6.48 ppm) in (A) 30 mM DPC with 0.5 mM Mistic and (B) 50 mM
DPC without Mistic. The arrow indicates the frequency for on-resonance
saturation at 0.58 ppm that is near the Hδ resonance of Leu and Ile
residues in Mistic. Note that the halothane signal was not observed in
panel B under the same NMR conditions as in A, but without Mistic,
indicating a direct interaction between halothane and Mistic. A stick
chemical structure of halothane is inserted for reference.
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tertiary structure were determined via measuring backbone
RDCs of Mistic in the absence and presence of 5 mM halothane.
The structures of Mistic without and with halothane were both
refined using RDC data. Relatively small values of root-mean-
square deviations (rmsd’s) of the refined structures in the
absence and presence of halothane, as color coded in the Mistic
structure in Figure 5, suggest that the overall tertiary structure
of Mistic is well preserved upon the addition of halothane.
It was reported previously15,33,34 that structures of transmem-
brane peptides remained unchanged in the presence of general
anesthetics. Several studies on globular proteins with general
anesthetics also found remarkable tolerance of overall protein
structures to the added anesthetics at low millimolar concen-
trations.9,35-37 Since the folding of Mistic in micelles resembles
the structural motif of four transmembrane domains of a subunit
in the Cys-loop receptors, the observed structure insensitivity
to anesthetic perturbation in the present study may also occur
in the Cys-loop receptors. Therefore, it is reasonable to speculate
that anesthetic action on those Cys-loop receptors is unlikely
via significantly altering receptor structures, although more
experimental data should be collected for a final conclusion.
Halothane Had Profound Effects on Mistic Motion.
Halothane-induced changes in Mistic motion were confirmed
by at least two lines of experimental evidence. First, some
residues showed profound changes in their NMR signal intensi-
ties (or line widths) after adding halothane. Second, 15N
relaxation dispersion experiments indicated that motion on the
microsecond-millisecond time scale existed in some regions
of Mistic, and halothane could alter such motion.
As shown in Figure 2, residues S58, Q66, and A40 gained
higher peak intensities and narrower peak line-widths in the
1H-15N HSQC NMR spectra in the presence of halothane.
Several CR resonance peaks of loop residues S58-L67 also
changed from weak to strong after the addition of halothane,
as summarized in Figure 4. In contrast, I52 peak intensity
dropped significantly after the addition of halothane (Figure 2).
These observations could not be adequately explained by the
halothane effect on Mistic motion in the picosecond-nanosecond
time scale. Changes in longitudinal (R1) and transverse (R2)
relaxation rates, as well as 1H-15N heteronuclear NOE due to
the presence of halothane, seem relatively small (see Figure 4S
in the Supporting Information). Intrinsically weak intensity of
Figure 2. Overlay of 1H-15N TROSY-HSQC spectra of 0.5 mM Mistic in 30 mM DPC micelles in the absence (black) and presence (red) of 10
mM halothane. The spectra were acquired at 30 °C. Despite many residues being undisturbed by the addition of halothane, some residues experienced
significant chemical shift changes and/or intensity changes of their resonance signals. A few examples are highlighted in small boxes.
Figure 3. Halothane interaction sites in Mistic. The residues whose
chemical shifts were significantly perturbed by halothane are highlighted
in orange color. The four transmembrane helices are marked as R1-R4.
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some NMR peaks could result from conformational-exchange
broadening in the microsecond-millisecond time scale. The
increasing intensity of these peaks after the addition of halothane
might be the consequence of changes in exchange process,38
though alternation in peak intensity alone would not provide
specific information regarding whether halothane had a potentia-
tion or inhibition effect on the exchange.
Quantitative characterization of Mistic’s motion on the
microsecond-millisecond time scale was achieved through 15N
R2 relaxation dispersion measurements. Majority residues of
Mistic showed no motion on the microsecond-millisecond time
scale, and their transverse relaxation rates were not affected by
a systematical variation of the CPMG field strength, νCPMG.
However, R2 dispersion dependence on the νCPMG variation was
observed for a number of residues located at the loop connecting
R2 and R3 helices (residues S58, D61, Q66, and D68), at the
loop connecting R1 and R2 helices (residues V29), along helix
R2 (T39 and N45), and at the loop connecting R3 and R4 (Y82)
helices. Figure 6 depicts relaxation dispersion profiles for two
representative residues, D61 and N45, in the absence and
presence of 10 mM halothane. Halothane quenched the exchange
contribution to R2 on residue N45 and suppressed the exchange
on D61. This is consistent with the aforementioned increase of
peak intensity and decrease of line widths in some residues upon
the addition of halothane. The fitting of relaxation dispersion
data using eq 1 for a two-site (a and b) exchange model28
provided estimation of exchange parameters, including differ-
ences in chemical shifts between exchanging sites (∆ω), the
exchange rate (kex), the relative population of a conformation
(pa or pb), and the intrinsic transverse relaxation rate (R20) in
the absence of chemical exchange. Table 1 summarizes these
parameters for several residues in the absence and presence of
10 mM halothane. The population of the major conformation,
pa was close to, or over, 90% for all these residues and had
0-3% increase after the addition of halothane. ∆ω remained
virtually the same for most residues, which is consistent with
the aforementioned result that Mistic structure remained the
same before and after adding halothane. The exchange rate kex
varied to a different extent on different residues.
Both residues T39 and N45 reside in the middle part of helix
R2, where a helical kink occurs between these two residues.
Residue Y82 resides at the end of helix R3. Although these
residues experienced the chemical exchange on the micro-
second-millisecond time scale in the absence of halothane, the
exchange disappeared in the presence of halothane, as shown
in Table 1. In all these cases, anesthetic halothane suppressed
exchange motion. Residue V29 is located at the end of helix
R1. Halothane did not completely remove the exchange
contribution, but the Rex value of V29 was reduced almost by
half, and the exchange rate kex became less than 1/3 of its
original value. Residue I52 is located at the end of helix R2. It
experienced fast exchange in the absence of halothane (Table
1) and possessed a relatively strong 1H-15N HSQC resonance
peak (Figure 2). However, the resonance peak of I52 virtually
vanished as a result of intermediate exchange induced by
halothane. Q66 resides at the beginning of helix R3 or end of
the loop connecting R2 and R3. The side chain of Q66 is within
a few angstroms of the D61 side chain. Both Q66 and D61 had
similar exchange rates that became much slower after the
addition of halothane. Interestingly, the R2-R3 loop folds in
such a way that S58 at the middle of the loop is not far away
from D68, which resides at the beginning of helix R3. The
kinetic data also suggest that S58 and D68 share similar
exchange rates, and both rates became greater in the presence
of halothane. One may wonder if it is possible that these two
Figure 4. The 13CR CSI of Mistic residues in the absence (top) and presence (bottom) of 10 mM halothane. The CR chemical shifts were referenced
with respect to random coil values at 0 ppm.
Figure 5. The refined structure of Mistic in DPC on the basis of RDC
NMR measurements. The rmsd (Å) of Mistic structure in the absence
and presence of 10 mM halothane is presented using a color scale.
Residues that showed the largest rmsd are labeled.
Figure 6. Backbone15N relaxation dispersion curves of two representa-
tive Mistic residues, N45 and D61, in the absence (0) and presence
(b) of 10 mM halothane.
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nearby pairs of residues, Q66 and D61 vs D68 and S58, have
different directions of rate change upon addition of halothane.
A close inspection of Mistic structure revealed that both D68
and S58 were oriented inward to helices, while Q66 and D61
were directed outward in the loop and pointed to the water phase
(see Figure 5S in the Supporting Information). Distinctive
motional characteristics of nearby residues upon ligand binding
were also observed previously in SH2 protein.39
Several features can be extracted from the 15N relaxation
dispersion data presented above. First, residues carrying motion
on the microsecond-millisecond time scale are often in loop
edges or helical ends (V29, I52, Q66, D68, Y82). Second, helical
residues are often not involved in slow (microsecond-milli-
second) dynamics, except those (T39 and N45) in helical kink
regions. Third, residues far away from each other in primary
sequence but close in space (Q66 and D61 vs D68 and S58)
exhibit concerted motion. Last, but most importantly for this
study, anesthetic halothane could alter the slow dynamics.
Anesthetic molecules could make protein motion faster in one
region but slower in another region. The exchange rate kex
decreased in most of the aforementioned Mistic residues, but
increased in some residues. Rex values of the majority of residues
in the presence of halothane decreased to different degrees,
indicating that halothane suppressed motion of these residues
on the microsecond-millisecond time scale. An opposite effect
might also exist. The NMR intensity of residue I52 was severely
decreased after adding halothane, indicating an intermediate
exchange promoted by halothane. However, a systematic
evaluation of the slow dynamics of I52 in the presence of 10
mM halothane was prohibited by the weak signal of this residue.
We want to point out that the aforementioned dynamical
changes due to the addition of halothane may not necessarily
result from direct halothane interaction with individual residues.
Most of the residues listed in Table 1 showed obvious chemical
shifts in response to halothane titration. However, neither I52
nor Y82 demonstrated significant changes in their chemical
shifts, suggesting that these two residues had no close interaction
with halothane molecules. The dynamical alternation of these
residues must result from halothane allosteric modulation.
Therefore, anesthetic molecules could induce changes in protein
motions on the microsecond-millisecond time scale either
through direct interaction with specific residues or through
allosteric modulation.
Conclusions
The most significant contribution of the present study is
providing unequivocal experimental evidence that inhaled
general anesthetics can modulate protein slow dynamics,
especially motion in the flexible loops that link different alpha
helices. It is well-known that protein motion on the micro-
second-millisecond time scale often couples with protein
functions.40 Low affinity drugs, such as volatile general
anesthetics, do not usually interact with proteins in a lock-and-
key fashion.41 Therefore, it is rational for us to determine how
anesthetics alter protein functions via altering protein motion.
Our previous computational studies established a theoretical
basis for anesthetic action on protein global dynamics.3,4
Experimental evidence is critical for validating the theory of
anesthetic action on protein dynamics. Our study demonstrates
that halothane perturbed slow dynamics of Mistic, indicating
the plausibility that changes in protein functions by general
anesthetic can be achieved by interrupting the mode of protein
motion4 instead of tight bindings with number of protein
hydrophobic pockets. These findings on Mistic certainly encour-
age us to look further into anesthetic effects on protein motion
in other functional proteins. By collecting enough experimental
data demonstrating anesthetic modulation on protein dynamics,
we can significantly advance our understanding of molecular
mechanisms of general anesthesia.
Identification of the halothane interaction sites on Mistic in
this study supports our view that anesthetics prefer to interact
with amphipathic sites of proteins.7,15,29,30 Although halothane
interaction occurred at multiple sites of Mistic, it did not
introduce significant secondary and tertiary structure changes.
This observation is consistent with our previous findings on other
proteins.15,29,34
One may wonder if the anesthetic effects, such as those
observed here on Mistic, are large enough to account for
anesthetic action on proteins. Because of the low affinity nature
of inhaled general anesthetics (submillimolar), their interaction
with proteins should not be expected to cause structural and
TABLE 1: 15N Relaxation Dispersion Parametersa of Exchanging Residues of Mistic in the Absence and Presence of 10 mM
Halothane
residues
absence (-) and
presence (+) of halothane Rex (s-1)b R20 (s-1) kex (s-1) pa ∆w (s-1)
V29 - 7.8 16.4 ( 0.7 532 ( 290 0.97 ( 0.02 508 ( 59
+ 4.2 16.9 ( 0.2 154 ( 22 0.97 ( 0.02 523 ( 69
T39 - 3.9 20.7 ( 0.3 1455 ( 296 0.98 ( 0.08 588 ( 65
+ NAc
N45 - 5.2 27.3 ( 0.4 635 ( 197 0.92 ( 0.02 258 ( 28
+ NA
I52 - 6.2 23.7 ( 0.4 722 ( 200 0.90 ( 0.02 241 ( 30
+ NDd
S58 - 6.4 15.8 ( 0.3 217 ( 83 0.91 ( 0.03 205 ( 12.5
+ 4.8 17.2 ( 0.5 551 ( 270 0.91 ( 0.03 189 ( 33
D61 - 26.7 13.5 ( 0.9 468 ( 144 0.89 ( 0.02 529 ( 26
+ 17.9 13.2 ( 0.5 199 ( 22 0.90 ( 0.01 550 ( 50
Q66 - 12.9 17.0 ( 0.7 376 ( 99 0.90 ( 0.03 362 ( 18
+ 12.0 17.1 ( 0.6 174 ( 33 0.92 ( 0.01 486 ( 74
D68 - 3.5 17.9 ( 0.2 279 ( 120 0.97 ( 0.02 317 ( 25
+ 3.3 16.3 ( 0.1 482 ( 84 0.97 ( 0.02 300 ( 15
Y82 - 11.5 25.0 ( 1.1 267 ( 148 0.87 ( 0.17 244 ( 24
+ NA
a Equation 1 was used for fitting of these parameters. b Rex ) R2(νcp f 0) - R2(νcp f !). c NA: no relaxation dispersion. d ND: the signal
was too weak to determine relaxation dispersion parameters.
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dynamical effects on proteins as great as those high-affinity
ligands or substrates. We are still in the process of determining
how large an anesthetic effect on protein structures and dynamics
is required to produce protein functional changes which
ultimately contribute to general anesthesia. Experiments on
model proteins are only the starting point of this process. The
demonstration of halothane perturbation to dynamics of Mistic
in the microsecond-millisecond time scale is such a starting
point.
Halothane perturbation on Mistic slow dynamics happened
not only to residues that might interact directly with halothane
molecules, but also to residues that seemed to be remote from
halothane, signifying halothane allosteric modulation on protein
dynamics. It is conceivable that the impact of general anesthetic
modulation on protein dynamics, be it direct or indirect through
allosteric effects, will be amplified on much larger protein
complexes, such as Cys-loop receptors, in which the concerted
motion among different subunits regulates the protein functions.
Normally, several different conformers of these protein com-
plexes coexist dynamically, and each conformer determines
different functional states. Anesthetic perturbation in a few
critical sites could introduce vital disturbance to highly coupled
motion in these molecular machineries, shift the equilibrium of
conformational states, and ultimately alter protein functions.
When a large enough number of proteins in the CNS are
dynamically perturbed by general anesthetics, even though the
perturbation on individual proteins is rather small, the cumula-
tive effects on the CNS could lead to the phenomena of general
anesthesia. The study on Mistic provides encouraging evidence
for pursuing a dynamical view of molecular mechanisms of
general anesthesia. Further investigation on other proteins is
necessary to confirm that anesthetic modulation to functionally
important motion in proteins contributes to general anesthesia.
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Channel functions of the neuronal α4β2 nicotinic acetylcholine receptor (nAChR), one of the most widely
expressed subtypes in the brain, can be inhibited by volatile anesthetics. Our Na+ flux experiments
confirmed that the second transmembrane domains (TM2) of α4 and β2 in 2:3 stoichiometry, (α4)2(β2)3,
could form pentameric channels, whereas the α4 TM2 alone could not. The structure, topology, and
dynamics of the α4 TM2 and (α4)2(β2)3 TM2 in magnetically aligned phospholipid bicelles were
investigated using solid-state NMR spectroscopy in the absence and presence of halothane and isoflurane,
two clinically used volatile anesthetics. 2H NMR demonstrated that anesthetics increased lipid conforma-
tional heterogeneity. Such anesthetic effects on lipids became more profound in the presence of
transmembrane proteins. PISEMA experiments on the selectively 15N-labeled α4 TM2 showed that the
TM2 formed transmembrane helices with tilt angles of 12°±1° and 16°±1° relative to the bicelle normal for
the α4 and (α4)2(β2)3 samples, respectively. Anesthetics changed the tilt angle of the α4 TM2 from 12°±1°
to 14°±1°, but had only a subtle effect on the tilt angle of the (α4)2(β2)3 TM2. A small degree of wobbling
motion of the helix axis occurred in the (α4)2(β2)3 TM2. In addition, a subset of the (α4)2(β2)3 TM2
exhibited counterclockwise rotational motion around the helix axis on a time scale slower than 10–4 s in the
presence of anesthetics. Both helical tilting and rotational motions have been identified computationally as
critical elements for ion channel functions. This study suggested that anesthetics could alter these motions to
modulate channel functions.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Nicotinic acetylcholine receptors (nAChRs) belong to a superfam-
ily of ligand gated ion channels involving the rapid chemical
transmission of nerve impulses at synapses. Previous studies found
that some subtypes of nAChRs might be potential targets of general
anesthetics and their normal channel functions could be inhibited by
general anesthetics [1-6]. Neuronal α4β2 nAChR is one of the
subtypes sensitive to general anesthetics [4,5,7]. It is also one of the
most abundant nAChR subtypes in the brain. Despite ample evidence
showing that general anesthetics could alterα4β2 nAChR functions, it
remains largely unclear how anesthetics perturb the protein struc-
tures and dynamics that ultimately affect the protein functions.
Therefore, the insights of anesthetic modulation on the structure and
dynamics of the α4β2 nAChR are valuable to resolve a long time
mystery of the molecular mechanisms of general anesthesia [8,9].
A comprehensive understanding of anesthetic action on α4β2
nAChR or other nAChR subtypes has often been restricted by limited
available structural information of nAChRs in the past. The structural
models of the closed- and open-channel α4β2 nAChR have been
generated [10] recently via computations using the known structure of
the Torpedo nAChR as a template [11]. More recent X-ray structures of
pentameric ion channels in closed- and open-channel forms from Er-
winia chrysanthemi and Gloeobacter violaceus provide high-resolution
structural information relevant to nAChRs [12–14]. These new devel-
opments certainly facilitate the understanding of anesthetic action on
α4β2nAChR, but experimental studies of structural and dynamic effects
of anesthetics on α4β2 nAChR may lead directly to insights into how
anesthetics act on α4β2 nAChR and alter the protein function.
Solid-state NMR spectroscopy is a powerful technique for the
characterization of membrane protein structures and dynamics and
for the investigation of ligand–protein interactions [15-23]. The
polarization Inversion and Spin Exchange at the Magic Angle
(PISEMA) experiment [24] is particularly useful for the determination
of topological structures and dynamics of helical proteins in a well-
oriented lipid environment [25-29]. Ligand binding to the Torpedo
nAChR was comprehensively analyzed using static 2H and cross
polarization magic angle spinning (CPMAS) 13C solid-state NMR
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experiments [30,31]. The structures of the transmembrane domains of
the Torpedo nAChR were also examined by various solid-state NMR
methods [32-34], including PISEMA [33]. However, no solid-state
NMR study on neuronal nAChR has been reported previously. In the
present study, we embedded the second transmembrane domains
(TM2) of α4β2 nAChR in lipid bicelles, which served as membrane
mimetic media and magnetically aligned the protein. The structural
and dynamic properties of the TM2 α4β2 nAChR in the absence and
presence of anesthetics halothane or isoflurane were investigated
using solid state NMR, especially PISEMA experiments. Anesthetics
were found to affect both helical tilting and rotational motions that
have been identified computationally as critical elements for ion
channel functions. This study suggested that anesthetics could alter
these motions to modulate channel functions.
2. Materials and methods
2.1. Materials and sample preparation
The second transmembrane (TM2) domains of the human nAChR
were obtained by solid phase synthesis [35,36]. The α4 and β2 TM2
domains have the sequences of EKITLCISVLLSLTVFLLLITE and
EKMTLCISVLLALTVFLLLISK, respectively. In order to simplify the
studies, only seven leucine residues in α4 TM2 domain, as indicated
in bold letters, were 15N labeled.
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL). A
conventional protocol of bicelle preparation [37] was followed. 1,2-
dimyristoyl-sn-glycero-3-phosphocoline (DMPC) and 1,2-dihexyl-sn-
glycero-3-phosphocholine (DHPC) were mixed in a desired molar
ratio (q=3.2). Lipid concentration was 28% of sample volume
(typically 220 μL). To extend sample stability for samples containing
the nAChR TM2 domains, 1,2-O-ditetradecyl-sn-glycero-3-phospho-
coline (14-O-PC)) and 1,2-O-dihexyl-sn-glycero-3-phosphocholine
(6-O-PC) replaced DMPC and DHPC, respectively. A small amount of
deuterated DMPCd54 (∼1 mg) was added to each sample for 2H NMR.
The α4 or β2 TM2 was dissolved in 100 μL trifluoroethanol and added
to the 6-O-PC-chloroform solution. The organic solvents were
removed under a stream of nitrogen gas, followed by further evapo-
ration under high vacuum overnight. The aqueous solutions were
prepared by adding 110 μL of deuterium-depleted water to dried
14-O-PC and 6-O-PC/peptide. The 14-O-PC suspension was vortexed
extensively followed by three freeze/thaw cycles (liquid nitrogen/
42 °C). The 14-O-PC suspension at 42 °C was then added to the 6-O-
PC/peptide, followed by vortexing and three freeze/thaw cycles.
Slow-speed centrifugation was sometimes necessary to remove air
bubbles in the sample. A transparent solution was obtained that
was viscous at 38 °C and fluid at 4 °C. Parallel-oriented peptide-
containing bicelles were prepared by adding 100 mM YbCl3 6H2O to
the peptide-bicelle solution to reach a final lanthanide concentra-
tion of 3 mM. The sample was transferred to a 5-mm OD glass tube
(New Era Enterprises, Newfield, NJ) using a pre-cooled pipet tip at
4 °C. The glass tube was sealed with a tight fitting rubber cap and
further sealed with hard bees wax. The α4-TM2 concentration was
7.4 mM in the α4 samples and 3 mM in the α4β2 samples. The molar
ratio of β2 toα4 was 1.5 in the α4β2 samples to ensure a formation of
(α4)2(β2)3. The peptide to lipid ratio is ∼1:60. Anesthetics halothane
(2-bromo-2-chloro-1,1,1-trifluoro-ethane) and isoflurane (2-chloro-
2-(difluoromethoxy)-1,1,1-trifluoro-ethane) were added directly to
the NMR tube (pre-cooled in an ice bath) and mixed thoroughly with
the samples. The anesthetic concentrations were determined using
19F NMR with 5 mM trifluoroacetic acid (TFA) as a reference.
2.2. NMR spectroscopy
All solid state NMR experiments were performed at 40 °C on a
Bruker Avance 600 MHz NMR spectrometer equipped with a 1H/31P/
15N(2H) Bruker flat-coil probe. 19F NMR experiments were performed
on a Bruker Avance 600 spectrometer with a Bruker TXO probe. The 1-
D 15N cross-polarization experiments were conducted using a 1H 90°
pulse of 5.1 μs, a 49 kHz 1H-decoupling field, 1 ms contact time, 3 s
recycle delay, and 10,000 scans. The same cross-polarization para-
meters were used in the 2-D 15N-1H PISEMA [38]. Other parameters
included ±35 kHz frequency jumps for the Lee-Goldberg condition,
400–1000 scans, and 6–8 s recycle delay. The 1H carrier frequencywas
set at ∼4.5 ppm on parallel oriented bicelle samples. The 15N chemical
shift frequencies were referenced to solid ammonium sulfate at
26.8 ppm (relative to liquid ammonia at 0 ppm). The 2H NMR
experiments were performed using a solid echo sequence ((pi/2)− τ
− (pi/2)− τ). The 90° pulse length was 2 μs and τ values were ∼40 μs
(perpendicular bicelle) and ∼20 μs (parallel bicelle). The recycle delay
of 0.5 s and the scans of 256 to 10,000 were used.
2.3. NMR data processing
All NMR spectra were processed using NMRPipe [39] and analyzed
using Sparky [40]. The data from PISEMA experiments were fitted to
the PISA (Polarity Index Slant Angle) [41,42] wheels using the
program developed by Veglia's group [26]. The tilt angle (θ) of the
helix axis with respect to the bicelle normal, rotation angle (ρ) of the
helix around its axis, the angle between the N-H bond and helix axis
(δ), and the dipolar coupling constant (KDD) were determined via
fittings. The principal values of the 15N chemical shift tensors [24] for
non-glycine residues, σ11=64 ppm, σ22=77 ppm, and
σ33=217 ppm, were adopted for the fittings. These values were
multiplied uniformly by a factor of 0.95 to accommodate reduced 15N
chemical shift anisotropy of proteins in bicelles, as reflected in the
reduction of spectral span of the same proteins in bicelles in
comparison to those in mechanically aligned lipids.
The TM2 chemical shift assignments were accomplished by
combining several sources of information, including the previous
assignments of δ–TM2 nAChR [33], the solution NMR structure of β2-
TM2 nAChR [36], and the best fitting of PISA wheel. L19 is distinctly
separated from the rest of leucine residues in a top view of the NMR
structure (pdb code: 2K59) [36]. L19 also has weaker NMR signal than
other leucines, presumably because it is located at the lipid-water
interface and has less protection from solvent exchange. The distinct
location and intensity of L19 convinced us to assign L19 to the most
downfield peak in the α4-TM2 PISEMA spectra. Once L19 is defined,
the rest of peaks were assigned automatically by PISA wheel fitting.
The final assignment of our α4-TM2 PISEMA spectra matches very
well with a 2-D projection of the leucine distribution along helical axis
from N- to C-terminus in the solution NMR structure [36]. The
assignment also agrees well with that for δ–TM2 nAChR [33].
The orientational order parameter, SiCD, of the ith CD bond vector
can relate to the residual quadrupolar splitting, ΔνiQ, in a 2H NMR
spectrum using the equation [43]
ΔmiQ =
3
2
AQ
3 cos2 θ − 1
2
SCDi ð1Þ
where AQ=e2Qq/h=167 kHz is the static deuterium quadrupolar
coupling constant for aliphatic CD bonds, θ is the angle between the
bilayer normal and the magnetic field.
2.4. The Na+ flux assay and confocal fluorescence microscopy
The Na+ flux assay, as measured by the enhancement of Sodium
Green™ dye (Invitrogen, Carlsbad, CA) fluorescence due to Na+ entry
into vesicles through open nAChR channels, is an effective way to
assess nAChR activity macroscopically. We prepared 30 mM large
lamellar vesicles with 250 μM α4β2. The vesicles contain phospha-
tidylcholine (PC) and phosphatidylglycerol (PG) in a 4:1 molar ratio
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methods [32-34], including PISEMA [33]. However, no solid-state
NMR study on neuronal nAChR has been reported previously. In the
present study, we embedded the second transmembrane domains
(TM2) of α4β2 nAChR in lipid bicelles, which served as membrane
mimetic media and magnetically aligned the protein. The structural
and dynamic properties of the TM2 α4β2 nAChR in the absence and
presence of anesthetics halothane or isoflurane were investigated
using solid state NMR, especially PISEMA experiments. Anesthetics
were found to affect both helical tilting and rotational motions that
have been identified computationally as critical elements for ion
channel functions. This study suggested that anesthetics could alter
these motions to modulate channel functions.
2. Materials and methods
2.1. Materials and sample preparation
The second transmembrane (TM2) domains of the human nAChR
were obtained by solid phase synthesis [35,36]. The α4 and β2 TM2
domains have the sequences of EKITLCISVLLSLTVFLLLITE and
EKMTLCISVLLALTVFLLLISK, respectively. In order to simplify the
studies, only seven leucine residues in α4 TM2 domain, as indicated
in bold letters, were 15N labeled.
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL). A
conventional protocol of bicelle preparation [37] was followed. 1,2-
dimyristoyl-sn-glycero-3-phosphocoline (DMPC) and 1,2-dihexyl-sn-
glycero-3-phosphocholine (DHPC) were mixed in a desired molar
ratio (q=3.2). Lipid concentration was 28% of sample volume
(typically 220 μL). To extend sample stability for samples containing
the nAChR TM2 domains, 1,2-O-ditetradecyl-sn-glycero-3-phospho-
coline (14-O-PC)) and 1,2-O-dihexyl-sn-glycero-3-phosphocholine
(6-O-PC) replaced DMPC and DHPC, respectively. A small amount of
deuterated DMPCd54 (∼1 mg) was added to each sample for 2H NMR.
The α4 or β2 TM2 was dissolved in 100 μL trifluoroethanol and added
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removed under a stream of nitrogen gas, followed by further evapo-
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prepared by adding 110 μL of deuterium-depleted water to dried
14-O-PC and 6-O-PC/peptide. The 14-O-PC suspension was vortexed
extensively followed by three freeze/thaw cycles (liquid nitrogen/
42 °C). The 14-O-PC suspension at 42 °C was then added to the 6-O-
PC/peptide, followed by vortexing and three freeze/thaw cycles.
Slow-speed centrifugation was sometimes necessary to remove air
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was viscous at 38 °C and fluid at 4 °C. Parallel-oriented peptide-
containing bicelles were prepared by adding 100 mM YbCl3 6H2O to
the peptide-bicelle solution to reach a final lanthanide concentra-
tion of 3 mM. The sample was transferred to a 5-mm OD glass tube
(New Era Enterprises, Newfield, NJ) using a pre-cooled pipet tip at
4 °C. The glass tube was sealed with a tight fitting rubber cap and
further sealed with hard bees wax. The α4-TM2 concentration was
7.4 mM in the α4 samples and 3 mM in the α4β2 samples. The molar
ratio of β2 toα4 was 1.5 in the α4β2 samples to ensure a formation of
(α4)2(β2)3. The peptide to lipid ratio is ∼1:60. Anesthetics halothane
(2-bromo-2-chloro-1,1,1-trifluoro-ethane) and isoflurane (2-chloro-
2-(difluoromethoxy)-1,1,1-trifluoro-ethane) were added directly to
the NMR tube (pre-cooled in an ice bath) and mixed thoroughly with
the samples. The anesthetic concentrations were determined using
19F NMR with 5 mM trifluoroacetic acid (TFA) as a reference.
2.2. NMR spectroscopy
All solid state NMR experiments were performed at 40 °C on a
Bruker Avance 600 MHz NMR spectrometer equipped with a 1H/31P/
15N(2H) Bruker flat-coil probe. 19F NMR experiments were performed
on a Bruker Avance 600 spectrometer with a Bruker TXO probe. The 1-
D 15N cross-polarization experiments were conducted using a 1H 90°
pulse of 5.1 μs, a 49 kHz 1H-decoupling field, 1 ms contact time, 3 s
recycle delay, and 10,000 scans. The same cross-polarization para-
meters were used in the 2-D 15N-1H PISEMA [38]. Other parameters
included ±35 kHz frequency jumps for the Lee-Goldberg condition,
400–1000 scans, and 6–8 s recycle delay. The 1H carrier frequencywas
set at ∼4.5 ppm on parallel oriented bicelle samples. The 15N chemical
shift frequencies were referenced to solid ammonium sulfate at
26.8 ppm (relative to liquid ammonia at 0 ppm). The 2H NMR
experiments were performed using a solid echo sequence ((pi/2)− τ
− (pi/2)− τ). The 90° pulse length was 2 μs and τ values were ∼40 μs
(perpendicular bicelle) and ∼20 μs (parallel bicelle). The recycle delay
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All NMR spectra were processed using NMRPipe [39] and analyzed
using Sparky [40]. The data from PISEMA experiments were fitted to
the PISA (Polarity Index Slant Angle) [41,42] wheels using the
program developed by Veglia's group [26]. The tilt angle (θ) of the
helix axis with respect to the bicelle normal, rotation angle (ρ) of the
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(δ), and the dipolar coupling constant (KDD) were determined via
fittings. The principal values of the 15N chemical shift tensors [24] for
non-glycine residues, σ11=64 ppm, σ22=77 ppm, and
σ33=217 ppm, were adopted for the fittings. These values were
multiplied uniformly by a factor of 0.95 to accommodate reduced 15N
chemical shift anisotropy of proteins in bicelles, as reflected in the
reduction of spectral span of the same proteins in bicelles in
comparison to those in mechanically aligned lipids.
The TM2 chemical shift assignments were accomplished by
combining several sources of information, including the previous
assignments of δ–TM2 nAChR [33], the solution NMR structure of β2-
TM2 nAChR [36], and the best fitting of PISA wheel. L19 is distinctly
separated from the rest of leucine residues in a top view of the NMR
structure (pdb code: 2K59) [36]. L19 also has weaker NMR signal than
other leucines, presumably because it is located at the lipid-water
interface and has less protection from solvent exchange. The distinct
location and intensity of L19 convinced us to assign L19 to the most
downfield peak in the α4-TM2 PISEMA spectra. Once L19 is defined,
the rest of peaks were assigned automatically by PISA wheel fitting.
The final assignment of our α4-TM2 PISEMA spectra matches very
well with a 2-D projection of the leucine distribution along helical axis
from N- to C-terminus in the solution NMR structure [36]. The
assignment also agrees well with that for δ–TM2 nAChR [33].
The orientational order parameter, SiCD, of the ith CD bond vector
can relate to the residual quadrupolar splitting, ΔνiQ, in a 2H NMR
spectrum using the equation [43]
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where AQ=e2Qq/h=167 kHz is the static deuterium quadrupolar
coupling constant for aliphatic CD bonds, θ is the angle between the
bilayer normal and the magnetic field.
2.4. The Na+ flux assay and confocal fluorescence microscopy
The Na+ flux assay, as measured by the enhancement of Sodium
Green™ dye (Invitrogen, Carlsbad, CA) fluorescence due to Na+ entry
into vesicles through open nAChR channels, is an effective way to
assess nAChR activity macroscopically. We prepared 30 mM large
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[44]. PC and PG were mixed in chloroform.α4 and β2 were mixed in a
molar ratio of 2:3 and dissolved in TFE. The dissolved lipids and α4β2
were mixed and dried to a thin film. Residual organic solvent was
removed by vacuum overnight. The lipid–protein mixture was
hydrated with a buffer solution at pH 7.5 containing 20 mM Tris,
50 mM CaCl2, and 6uMmembrane impermeable Sodium Green™. The
vesicles were obtained by incubating the lipid–protein solution at
42 °C overnight and subsequentmultiple cycles of freeze and thaw. An
extensive dialysis was performed to remove Sodium Green™ dye
outside the vesicles.
The Na+ flux assay was performed using an Olympus Fluoview300
Confocal Laser Scanning head with an Olympus IX70 inverted
microscope (Olympus, Melville, NY). Sodium Green™ was excited
by the 488-nm argon laser line and the emission was detected using
sharp cutoff 510IF long-pass and BA530RIF short-pass filters. For each
measurement, 50 μL vesicles containing α4β2 were added into a tray
coated with poly-lysine that facilitated vesicle adhesion due to the
interactions between negatively charged PG and positively charged
poly-lysine. The image acquisition began before the addition of an
isotonic 100 mM NaCl solution to the media outside the vesicles and
continued for 200 s after the exposure to Na+. The program
MetaMorph was used for analyzing the image data.
3. Results and discussion
3.1. Anesthetic effects on bicelles
Solid-state 2H NMR spectra of bicelles with deuterated DMPCd54, as
shown in Fig. 1, provided insight of lipid alignment and dynamics. The
high-resolution 2H NMR spectra with distinguished quadrupolar
splittings in Fig. 1A and 1B attested that the bicelles, without
incorporating proteins, were well oriented. The quadrupolar splitting
of individual 2H peaks corresponding to carbon positions close to the
tail of the aliphatic chains showed little difference in Fig. 1A and 1B,
suggesting that anesthetic halothane molecules had no access to the
hydrophobic tail region. However, halothane diffused to the carbon
positions close to the glycerol group, as evidenced by significantly
broadened 2H signals of the region in Fig. 1B. The order parameters of
individual C-2H bonds of DMPCd54, SCD, were calculated using Eq. (1)
in the presence and absence of 6mMhalothane. SCD normally contains
information on (a) collective motions of lipids, including bicelle
wobbling, (b) trans-gauche isomerizations around C-C bonds of lipids,
and (c) the anisotropic reorientation of a whole lipid molecule.
Collective motions of lipids were small in our systems, in which a 72%
hydration level was remained and bicelles were well magnetically
oriented. A recent comprehensive NMR analysis also suggested a good
bicelle alignment at such a hydration level [45]. The contribution of
anisotropic lipid reorientation to SCD was expected to be uniform for
all C–2H bonds linked to a rigid structure. Therefore, a small increase
in SCD values in the presence of halothane in Fig. 2 predominately
resulted from orientation of the C–2H bonds with respect to the
principal axis of motion of individual lipid molecule. However, since
only the readable quadrupolar splitting was used for SCD calculations,
the disordered component reflected in the broader peaks might be
underestimated in Fig. 2.
Fig. 1C and D shows the solid-state 2H NMR spectra of the bicelles
incorporated with the (α4)2(β2)3 TM2 in the absence and presence of
6mM anesthetic isoflurane, respectively. The bicelles were flipped 90°
by YbCl3 so that their quadropolar splittings were double of that in Fig.
1A and 1B. The presence of the (α4)2(β2)3 TM2 made the 2H peaks
much broader, presumably because the lipid bilayer was severely
disturbed by the insertion of the TM2 domains. A small amount of
lipids were in isotropic phase after incorporating TM2 domains into
the bicelles and the amount increased upon addition of 6 mM
isoflurane, as reflected in the peak at zero frequency. The degree of
anesthetics-induced 2H peak broadening in Fig. 1D seemed to bemore
severe than that in Fig. 1B, especially to the carbon positions at the
middle of DMPC aliphatic chains. Formation of the (α4)2(β2)3
channels might facilitate anesthetic diffusion into the deep bilayer
where anesthetics normally have less access. Direct interactions
between anesthetics and transmembrane proteins were observed
previously [35,46-48]. Anesthetics could modulate protein dynamics
directly and allosterically [46]. Such changes in protein motions could
affect lipids surrounding proteins and contribute to the observed lipid
peak broadening in Fig. 1D.
3.2. TM2 domains in channel and non-channel forms
The α4 and β2 subunits of nAChR need to be in 2:3 stoichiometry
to form pentameric channels [49]. Our Na+ flux experiments
confirmed that ion channels could be formed by combining the α4
and β2 TM2 domains in a 2:3 molar ratio, but not by the α4 TM2
domain alone. As shown in Fig. 3, large vesicles made of phosphati-
dylcholine (PC) and phosphatidylglycerol (PG) with (α4)2(β2)3 TM2
could be easily identified. A time-dependent increase of sodium green
fluorescence intensity upon injection of 10 μL 100 mM NaCl signaled
channel formation. Control vesicles without channels showed no
increase in fluorescence intensity, nor did the channel-containing
vesicles when isotonic CaCl2 was added instead of the NaCl solution.
The same experiment was also performed on the PC-PG vesicles
containing the α4 TM2 domain alone and found no indication of
Fig. 1. 2H NMR spectra of perdeuterated DPMCd54 phospholipids embedded in (A) a
pure DMPC/DHPC (q=3.2) bicelle system; (B) after adding 6 mM halothane to the
system in (A); (C) the 4OPC/6OPC bicelle system incorporated with (α4)2(β2)3 nAChR
TM2 domains; (D) after adding 6mMhalothane to the system in (C). The bicelle normal
was perpendicular to the magnetic field in (A) and (B), parallel to the magnetic field in
(C) and (D) due to the addition of 3mM lanthanide. The spectra were acquired with the
solid echo pulse sequence at 40 °C. The spectrum center was arbitrarily set to 0 Hz.
Fig. 2. C-2H order parameter SCD as a function of DPMCd54 carbon positions in the
absence (▵) and presence (▪) of 6 mM anesthetic halothane.
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channel formation, suggesting different topology and dynamics of the
α4 and (α4)2(β2)3 TM2 assemblies.
3.2.1. PISEMA: Effect of β2 TM2 on α4 TM2
The solid state 1H-15N dipolar /15N chemical shift correlation
PISEMA spectra of the 15N-Leu labeled α4 TM2 in Fig. 4 demon-
strated distinct differences in the absence and presence of the
unlabeled β2 TM2. Wheel-like patterns in the PISEMA spectra of
parallel 14-O-PC/6-O-PC bicelles confirmed the transmembrane
helical structure of the TM2 domains [36]. Six out of seven total
leucine residues of the α4 TM2 showed amide 15N resonances
between ∼180 and 200 ppm. Their resonance patterns are similar
to those composed by the TM2 of the δ nAChR [33]. Leu 5 at the
N-terminus of the TM2 did not show up in this region of PISEMA
spectra, confirming our early solution NMR finding that Leu 5 was not
part of the TM2 helix [36]. Leu 19 resides close to the C terminus of
the TM2. Its relatively weak intensity in the PISEMA spectra is
probably due to a conformational exchange and less efficient cross-
polarization in the dynamic C-terminal region. The most downfield
15N chemical shift in the PISEMA spectra is ∼12 ppm smaller than the
conventional value of σ33 (217 ppm), suggesting a more dynamical
environment in bicelles.
Although the α4 TM2 had a single set of 15N-Leu resonances in the
PISEMA spectrum in Fig. 4, the presence of unlabeled β2 TM2 brought
up several minor resonances for the (α4)2(β2)3 TM2. Leu10, Leu17,
and Leu13 showed almost the same 15N chemical shifts in both major
and minor resonances, but their dipolar couplings were about 1 kHz
greater in the minor resonances. Although it was almost impossible to
accurately define topology of the minor conformation due to too few
numbers of resonances, the chemical shift and dipolar coupling data
suggested that the helix tilt angle relative to the bicelle normal must
be smaller in the minor conformation than in the major population
[41,42]. The minor peaks might also result from a sub-population α4
TM2 in a slightly different motional environment.
A more noticeable difference between the α4 and (α4)2(β2)3
spectra in Fig. 4 is the shift of the amide resonances along both 15N
chemical shift and 1H-15N dipolar coupling axis. Leu11 and Leu18 of
the α4 TM2 experienced relatively small shifts before and after
mixingwith the β2 TM2, but Leu10, Leu13, Leu17 and Leu19 hadmore
profound changes. It is plausible that Leu11 and Leu18 have
experienced little interaction with residues in other helices. The
best fitting of all downfield resonances to ideal PISA wheels revealed
the helical tilt angles of 12±1° and 16±1° of the α4 TM2 and the
(α4)2(β2)3 TM2, respectively. The rotation angle, ρ, was 65° for both
α4 and (α4)2(β2)3. The tilt angle of 12° for the α4 TM2 in bicelles
agrees with the result of the δ nAChR [33], where the δ TM2 helix was
also tilted 12° relative to the normal of mechanically oriented DMPC
bilayers. Neitherα4 nor δ subunit could form nAChR channels without
partitioning of other subunit types [49]. The tilt angle of 16±1° of the
(α4)2(β2)3 TM2 is comparable to the tilt angle of 15±2° found for the
GABAA receptor TM2 domain, an anion channel-forming peptide, by a
recent solid-state NMR study [18].
It is worth mentioning that all the resonances in our PISEMA
spectra resulted solely from the 15N-Leu residues of the α4 TM2. The
unlabeled β2 TM2 did not generate 15N NMR signals. If the α4 TM2
was isolated from the β2 TM2, the (α4)2(β2)3 TM2 would give the
same PISEMA spectrum as the α4 TM2. The notable difference
between the two spectra in Fig. 4 prove that the α4 TM2 must have
interacted with the β2 TM2 in the (α4)2(β2)3 TM2 sample. A
thorough NMR characterization of oligomerization states of 2H
selective labeled transmembrane peptides in oriented lipid bilayers
was demonstrated previously [50]. The same method can also be
applied to the α4 and β2 TM2 if proper labeled samples become
available. Nevertheless, the data in Fig. 4 indicate that interaction
Fig. 3. (A) Confocal fluorescence images of large unilamellar vesicles (LUV) made of
phosphatidylcholine and phosphatidylglycerol containing α4β2 nAChR channels after
exposure to ∼100 mM NaCl solution at different time points. Membrane-impermeable
Sodium Green fluorescent dyes were enclosed and trapped inside the LUVs to indicate
intra-vesicle Na+ concentration. The fluorescence intensity of the vesicles with α4β2
channels increased significantly within a short period of time after exposure to extra-
vesicle NaCl, indicating an influx of Na+ through the channels. (B) The intensity
changes in the circled vesicles over time after the exposure to extra-vesicle Na+. The
background refers to the region without vesicles. The control refers to vesicles without
channels, whose fluorescence intensity remained constant before and after exposure to
extra-vesicle Na+.
Fig. 4. PISEMA spectra of the 15N-Leu labeled α4 TM2 in the absence (black) and
presence (green) of unlabeled β2 TM2. Best fit simulations to the PISEMA data reveal
the helical tilt angles of 12±1° and 16±1° of the α4 TM2 and the (α4)2(β2)3 TM2,
respectively. The notable difference between two PISEMA spectra suggests that the α4
TM2 must have experienced the existence of the β2 TM2 in the (α4)2(β2)3 TM2
sample.
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between α4 and β2 subunits that might be the driving force for
assembling a functional channel. The larger helix tilt angle found in
the (α4)2(β2)3 TM2 supported the previous prediction that channel
opening might involve tilting of pore lining helices [10,12,51,52].
3.3. Anesthetic effect on the TM2 domains
Fig. 5 displays an overlay of the PISEMA spectra of the α4 TM2 in
the absence and presence of 6 mM halothane. Halothane lowered 1H-
15N dipolar coupling and 15N chemical shift of six leucine residues
noticeably. The data fitting into PISA wheels provided a helical tilt
angle of 14° in the presence of halothane. The dipolar coupling
constant, KDD, decreased from 8700 to 8100 KHz, but the rotational
angle (ρ = 65°) and the angle between N-H bone and helix axis
(δ=13°) remained the same in the absence and presence of 6 mM
halothane.
In comparison to the α4 TM2, the (α4)2(β2)3 TM2 seemed less
susceptible to anesthetics. Fig. 6 shows the PISEMA spectra of the
(α4)2(β2)3 TM2 before and after adding 12 mM anesthetic isoflurane.
The helix tilt angle of the (α4)2(β2)3 TM2 with respect to the bicelle
normal changed less than 1° (θ =16.5°). The KDD value changed from
8400 to 7900 KHz. The other two parameters, ρ=65° and δ =13°,
remain unchanged. To the majority of the (α4)2(β2)3 TM2 in the
sample, anesthetic isoflurane had a subtle but real impact on their
helical orientation in bicelles. The anesthetic-induced changes in the
major resonance pattern also implicate the possibility of a wobbling
motion of the helix axis with respect to the bicelle normal [53]. Those
aforementioned minor resonances of Leu10, Leu13, and Leu17 shown
in Fig. 4 disappeared after adding 6 mM isoflurane to the sample (see
the on-line supporting information). However, another subset of
minor resonances appeared upon further increasing the isoflurane
concentration to 12 mM, as shown in Fig. 6. The new minor peaks,
labeled as L19′, L11′, L13′ L17′, and L19′ in Fig. 6, appeared as if they
resulted from corresponding major resonances rotating ∼50° coun-
terclockwise around the helical axis. Distinct major and minor
resonances signify that the helix rotational motion was on a time
scale slower than 10–4 s [54]. Both tilting and rotational motions of the
TM2 helices are critical elements for channel functions [10]. Our data
reveal that anesthetic molecules are able to alter motions of the TM2
helices that could account, at least partially, for anesthetic inhibition
effects on the α4β2 nAChR [7].
It is not surprising to observe different responses of the α4 TM2
and the (α4)2(β2)3 to anesthetics, considering that one might exist as
monomer but the other could form channels. Without the presence of
the β2 TM2, the α4 TM2 interacted loosely with other α4 TM2 helices
so that individual helix orientation was affected by anesthetics more
severely. In a pentameric (α4)2(β2)3 TM2, the helix tilting in respect
to the bicelle normal became less sensitive to the addition of
anesthetics, presumably due to stronger interaction between the α4
TM2 and its adjacent β2 TM2. One may wonder if small changes in
helix orientation induced by anesthetics, either through tilting or
rotational motion, are significant enough to alter channel functions.
The X-ray structures of pentameric ion channels from bacterial
demonstrated that the pore-lining TM2 domains in closed- and open-
channel conformations differ by merely 9° rotation around an axis
that is parallel to the membrane normal [12-14], suggesting that a
small change in the TM2 orientation could elicit a sizable change in
channel functions. Although further structural and dynamical inves-
tigations on integral α4β2 nAChR are necessary to define a final
answer, the present study highlights the possibility that anesthetics
may modulate the channel function via altering the motion as well as
orientation of the pore-ling domain.
4. Conclusions
Several key findings emerged from the current study. First,
transmembrane proteins could facilitate anesthetic diffusion into
deep membrane bilayers even though anesthetics normally prefer
amphiphilic lipid-water interface region [55]. Consequently, anes-
thetics affected lipid alignment and conformation more severely in
bicelles containing proteins. Secondly, the α4 TM2 could not form
channels unless it had been mixed with the β2 TM2. The interactions
between the α4 and β2 TM2 subunits do exist and such interactions
may be essential to drive channel formation. Thirdly, general
anesthetics could perturb orientations of the transmembrane helices
in lipid bilayers and introduce changes in helical motions. The
observed anesthetic effects on the tilt and rotational angles of pore
lining TM2 helices reveal a potential pathway for anesthetic inhibition
of channel functions. A more challenging question has arisen based on
the current study: how do anesthetics make changes in transmem-
brane protein orientations and motions that are related to protein
functions? This is certainly a question worth further investigation.
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